<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":7246,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
United States v. Loughner, 672 F.3d 731 (9th Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/172c55d351f5030f8037b1b2000320c9'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/172c55d351f5030f8037b1b2000320c9'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>
<div class='document_search_links_container printHide'>
<div class='prev_search_result_container'>
<div class='attachmentPanelBackButton' onclick="document.location = $('.prev_search_result_link a').attr('href')"></div>
<div class='prev_search_result_link'>
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1H7E1U003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1H7E1U003">Previous Result: <span>Fitzgerald v. McHan, No. 4:12CV00080 JLH...</span></a>
<div class='clearfix'></div>
</div>
</div>
<div class='next_search_result_container'>
<div class='next_search_result_link'>
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1H7E26003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1H7E26003">Next Result: <span>Fatemi v. White, No. 4:11-ev-458-DPM, 20...</span></a>
<div class='clearfix'></div>
</div>
<div class='attachmentPanelForwardButton' onclick="document.location = $('.next_search_result_link a').attr('href')"></div>
</div>
<div class='clearfix'></div>
</div>
<div class='clearfix'></div>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation distinguished" title="Distinguished"></div>
<div class='title left' title='United States v. Loughner, 672 F.3d 731 (9th Cir. 2012), Court Opinion'>
United States v. Loughner, 672 F.3d 731 (9th Cir. 2012), Court Opinion
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>United States v. Loughner, 672 F.3d 731 (9th Cir. 2012), Court Opinion</div>
<div class='docId'>X1H7D5I003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>United States v. Loughner</div>
<div class='displayCitation'>2012 BL 51594</div>
<div class='displayCitation'>672 F.3d 731</div>
<div class='displayCitation'>wkf9case:25811545</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1H7D5I003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="United States v. Loughner, 672 F.3d 731 (9th Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="United States v. Loughner" />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1H7D5I003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1H7D5I003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1H7D5I003" /><input id="title" name="title" type="hidden" value="United States v. Loughner, 672 F.3d 731 (9th Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="DISTINGUISHED" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="172c55d351f5030f8037b1b2000320c9" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1H7D5I003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="false" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2F%31%37%32c%35%35d%33%35%31f%35%30%33%30f%38%30%33%37b%31b%32%30%30%30%33%32%30c%39%2Fdocument%2FX%31H%37D%35I%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/bcite/X1H7D5I003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/bcite/X1H7D5I003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/bcite/X1H7D5I003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/related_content/X1H7D5I003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1691585413123";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">672 F.3d 731</div>
<div class="cite" data-cite-type="DocketNumber">Nos. 11-10339, 11-10504, 11-10432.</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 51594</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Ninth Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
UNITED STATES of America, Plaintiff-Appellee, v. Jared Lee LOUGHNER,
Defendant-Appellant.
</center></p>
<hr align="center" width="65%">
<p><center>
Nos. 11-10339, 11-10504, 11-10432.
</center></p>
<p><center>
March 5, 2012.
</center></p>
<span CLASS="page_no" data-cite="672 f 3d 732" data-cite-type="PrimaryFederalReporter" data-cite-pageno="732" data-primary-citation="672 F.3d 731">[*732]</span> <div id="contentOpinion" printdualcolumn="true">
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
[EDITORS' NOTE:  THIS PAGE CONTAINS HEADNOTES. HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
<span CLASS="page_no" data-cite="672 f 3d 733" data-cite-type="PrimaryFederalReporter" data-cite-pageno="733" data-primary-citation="672 F.3d 731">[*733]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
[EDITORS' NOTE:  THIS PAGE CONTAINS HEADNOTES. HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
<span CLASS="page_no" data-cite="672 f 3d 734" data-cite-type="PrimaryFederalReporter" data-cite-pageno="734" data-primary-citation="672 F.3d 731">[*734]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
[EDITORS' NOTE:  THIS PAGE CONTAINS HEADNOTES. HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
<span CLASS="page_no" data-cite="672 f 3d 735" data-cite-type="PrimaryFederalReporter" data-cite-pageno="735" data-primary-citation="672 F.3d 731">[*735]</span> 
</p></div>
</div>
<div id="para2" printdualcolumn="true"><p>
  Judy Clarke, Clark &amp; Rice, APC; Mark Fleming, Law
Office of Mark Fleming; Reuben Camper Cahn, Ellis M. Johnston
III, Janet Tung, Federal Defenders of San Diego, Inc., San
Diego, CA, for the appellant.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Ann Birmingham Scheel, Acting United States Attorney, Dennis K.
Burke, United States Attorney, Christina M. Cabanillas,
Appellate Chief, Bruce M. Ferg, Assistant United States
Attorney, United States Department of Justice, Tucson, AZ, for
the appellee.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Aaron M. Panner, Kellogg, Huber, Hansen, Todd, Evans
&amp; Figel, PLLC, Washington, D.C., for Amici American Psychiatric
Association and the American Academy of Psychiatry and the Law.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Appeal from the United States District Court for the
District of Arizona, Larry A. Burns, District Judge, Presiding.
D.C. No. 4:11-cr-00187-LAB-1.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Before: J. CLIFFORD WALLACE, MARSHA S. BERZON, and JAY S.
BYBEE, Circuit Judges.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Opinion by Judge BYBEE; Concurrence by Judge WALLACE; Dissent
by Judge BERZON.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                 <b>OPINION</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  BYBEE, Circuit Judge:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  San Francisco, California<a HREF="#fn*00" name="fnref_fn*00">[fn*]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Jared Lee Loughner stands accused of the January 2011 murder of
six people, including U.S. District Judge John Roll, and the
attempted murder of thirteen others, including U.S.
Representative Gabrielle Giffords. Loughner was committed to a
Bureau of Prisons ("BOP") medical facility to determine if he
was competent to stand trial. After the medical staff concluded
that he was not competent, the district court ordered him
committed for a period of four months to determine if he could
be restored to competency. While he was in custody, the
facility determined that Loughner was a danger to himself or
others and conducted hearings pursuant to
28 C.F.R. &sect; 549.46(a), referred to as <i>Harper</i> hearings, to
determine if he could be involuntarily medicated. <i>See</i>
<i>Washington v. Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. 210</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=108%20l%20ed%202d%20178&amp;summary=yes#jcite">108 L.Ed.2d 178</a> (1990). The district court denied Loughner's
emergency motion to enjoin the involuntary medication decision
of June 14, 2011. The appeal from that order is before us as
<cite>No. 11-10339</cite>. In the interim, Loughner was involuntarily
medicated on an emergency basis pursuant to
28 C.F.R. &sect; 549.43(b) (2010) and the district court denied Loughner's
emergency motion for a prompt post-deprivation judicial
hearing. The appeal from that order is before us as
No. <cite>11-10432</cite>. The district court likewise denied Loughner's
emergency motion to enjoin the involuntary medication decision
of September 15, 2011. Subsequently, the district court ordered
Loughner's commitment to be extended by an additional four
months to render him competent to stand trial. <i>See</i>
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d). The appeal from the September
<span CLASS="page_no" data-cite="672 f 3d 736" data-cite-type="PrimaryFederalReporter" data-cite-pageno="736" data-primary-citation="672 F.3d 731">[*736]</span> 
15 involuntary <span CLASS="page_no" data-cite="2012 bl 51594 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[**2]</span> medication and extension of commitment
orders is before us as No. <cite>11-10504</cite>. We affirm both orders at
issue in appeal No. <cite>11-10504</cite>. We dismiss appeals No. <cite>11-10339</cite>
and No. <cite>11-10432</cite> as moot.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                      I. BACKGROUND AND PROCEEDINGS
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On March 3, 2011, a federal grand jury indicted Jared Lee
Loughner for multiple criminal offenses arising from a January
8, 2011, shooting incident in Tucson, Arizona, in which six
people were killed and thirteen people were injured. The
charges included the attempted assassination of Congresswoman
Gabrielle D. Giffords, the murder of Federal Judge John M.
Roll, the murder and attempted murder of other federal
employees, injuring and causing death to participants at a
federally provided activity, and several related weapons
offenses.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  At a detention hearing on January 10, 2011, the district court
determined that Loughner was a danger to the community and
should be federally detained pending trial. Magistrate Judge
Lawrence O. Anderson found that there was no condition or
combination of conditions that would reasonably assure the
safety of the community, and ordered Loughner committed to the
custody of the Attorney General for confinement in a
corrections facility.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On March 9, 2011, the district court granted the government's
motion for a competency examination to be conducted at the U.S.
Medical Center for Federal Prisoners in Springfield, Missouri
("FMC-Springfield"), by BOP medical personnel, pursuant to
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU2E003?jcsearch=18%20usc%204247&amp;summary=yes#jcite">18 U.S.C. &sect; 4247</a>. BOP psychologist Dr. Christina Pietz and
court-appointed psychiatrist Dr. Matthew Carroll determined
that Loughner was not, at that time, competent to stand trial
and diagnosed him with schizophrenia. The district court
agreed, and on May 25, 2011, ordered Loughner committed for a
four-month period of hospitalization at FMC-Springfield to
determine whether he could be restored to competency, pursuant
to <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(1)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(1).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
A. <i>Involuntary Medication</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  After he was returned to FMC-Springfield, Dr. Pietz asked
Loughner, "on a daily basis," if he was willing to take
psychotropic medication voluntarily, but Loughner consistently
declined to engage in such treatment.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  1. <i>Harper I</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On June 14, FMC-Springfield staff conducted an administrative
hearing, pursuant to the procedures outlined in
28 C.F.R. &sect; 549.43<a HREF="#fn100" name="fnref_fn100">[fn1]</a> and <i>Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. 210</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>,
to determine whether Loughner should be forcibly medicated on
dangerousness grounds ("<i>Harper I</i> hearing"). Dr. Carlos
Tomelleri, an independent psychiatrist not involved in
Loughner's diagnosis or treatment, presided over the <i>Harper</i>
<i>I</i> hearing, and Dr. Pietz and Dr. Robert Sarrazin,
Loughner's treating psychiatrist, also participated. John
Getchell, a licensed clinical social worker ("LCSW"), was
appointed by FMC-Springfield to serve as Loughner's staff
representative in the administrative hearing process. According
to Getchell, he met with Loughner the day before the hearing to
explain his (Getchell's) role in the proceeding, the purpose of
the hearing, Loughner's rights, and to answer any questions
Loughner may have about the process. In a written statement,
Getchell
<span CLASS="page_no" data-cite="672 f 3d 737" data-cite-type="PrimaryFederalReporter" data-cite-pageno="737" data-primary-citation="672 F.3d 731">[*737]</span> 
stated that he informed Loughner of his right to have
witnesses <span CLASS="page_no" data-cite="2012 bl 51594 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[**3]</span> present at the hearing, but that Loughner did not
wish to have any witnesses present. Before the hearing,
Getchell again asked if Loughner wanted any witnesses and
Loughner responded, "Just my attorney." Getchell then notified
Dr. Pietz and Dr. Tomelleri of Loughner's "request to have an
attorney present for the proceeding."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The <i>Harper I</i> hearing took place in Loughner's cell. At
the outset, Loughner said "You have to read me the Bill of Rights
or I won't talk to you" and "I'm not an American
citizen." After Dr. Tomelleri explained that that was not
part of the hearing procedure, Loughner barricaded himself behind
his bed and refused to participate in the hearing, even though
he was encouraged to do so by Dr. Pietz, Dr. Sarrazin, and Mr.
Getchell. When he finally spoke, Loughner stated he would
"plead the fifth," he denied that he had a mental illness, and
he responded "No" when asked if he would consider taking
medication that would improve his condition. There is no record
of Getchell making any statements or inquiries on Loughner's
behalf.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In the Involuntary Medication Report, Dr. Tomelleri authorized
involuntary medication after finding that Loughner's mental
disease made him a danger to others. In the Justification
section of the report, Dr. Tomelleri explained that Loughner
had become enraged while being interviewed and yelled
obscenities; had thrown objects, including plastic chairs and
toilet paper; had spat on his attorney, lunged at her, and had
to be restrained by staff; and his behavior had been
characterized by indications that he was experiencing auditory
hallucinations, including inappropriate laughter, poor eye
contact, yelling "No!" repeatedly, and covering his ears.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Noting that Loughner had been diagnosed with schizophrenia, Dr.
Tomelleri explained in the report that "[t]reatment with
psychotropic medication is universally accepted as the choice
for conditions such as Mr. Loughner's." Dr. Tomelleri rejected
other, less intrusive measures (e.g., psychotherapy, minor
tranquilizers, seclusion and restraints), because they "are not
practicable," "do not address the fundamental problem," "have
no direct effect on the core manifestations of the mental
disease," or "are merely temporary protective measures with no
direct effect on mental disease."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner was advised that if involuntary medication was
approved, he would have twenty-four hours to appeal the
decision to the Administrator of the Mental Health Division.
With the help of Getchell, Loughner submitted a written appeal
that was laced with profanities. The Associate Warden of Health
Services ("Associate Warden") denied the appeal. The Associate
Warden restated the evidence and found that "[w]ithout
psychiatric medication, you are dangerous to others by engaging
in conduct, like throwing chairs, that is either intended or
reasonably likely to cause physical harm to another or cause
significant property damage. . . . At this time, medication is
the best treatment for your symptoms."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On June 21, 2011, FMC-Springfield began medicating Loughner as
prescribed by Dr. Sarrazin. <span CLASS="page_no" data-cite="2012 bl 51594 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[**4]</span> After becoming aware of Loughner's
involuntary medication, defense counsel filed an emergency
motion in the district court on June 24, asking the court to
enjoin FMC-Springfield from forcibly medicating Loughner.
Loughner argued that the involuntary medication order violated
his substantive due process rights by treating his mental
illness without considering less intrusive methods to
ameliorate his dangerousness; failed to consider
<span CLASS="page_no" data-cite="672 f 3d 738" data-cite-type="PrimaryFederalReporter" data-cite-pageno="738" data-primary-citation="672 F.3d 731">[*738]</span> 
how the medication would implicate his fair trial rights;
and violated his procedural due process rights, as a pretrial
detainee, because the hearing should have been held before a
court, Loughner's requested witness should have been called,
and the specific drug and dosage that would be administered
should have been set out in the hearing.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On June 29, 2011, the district court held a hearing on the
motion. At the hearing, defense counsel requested an
evidentiary hearing and the opportunity to present testimony
from a former BOP official and a forensic psychiatrist
experienced in prison administration and forced medication
decisions. The district court denied both the motion and the
request for an evidentiary hearing, first in an oral order from
the bench, and then in a written order. In the written order,
the district court explained that because Loughner was being
medicated on dangerousness grounds, the substantive and
procedural standards described in the Supreme Court's decisions
in "<i>Harper</i>, and not <i>Riggins</i><a HREF="#fn200" name="fnref_fn200">[fn2]</a> or
<i>Sell</i>,<a HREF="#fn300" name="fnref_fn300">[fn3]</a> applies," and "<i>Harper</i> is clear
that doctors, not lawyers and judges, should answer the
question whether an inmate should be involuntarily medicated to
abate his dangerousness and maintain prison safety." Order on
Defs Mot. to Enjoin Medication 3, July 1, 2011. The court
rejected any argument that Loughner was entitled to the higher
substantive due process rights afforded in <i>Riggins</i> and
<i>Sell</i> because of his status as a pretrial detainee,
finding that a "dangerous individual is dangerous, whether he
is a pretrial detainee or has been convicted and sentenced."
<i></i><cite>Id. at 4</cite>. The district court also rejected any
argument that the staff at FMC-Springfield operates under a
structural conflict of interest.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  To determine the appropriate standard of review for
FMC-Springfield's decision to medicate forcibly a pretrial
detainee on dangerousness grounds pursuant to <i>Harper</i>,
the district court adopted the holding and rationale of
<i>United States v. Morgan</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3OCSV?jcsearch=193%20f%203d%20252&amp;summary=yes#jcite">193 F.3d 252</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3OCSV?jcsearch=193%20f%203d%20252&amp;summary=yes#jcite">262</a> (4th
Cir. 1999). In that decision, the Fourth Circuit found that the
dangerousness determination is to be made by prison medical
personnel and that the court's involvement should be limited to
a review for arbitrariness. The district court found that the
procedures followed by FMC-Springfield staff at the <i>Harper</i>
<i>I</i> hearing, and the findings of the presiding psychiatrist,
were not arbitrary. In response to Loughner's argument that he
was denied his right to call a witness, the district court
agreed "with the apparent interpretation of [the request] by
[Loughner's] staff representative who . . . construed the
statement <span CLASS="page_no" data-cite="2012 bl 51594 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[**5]</span> as a request for legal representation at the hearing,
to which he is not entitled." Order on Def.'s Mot. to Enjoin
Medication 7-8.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner filed a Notice of Appeal from the district court's
order on July 1, 2011, and sought an emergency stay of forced
medication from this court (No. 11-10339). A motions panel
granted a temporary stay of forced medication that evening.
After hearing oral arguments on the emergency motion, the
motions panel issued an order on July 12, 2011, staying
involuntary administration of all psychotropic medication until
resolution of this appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  2. Emergency Medication Decision
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  After medication was discontinued on July 1, Loughner's
condition deteriorated significantly. On July 8, because of
perceived changes in his behavior, FMC-Springfield placed
Loughner on suicide watch. On July 18, FMC-Springfield doctors
<span CLASS="page_no" data-cite="672 f 3d 739" data-cite-type="PrimaryFederalReporter" data-cite-pageno="739" data-primary-citation="672 F.3d 731">[*739]</span> 
determined that Loughner was a severe danger to himself and
needed to be administered antipsychotic medication on an
emergency basis, pursuant to 28 C.F.R. &sect; 549.43(b).<a HREF="#fn400" name="fnref_fn400">[fn4]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On July 22, 2011, we denied Loughner's emergency motion seeking
to enforce the July 12 involuntary medication injunction. On
August 11, 2011, Loughner filed an Emergency Motion for Prompt
Post-Deprivation Hearing on Forced Medication, asking the
district court to enjoin the emergency medication
determination. After argument on August 26, 2011, the district
court denied Loughner's motion. On August 29, 2011, Loughner
filed a Notice of Appeal from that decision (<cite>No. 11-10432</cite>).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  3. <i>Harper II</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On August 25, 2011, FMC-Springfield conducted a second
<i>Harper</i> hearing ("<i>Harper II</i>"), pursuant to
28 C.F.R. &sect; 549.46(a), and Dr. Tomelleri found continued
medication justified based on Loughner's danger to himself.
Although it appears that Loughner again requested Anne Chapman,
one of his attorneys, to attend as a witness, she was contacted
only after the hearing took place and then informed of
Loughner's request. Getchell, again acting as Loughner's staff
representative, filed an administrative appeal after Loughner
declined to complete the form himself. On appeal, the Associate
Warden determined that a statement from Loughner's requested
witness, Ms. Chapman, should have been obtained before, and not
after, the hearing. The appeal was therefore granted, pending a
new hearing.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  4. <i>Harper III</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  FMC-Springfield conducted a third <i>Harper</i> hearing
("<i>Harper III</i>") on September 15, 2011, with Dr.
Tomelleri again presiding. Loughner again requested Ms. Chapman
as a witness. This time, Ms. Chapman was contacted and
permitted to submit a written statement, which contained legal
objections to the continuing involuntary medication. According
to the Involuntary Medication Report, Dr. Tomelleri authorized
involuntary medication based on a finding that Loughner was a
danger to himself. In the Justification section of the report,
Dr. Tomelleri cited the deterioration of Loughner's condition
after psychotropic medication was discontinued in July. The
report indicates that many of Loughner's most serious symptoms
had receded since involuntary medication recommenced pursuant
to the July emergency <span CLASS="page_no" data-cite="2012 bl 51594 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[**6]</span> order, but noted that Loughner "still
exhibits a tendency toward motor restlessness and pacing, . . .
cries frequently, and expresses intense feelings of guilt." Dr.
Tomelleri noted that Dr. Pietz had expressed concern about
Loughner's potential for suicide, and at one point Loughner had
asked her, "How did you know I was going to hang myself?"
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The report noted Loughner's then-current medication regimen: 3
mg of risperidone (antipsychotic), twice a day; 300 mg of
buproprion XL (antidepressant); 1 mg of benztropine
(anti-cholinergic to control side effects of antipsychotics),
twice a day; 1 mg of clonazepam (anxiolytic), twice a day and 2
mg at bedtime. Finding that "psychotropic medication is the
treatment of choice," Dr. Tomelleri noted that other measures
did not address the fundamental problem or had no direct effect
on the core manifestations of Loughner's mental condition. The
report concluded that "[d]iscontinuation of current medications
is virtually certain to result in an exacerbation of Mr.
Loughner's illness as it did when medication was discontinued
in July."
<span CLASS="page_no" data-cite="672 f 3d 740" data-cite-type="PrimaryFederalReporter" data-cite-pageno="740" data-primary-citation="672 F.3d 731">[*740]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Getchell filed an appeal on Loughner's behalf. On the appeal
form, Getchell relayed that Loughner wanted to appeal because
he "do[esn't] do drugs." The Associate Warden upheld the
involuntary medication determination, finding that
"[m]edication is the least intrusive treatment for you at this
time."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On September 23, 2011, Loughner filed an emergency motion in
the district court to enjoin the involuntary medication
authorized by the <i>Harper III</i> hearing. Loughner
reiterated arguments raised in his prior involuntary medication
challenges and, particular to this hearing, argued that BOP
failed to find that the medication was necessary to treat his
dangerousness and that his staff representative had provided
inadequate assistance.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court denied Loughner's motion at a hearing on
September 28, 2011, and again in a September 30 written order.
During the hearing, the district court noted that the
involuntary medication of Loughner is "predicated on the ground
of dangerousness and really has nothing to do with his
competency," and thus, those with medical training and
experience "who have interaction with Mr. Loughner on a daily
basis are in the best position to assess whether he's a danger
to himself and to assess his institutional needs." Status Hr'g
Tr. 295, Sept. 28, 2011. In the written order, the district
court reiterated that the "decision to medicate Mr. Loughner to
prevent him from harming himself or others is best made by
prison doctors following <i>administrative</i> procedures,"
and that the only issue for the court was whether the decision
to medicate involuntarily was factually or procedurally
deficient. Order Extending Restoration Commitment 5, Sept. 30,
2011. Finding no merit in Loughner's challenge to the adequacy
of his staff representative, the court concluded that there was
"no defect in the <i>Harper</i> hearing conducted on
September 15." <i></i><cite>Id. at 6</cite>. The district court therefore
denied the motion to enjoin Loughner's involuntary medication,
and Loughner appealed (<span CLASS="page_no" data-cite="2012 bl 51594 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[**7]</span> <cite>No. 11-10504</cite>).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
B. <i>Extension of Commitment</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Independent of the question whether Loughner could be
involuntarily medicated because he was a danger to himself, the
district court also addressed whether Loughner's commitment at
FMC-Springfield could be extended to render him competent to
stand trial. <i>See</i> <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2). On August
22 and September 7, 2011, Dr. Pietz provided the district court
with reports summarizing Loughner's hospital course at
FMC-Springfield between May 27 and August 22, 2011; his current
mental status and psychiatric treatment; and her opinion as to
the likelihood that he could be restored to competency and the
length of time it would likely take. Dr. Pietz reported that
although. Loughner presently remained incompetent to stand
trial, she believed that "he w[ould] likely be[come] competent
in the near future." She could not predict with any degree of
certainty how much additional time was needed, but stated that
"[h]istorically, most defendants reach competency within 8
months of their commitment." She then recommended a four-month
extension for purposes of restoring Loughner to
competency.<a HREF="#fn500" name="fnref_fn500">[fn5]</a> Loughner objected to the extension of his
commitment under <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On September 28, the district court conducted an evidentiary
hearing to determine
<span CLASS="page_no" data-cite="672 f 3d 741" data-cite-type="PrimaryFederalReporter" data-cite-pageno="741" data-primary-citation="672 F.3d 731">[*741]</span> 
whether there was a substantial probability that Loughner
could be restored to trial competency in a reasonable period of
time. The government submitted exhibits and presented testimony
from Dr. Pietz and Dr. James Ballenger, a clinical
psychiatrist, to support its request for an extension of time.
The defense submitted several exhibits, and cross-examined the
government's witnesses, but did not call any witnesses of its
own.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  At the hearing, Dr. Pietz described her observations of
Loughner and discussed the differences in his behavior and
abilities before medication was administered and since being
medicated. Dr. Pietz testified that, in her opinion, Loughner
has not experienced any significant side effects from the
medication. She acknowledged, however, that the medication may
be contributing to the flat, expressionless affect Loughner
displayed when medication resumed. Dr. Pietz noted that
Loughner is clearly improving: he no longer responds to
internal stimuli, his thoughts are more rational and organized,
he is better able to concentrate and hold conversations, and he
is becoming more aware of how others perceive him. Overall, Dr.
Pietz testified that Loughner is still depressed, but that his
cognitive abilities and functioning have improved, and he is
more oriented, less delusional, and less obsessed. Based on
these observations, Dr. Pietz testified that she believes
Loughner can be restored to competency.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Dr. Ballenger, who had not examined Loughner, testified about
the rates and likelihood of restoration generally and about the
history and side effects of first-and second-generation
antipsychotic drugs. He testified that, in his experience, a
very high percentage of people in Loughner's condition are
restored to functional competency in the clinical <span CLASS="page_no" data-cite="2012 bl 51594 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[**8]</span> setting
within one year of being medicated, with most of the
improvement occurring between months three and twelve. He
explained that restoration was indicated by the fact that such
patients are no longer as delusional, are more organized in
thought, can focus and concentrate, and show improvement in
taking care of themselves. Dr. Ballenger testified that he had
reviewed Loughner's history and medication and, in his opinion,
the current medication regimen is "highly appropriate." Dr.
Ballenger concluded that, in light of Dr. Pietz's testimony and
his own review of the records in this case, Loughner would
likely be restored to trial competency within "two to six,
eight more months."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court held that because the burden of proof for
granting an extension of commitment under <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">&sect; 4241(d)(2)</a> is
"substantial probability," the government must demonstrate that
Loughner is "likely" to attain competency within a reasonable
time. Relying on reports submitted by Dr. Pietz before the
hearing, and the testimony of Dr. Pietz and Dr. Ballenger at
the hearing, the district court found that the evidence
established that it is likely that Loughner will become
competent to stand trial in this case and extended Loughner's
commitment under <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">&sect; 4241(d)(2)</a> for four months. Loughner
appealed the district court decision, and that appeal is before
us now (No. <cite>11-10504</cite>).<a HREF="#fn600" name="fnref_fn600">[fn6]</a>
<span CLASS="page_no" data-cite="672 f 3d 742" data-cite-type="PrimaryFederalReporter" data-cite-pageno="742" data-primary-citation="672 F.3d 731">[*742]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                            II. JURISDICTION
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Before turning to the merits, we first address our jurisdiction
over Loughner's appeals.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
A. <i>The Basis for the District Court's Authority</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In No. <cite>11-10504</cite>, Loughner appeals the district court's denial
of his motion challenging FMC-Springfield's September 15
decision authorizing involuntary medication.<a HREF="#fn700" name="fnref_fn700">[fn7]</a> The district
court's ruling, from which Loughner appealed, was a pretrial
order. As the court overseeing Loughner's criminal prosecution,
the district court has the authority to review Loughner's
motion to enjoin forcible medication. <i>See</i>
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHTGO003?jcsearch=18%20usc%203231&amp;summary=yes#jcite">18 U.S.C. &sect; 3231</a>. The district court's order "embodied legal
conclusions related to [FMC-Springfield]'s administrative
efforts to medicate [Loughner]; these efforts grew out of
[Loughner]'s provisional commitment; and that provisional
commitment took place pursuant to an earlier [district court]
order seeking a medical determination about [Loughner]'s future
competence to stand trial." <i>Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 175</a>,
<cite>123 S.Ct. 2174</cite> (citing <i>Riggins</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. 127</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>; <i>Stack v. Boyle</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C26R?jcsearch=342%20us%201&amp;summary=yes#jcite">342 U.S. 1</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C26R?jcsearch=342%20us%201&amp;summary=yes#jcite">6-7</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C26R?jcsearch=72%20supreme%20court%201&amp;summary=yes#jcite">72 S.Ct. 1</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C26R?jcsearch=96%20l%20ed%203&amp;summary=yes#jcite">96 L.Ed. 3</a> (1951)). The district court's authority to review
pretrial orders, therefore, gave it authority to review the
involuntary medication of Loughner. <i>See Riggins</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. 127</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a> (reviewing trial court's denial of
defendant's motion to suspend administration of medication
during trial); <i>United States v. Weston</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3F9L5?jcsearch=206%20f%203d%209&amp;summary=yes#jcite">206 F.3d 9</a>
(D.C. Cir. 2000) (reviewing district court's order upholding
BOP's decision to medicate involuntarily Weston);
<i>Morgan</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3OCSV?jcsearch=193%20f%203d%20252&amp;summary=yes#jcite">193 F.3d at 257-59</a> (reviewing district court's
order authorizing forcible medication pursuant to the
administrative determination after the district court rejected
Morgan's motion to enjoin).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In No. <cite>11-10504</cite>, Loughner appeals from the district court's
order extending his commitment to FMC-Springfield. The district
court has the authority to extend <span CLASS="page_no" data-cite="2012 bl 51594 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[**9]</span> Loughner's commitment
pursuant to <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
B. <i>Appellate Jurisdiction</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Ordinarily, an appellate court may hear appeals only from a
district court's final decision. <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEIMU8003?jcsearch=28%20usc%201291&amp;summary=yes#jcite">28 U.S.C. &sect; 1291</a>. Under
the collateral order doctrine, however, we may review a
district court's preliminary or interim decision when it: "(1)
conclusively determines the disputed question, (2) resolves an
important issue completely separate from the merits of the
action, and (3) is effectively unreviewable on appeal from a
final judgment." <i>Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 176</a>, <cite>123 S.Ct. 2174</cite>
(quoting <i>Coopers &amp; Lybrand v. Livesay</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X2N6QC?jcsearch=437%20us%20463&amp;summary=yes#jcite">437 U.S. 463</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X2N6QC?jcsearch=437%20us%20463&amp;summary=yes#jcite">468</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X2N6QC?jcsearch=98%20supreme%20court%202454&amp;summary=yes#jcite">98 S.Ct. 2454</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X2N6QC?jcsearch=57%20l%20ed%202d%20351&amp;summary=yes#jcite">57 L.Ed.2d 351</a> (1978)) (internal
quotation marks omitted); <i>see also Cohen v. Beneficial</i>
<i>Indus. Loan Corp.</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X2N62K?jcsearch=337%20us%20541&amp;summary=yes#jcite">337 U.S. 541</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X2N62K?jcsearch=337%20us%20541&amp;summary=yes#jcite">546</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X2N62K?jcsearch=69%20supreme%20court%201221&amp;summary=yes#jcite">69 S.Ct. 1221</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X2N62K?jcsearch=93%20l%20ed%201528&amp;summary=yes#jcite">93 L.Ed. 1528</a> (1949).
<span CLASS="page_no" data-cite="672 f 3d 743" data-cite-type="PrimaryFederalReporter" data-cite-pageno="743" data-primary-citation="672 F.3d 731">[*743]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court's involuntary medication order falls within
the collateral order doctrine.<a HREF="#fn800" name="fnref_fn800">[fn8]</a> First, the order
conclusively determined the disputed question &mdash; whether
there is any legal basis to medicate Loughner forcibly and
whether Loughner has a legal right to a judicial hearing before
involuntary medication. <i>See Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 176</a>,
<cite>123 S.Ct. 2174</cite>; <i>Morgan</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3OCSV?jcsearch=193%20f%203d%20252&amp;summary=yes#jcite">193 F.3d at 259</a>. Second, the
involuntary medication issue is important and completely
separate from the merits of the action &mdash; i.e., whether
Loughner is guilty or innocent of the crimes charged. <i>See</i>
<i>Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 176</a>, <cite>123 S.Ct. 2174</cite>; <i>Morgan</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3OCSV?jcsearch=193%20f%203d%20252&amp;summary=yes#jcite">193 F.3d at 259</a>. Finally, the issue is effectively unreviewable
because "[b]y the time of trial [Loughner] will have undergone
forced medication &mdash; the very harm that he seeks to
avoid." <i>Sell</i> <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 176-77</a>, <cite>123 S.Ct. 2174</cite>. We
therefore have appellate jurisdiction, under the collateral
order doctrine, to review the district court's involuntary
medication order. <i>See United States v. Ruiz-Gaxiola</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1E7A46003?jcsearch=623%20f%203d%20684&amp;summary=yes#jcite">623 F.3d 684</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1E7A46003?jcsearch=623%20f%203d%20684&amp;summary=yes#jcite">688</a> (9th Cir. 2010); <i>United States v.</i>
<i>Grape</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1A7982003?jcsearch=549%20f%203d%20591&amp;summary=yes#jcite">549 F.3d 591</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1A7982003?jcsearch=549%20f%203d%20591&amp;summary=yes#jcite">597</a> (3d Cir. 2008).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court's commitment order is also appealable under
the collateral order doctrine. <i>See United States v.</i>
<i>Friedman</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X6BFA3?jcsearch=366%20f%203d%20975&amp;summary=yes#jcite">366 F.3d 975</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X6BFA3?jcsearch=366%20f%203d%20975&amp;summary=yes#jcite">978-79</a> (9th Cir. 2004). First, the
order "conclusively determines [Loughner]'s `present right to
be at liberty prior to trial.'" <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X6BFA3?jcsearch=366%20F.3d%20975&amp;summary=yes#jcite">Id. at 979</a> (quoting
<i>United States v. Gold</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XABTAU?jcsearch=790%20f%202d%20235&amp;summary=yes#jcite">790 F.2d 235</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XABTAU?jcsearch=790%20f%202d%20235&amp;summary=yes#jcite">239</a> (2d
Cir. 1986)). Second, "the issue of involuntary commitment is
completely separate from the issue of whether [Loughner]
committed the crime with which he is charged," and is important
because it implicates his freedom. <i>Id.</i> And finally,
the order is effectively unreviewable because "nothing could
recover for [Loughner] the time lost during his confinement."
<i>Id.</i> at 979 (quoting <i>Gold</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XABTAU?jcsearch=790%20f%202d%20235&amp;summary=yes#jcite">790 F.2d at 239</a>).
Therefore, we have appellate jurisdiction to review the
district court's commitment order as well.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                 III. THE INVOLUNTARY MEDICATION ORDERS
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner raises both substantive and procedural due process
challenges to his involuntary medication.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  "[T]he substantive issue involves a definition of
  th[e] protected constitutional interest, as well as
  identification of the conditions under which competing
  state interests might outweigh it. The procedural
  issue concerns the minimum procedures required by the
  Constitution for determining that the individual's
  liberty interest actually is outweighed in a
  particular instance."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i>Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 220</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a> (alterations
in original) (quoting <i>Mills v. Rogers</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CAA9?jcsearch=457%20us%20291&amp;summary=yes#jcite">457 U.S. 291</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CAA9?jcsearch=457%20us%20291&amp;summary=yes#jcite">299</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CAA9?jcsearch=102%20supreme%20court%202442&amp;summary=yes#jcite">102 S.Ct. 2442</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CAA9?jcsearch=73%20l%20ed%202d%2016&amp;summary=yes#jcite">73 L.Ed.2d 16</a> (1982)). In other words, the
<span CLASS="page_no" data-cite="672 f 3d 744" data-cite-type="PrimaryFederalReporter" data-cite-pageno="744" data-primary-citation="672 F.3d 731">[*744]</span> 
substantive issue is "what factual circumstances must
exist" before the government may involuntarily medicate
Loughner; the procedural issue is whether the government'<span CLASS="page_no" data-cite="2012 bl 51594 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[**10]</span> s
nonjudicial process used to determine the facts was sufficient.
<i>See id.</i><a HREF="#fn900" name="fnref_fn900">[fn9]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The determination of the appropriate constitutional standard
that governs a particular inquiry is a question of law subject
to de novo review. <i>See Pierce v. Multnomah Cnty., Or.</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3PH9P?jcsearch=76%20f%203d%201032&amp;summary=yes#jcite">76 F.3d 1032</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3PH9P?jcsearch=76%20f%203d%201032&amp;summary=yes#jcite">1042</a> (9th Cir. 1996). Factual findings are
reviewed for clear error. <i>See United States v.</i>
<i>Hinkson</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1C391Q003?jcsearch=585%20f%203d%201247&amp;summary=yes#jcite">585 F.3d 1247</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1C391Q003?jcsearch=585%20f%203d%201247&amp;summary=yes#jcite">1260</a> (9th Cir. 2009) (en banc).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We first address the contours of Loughner's substantive due
process right and then turn to his objections to the procedures
afforded by 28 C.F.R. &sect; 549.46.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
A. <i>Substantive Due Process Standard</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The parties dispute the proper substantive due process standard
that applies when the government seeks to medicate forcibly a
pretrial detainee on the grounds that he is a danger to himself
or others. The government argues that the standard announced in
<i>Harper</i> applies; Loughner argues that the heightened
standards enunciated in <i>Riggins</i> and <i>Sell</i>
should apply instead. As we explain below, neither
<i>Harper</i> nor <i>Riggins</i> addresses the precise
question at issue here. <i>Sell</i> suggests an answer, and
we and every court of appeals to apply this framework has
assumed that the Court answered the question in <i>Sell</i>
Consistent with <i>Sell's</i> suggestion, we hold that the
standard announced in <i>Harper</i> applies with equal force
in the context of pretrial detainees.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  1. <i>Harper, Riggins</i>, and <i>Sell</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>Washington v. Harper</i> is the seminal involuntary
medication case. <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. 210</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. It involved a
prisoner's substantive and procedural due process challenge to
a Washington state prison regulation authorizing the forcible
medication of an inmate suffering from a mental disorder if he
was "gravely disabled or pose[d] a likelihood of serious harm
to himself, others, or their property." <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20210&amp;summary=yes#jcite">Id. at 215</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a> (internal quotation marks omitted). Harper
argued that, under the Due Process Clause, the State of
Washington could not override his choice to refuse
antipsychotic drugs absent a finding of incompetence and
substituted judgment that, if he were competent, he would
consent to drug treatment. <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20210&amp;summary=yes#jcite">Id. at 222</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>.
The Court framed the substantive issue as: "what factual
circumstances must exist before the State may administer
antipsychotic drugs to the prisoner against his will."
<i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20210&amp;summary=yes#jcite">Id. at 220</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Court began its analysis by recognizing that inmates
possess "a significant liberty interest in avoiding the
unwanted administration of antipsychotic drugs under the Due
Process Clause of the <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/1?citation=US%20CONST%20AMEND%20XIV&amp;summary=yes#jcite">Fourteenth Amendment</a>." <i></i><cite>Id.
at 221-22</cite>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. This liberty interests stems
<span CLASS="page_no" data-cite="672 f 3d 745" data-cite-type="PrimaryFederalReporter" data-cite-pageno="745" data-primary-citation="672 F.3d 731">[*745]</span> 
from both the drugs' intended mind-altering effects and
from their "serious, even fatal, side effects" &mdash;
including acute dystonia ("severe involuntary spasm of the
upper body, tongue, throat, or eyes"), akathisia "(motor
restlessness, often characterized by an inability to sit
still)," neuroleptic malignant syndrome "(a relatively rare
condition which can lead to death from cardiac dysfunction),"
and tardive dyskinesia ("a neurological disorder, irreversible
in some cases, that is characterized by involuntary,
uncontrollable movements of various muscles, especially around
the face").<a HREF="#fn1000" name="fnref_fn1000">[fn10]</a> <i></i><cite>Id. at 229-30</cite>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Court recognized, <span CLASS="page_no" data-cite="2012 bl 51594 p 11" data-cite-type="Bloomberg" data-cite-pageno="11" data-primary-citation="">[**11]</span> however, that an inmate's liberty
interest in avoiding unwanted medication must be "defined in
the context of the inmate's confinement." <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20210&amp;summary=yes#jcite">Id. at 222</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. Specifically, the Court noted "the need to
reconcile our longstanding adherence to the principle that
inmates retain at least some constitutional rights despite
incarceration with the recognition that prison authorities are
best equipped to make difficult decisions regarding prison
administration." <i></i><cite>Id. at 223-24</cite>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. To
accommodate this need, the Court reiterated that "the proper
standard for determining the validity of a prison regulation
claimed to infringe on an inmate's constitutional rights is to
ask whether the regulation is `reasonably related to legitimate
penological interests.'" <i></i><cite>Id. at 223</cite>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>
(quoting <i>Turner v. Safley</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBGD?jcsearch=482%20us%2078&amp;summary=yes#jcite">482 U.S. 78</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBGD?jcsearch=482%20us%2078&amp;summary=yes#jcite">89</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBGD?jcsearch=107%20supreme%20court%202254&amp;summary=yes#jcite">107 S.Ct. 2254</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBGD?jcsearch=96%20l%20ed%202d%2064&amp;summary=yes#jcite">96 L.Ed.2d 64</a> (1987)). Among the factors that determine
the reasonableness of a prison regulation, the Court found
three particularly relevant in the context of involuntary
medication: (1) "there must be a valid, rational connection
between the prison regulation and the legitimate governmental
interest put forward to justify it"; (2) "a court must consider
the impact accommodation of the asserted constitutional right
will have on guards and other inmates, and on the allocation of
prison resources generally"; and (3) "the absence of ready
alternatives is evidence of the reasonableness of a prison
regulation." <i></i><cite>Id. at 224-25</cite>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a> (internal
quotation marks omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Applying these factors to the Washington regulation, the Court
concluded that the policy comported with constitutional
requirements. <i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20210&amp;summary=yes#jcite">Id</a>.</i> at 225, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. Having
deprived inmates of their liberty, the State has an obligation
to provide prisoners with medical treatment consistent with
both the inmates' and the institution's needs. <i><cite>Id.</cite></i>
Thus, when the root cause of the inmate's threat is his mental
disability, "the State's interest in decreasing the danger
<span CLASS="page_no" data-cite="672 f 3d 746" data-cite-type="PrimaryFederalReporter" data-cite-pageno="746" data-primary-citation="672 F.3d 731">[*746]</span> 
to others necessarily encompasses an interest in providing
him with medical treatment for his illness." <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20210&amp;summary=yes#jcite">Id.
at 225-26</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. Therefore, the Court determined that
involuntary medication is a rational means of furthering the
State's legitimate objectives: the interest in "ensuring the
safety of prison staffs and administrative personnel," and the
"duty to take reasonable measures for the prisoners' own
safety." <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20210&amp;summary=yes#jcite">Id. at 225</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. Finally, the
Court found that the government was not required to adopt the
alternative means proffered by Harper (seclusion and physical
restraints) because Harper failed to demonstrate that they were
"acceptable substitutes for antipsychotic drugs, in terms of
either their medical effectiveness or their toll on limited
prison resources." <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20210&amp;summary=yes#jcite">Id. at 226-27</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>.
Accordingly, the Court held that "given the requirements of the
prison environment, the Due Process Clause permits the State to
treat a prison inmate who has a serious mental illness with
antipsychotic drugs against his will, if the inmate is
dangerous to himself or others and the treatment is in the
inmate's medical interest." <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20210&amp;summary=yes#jcite">Id. at 227</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Riggins</i>, the Court addressed a slightly different
set of interests: <span CLASS="page_no" data-cite="2012 bl 51594 p 12" data-cite-type="Bloomberg" data-cite-pageno="12" data-primary-citation="">[**12]</span> a criminal defendant's challenge to his
conviction on the grounds that Nevada forced him to take
antipsychotic drugs during his trial. <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. at 128</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>. After being taken into custody, Riggins began
voluntarily taking Mellaril because he was hearing voices and
having trouble sleeping. <i>See </i><cite>id. at 129</cite>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>. As preparations for trial went forward, Riggins asked the
court to suspend the medication until the end of the trial,
arguing that the drugs infringed upon his freedom and would
deny him due process because of their effect on his demeanor
and mental state during trial. <i>See </i><cite>id. at 130</cite>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>. The court held an evidentiary hearing, in which
three different doctors questioned the need for continued
administration of the drugs, and then denied Riggins's motion,
giving no indication for the court's rationale. <i>See</i>
<i></i><cite>id. at 131-32</cite>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>. Riggins continued to be
medicated throughout the trial. <i>See </i><cite>id. at 132</cite>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In reviewing the forced medication of Riggins during trial, the
Supreme Court began from the premise that "[u]nder
<i>Harper</i>, forcing antipsychotic drugs on a convicted
prisoner is impermissible absent a finding of overriding
justification and a determination of medical appropriateness."
<i>Id.</i> at 135, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>. Noting that the
"Fourteenth Amendment affords <i>at least as much</i>
<i>protection</i> to persons the State detains for trial," the
Court held that the government must show both the need for and
the medical appropriateness of anti-psychotic medication.
<i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20U.S.%20128&amp;summary=yes#jcite">Id</a>.</i> (emphasis added).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Court denied that <i>Harper</i> had determined the full
constitutional protections of <i>pretrial</i> detainees.
Admitting that it had "not had occasion to develop substantive
standards for judging forced administration of such drugs in
the trial or pre-trial settings," the Court suggested that
"Nevada certainly would have satisfied due process if the
prosecution had demonstrated, and the District Court had found,
that treatment with antipsychotic medication was medically
appropriate and, considering less intrusive alternatives,
essential for the sake of Riggins' own safety or the safety of
others." <i>Id.</i> The Court explained, however, that it did
not have "occasion to finally prescribe such substantive
standards" because the district court's involuntary medication
order made no determination of the need for the medication and
no findings about reasonable alternatives. <i>Id.</i> at 136,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>. In other words, "[t]he [district] court did not
acknowledge the
<span CLASS="page_no" data-cite="672 f 3d 747" data-cite-type="PrimaryFederalReporter" data-cite-pageno="747" data-primary-citation="672 F.3d 731">[*747]</span> 
defendant's liberty interest in freedom from unwanted
antipsychotic drugs." <i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20U.S.%20128&amp;summary=yes#jcite">Id</a>.</i> at 137, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>. The
Court observed that this failure may have impaired Riggins's
constitutionally protected trial rights &mdash; including "the
substance of his own testimony, his interaction with counsel,
or his comprehension at trial" &mdash; and concluded that there
was no basis for finding that, if Riggins had been affected by
his involuntary medication, any prejudice was justified.
<i>Id.</i> at 137-38, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>. The Court accordingly
reversed the Nevada Supreme Court's decision upholding
Riggins's conviction and remanded for further proceedings.
<i>Id.</i> at 138, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Most recently, in <i>Sell</i>, the Supreme Court set out the
substantive <span CLASS="page_no" data-cite="2012 bl 51594 p 13" data-cite-type="Bloomberg" data-cite-pageno="13" data-primary-citation="">[**13]</span> standards for when the government may administer
anti-psychotic drugs involuntarily to a mentally ill criminal
defendant to render him competent for trial. <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. 166</a>,
<cite>123 S.Ct. 2174</cite>. The Court adopted a more demanding standard for
medicating a defendant facing trial to render that defendant
competent than it required in <i>Harper</i> for medicating a
convicted inmate to render that inmate nondangerous. The Court
held that the government may forcibly medicate a mentally ill
pretrial detainee for the purpose of rendering him competent to
stand trial, but only if a court determines that there are
important governmental trial-related interests at stake; that
involuntary medication will significantly further these
government interests, without causing side effects that will
interfere significantly with the defendant's fair trial rights;
that the medication is necessary to further the government's
interests, taking into account less intrusive alternatives; and
that the administration of the antipsychotic drugs is medically
appropriate, i.e., in the defendant's best medical interest.
<i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20166&amp;summary=yes#jcite">Id. at 180-81</a>, <cite>123 S.Ct. 2174</cite>; <i>see also Witt v.</i>
<i>Dep't of Air Force</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18UGOI003?jcsearch=527%20f%203d%20806&amp;summary=yes#jcite">527 F.3d 806</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18UGOI003?jcsearch=527%20f%203d%20806&amp;summary=yes#jcite">818</a> (9th Cir. 2008)
(referring to <i>Sell</i> as an application of heightened
scrutiny in the substantive due process context).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>Sell</i> came with an important caveat, however. "A court
need not consider whether to allow forced medication for [trial
competency purposes], if forced medication is warranted for a
<i>different</i> purpose, such as the purposes set out in
<i>Harper</i> related to the individual's dangerousness."
<i>Id.</i> at 181-82, <cite>123 S.Ct. 2174</cite>. The Court noted that
there are three reasons for determining whether forced
medication can be justified on alternative grounds before
turning to the trial competency question: First, "the inquiry
into whether medication is permissible . . . to render an
individual nondangerous is usually more `objective and
manageable' than the inquiry into whether medication is
permissible to render a defendant competent." <i>Id.</i>
at 182, <cite>123 S.Ct. 2174</cite> (quoting <i>Riggins</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. at 140</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a> (Kennedy, J., concurring)). Second, "courts
typically address involuntary medical treatment as a civil
matter, and justify it on these alternative,
<i>Harper</i>-type grounds." <i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20166&amp;summary=yes#jcite">Id</a>.</i> Finally, if
medication is authorized on alternative grounds, "the need to
consider authorization on trial competence grounds will likely
disappear." <i>Id.</i> at 183, <cite>123 S.Ct. 2174</cite>. The Court
explained why the purpose of the involuntary medication is
relevant:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Whether a particular drug will tend to sedate a
  defendant, interfere with communication with counsel,
  prevent rapid reaction to trial developments, or
  diminish the ability to express emotions are matters
  important in determining the permissibility of
  medication to restore competence, but not necessarily
  relevant when dangerousness is primarily at issue.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i>Id.</i> at 185, <cite>123 S.Ct. 2174</cite> (citation omitted).
<span CLASS="page_no" data-cite="672 f 3d 748" data-cite-type="PrimaryFederalReporter" data-cite-pageno="748" data-primary-citation="672 F.3d 731">[*748]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  2. Post-<i>Sell</i> Cases
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The parties dispute whether the Supreme Court's precedent
answers the question in this case: what substantive due process
standard must the government satisfy to medicate involuntarily
a pretrial detainee on the ground that he is dangerous? The
government <span CLASS="page_no" data-cite="2012 bl 51594 p 14" data-cite-type="Bloomberg" data-cite-pageno="14" data-primary-citation="">[**14]</span> argues that, because Loughner was being medicated
for dangerousness, he may be medicated following a
<i>Harper</i> hearing, and that <i>Sell</i> approved the
use of "<i>Harper-type</i> grounds" for medicating pretrial
detainees. <i>See Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 182</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">183</a>,
<cite>123 S.Ct. 2174</cite>. Loughner responds that <i>Harper</i> addressed
involuntary medication for convicted inmates, not pretrial
detainees, and that <i>Riggins</i> requires that the
government demonstrate that a pretrial detainee's "treatment
with antipsychotic medication [i]s medically appropriate and,
considering less intrusive alternatives, essential for the sake
of [the pretrial detainee]'s own safety or the safety of
others." <i>Riggins</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. at 135</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Court's cases have not addressed the issue directly. The
Court in <i>Sell</i> seemed to assume, however, that a
<i>Harper</i> hearing would be sufficient to medicate
involuntarily a pre-trial detainee on dangerousness grounds.
More importantly, we have made the same assumption in our prior
discussions of <i>Harper, Riggins</i>, and <i>Sell.</i>
Finally, post-<i>Sell</i>, every court of appeals to have
considered the application of <i>Harper</i> in the pretrial
detainee context has made the same assumption.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The core of Loughner's argument comes from two statements in
<i>Riggins.</i> First, the Court was careful to acknowledge
that <i>Harper</i> involved a convicted prisoner: "Under
<i>Harper</i>, forcing antipsychotic drugs <i>on a convicted</i>
<i>prisoner</i> is impermissible absent a finding of overriding
justification and a determination of medical appropriateness.
The <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/1?citation=US%20CONST%20AMEND%20XIV&amp;summary=yes#jcite">Fourteenth Amendment</a> affords <i>at least</i> as <i>much</i>
<i>protection</i> to persons the State detains for trial."
<i>Riggins</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. at 135</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a> (emphasis
added). That parsing of <i>Harper</i> was followed with this
observation:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although we have not had occasion to develop
  substantive standards for judging forced
  administration of such drugs <i>in the trial or</i>
  <i>pretrial settings</i>, Nevada certainly would have
  satisfied due process if the prosecution had
  demonstrated . . . that treatment with antipsychotic
  medication was medically appropriate and, considering
  less intrusive alternatives, essential for the sake of
  Riggins' own safety or the safety of others.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20U.S.%20at%20135&amp;summary=yes#jcite">Id</a>.</i> (emphasis added). Nothing in the holding of
<i>Sell</i> fills this gap, except for the Court's
significant aside that "if forced medication is warranted for a
<i>different</i> purpose, such as the purposes set out in
<i>Harper</i> related to the individual's dangerousness,"
then the district court need not conduct a <i>Sell</i>
hearing to determine whether a pretrial detainee may be
medicated to render him competent to stand trial.
<i>Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 181-82</a>, <cite>123 S.Ct. 2174</cite>. When the
Court later referred to "<i>Harper</i>-type grounds,"
<i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20166&amp;summary=yes#jcite">id. at 182</a>, <cite>123 S.Ct. 2174</cite>, and failed to renew its
disclaimer that it had not decided the <i>Harper</i> question
for pre-trial detainees,<a HREF="#fn1100" name="fnref_fn1100">[fn11]</a> we and other circuits believed
<span CLASS="page_no" data-cite="672 f 3d 749" data-cite-type="PrimaryFederalReporter" data-cite-pageno="749" data-primary-citation="672 F.3d 731">[*749]</span> 
that the Court had, indeed, decided just such a question.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We first addressed the Supreme Court's trilogy with respect to
a pretrial detainee in <i>United States v.</i>
<i>Rivera-Guerrero</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20f%203d%201130&amp;summary=yes#jcite">426 F.3d 1130</a> (9th Cir. 2005).
Rivera-Guerrero was charged with illegal reentry. <i>See</i>
<i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20F.3d%201130&amp;summary=yes#jcite">id. at 1134</a>. After he was found incompetent to stand
trial, FMC-Springfield requested an order allowing it to
medicate Rivera-Guerrero <span CLASS="page_no" data-cite="2012 bl 51594 p 15" data-cite-type="Bloomberg" data-cite-pageno="15" data-primary-citation="">[**15]</span> to restore his competence to stand
trial. <i>See <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20F.3d%201130&amp;summary=yes#jcite">id</a>.</i> The magistrate judge held a
<i>Sell</i> rather than a <i>Harper</i> hearing and
determined that Rivera-Guerrero could be medicated. <i>See</i>
<i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20F.3d%201130&amp;summary=yes#jcite">id. at 1134-35</a>. We reversed the order on appeal on the
grounds that a pretrial involuntary medication decision could
not be delegated to a magistrate judge. <i>See </i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20F.3d%201130&amp;summary=yes#jcite">id.
at 1136</a>. Following the remand, FMC-Springfield began involuntarily
medicating Rivera-Guerrero on an emergency basis. The district
court thereafter issued an opinion adopting the recommendations
of the magistrate judge &mdash; a nearly identical
justification as the order we previously vacated. <i>See</i>
<i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20F.3d%201130&amp;summary=yes#jcite">id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We began our discussion by noting that "<i>Sell</i> orders
are disfavored. The Supreme Court clearly intends courts to
explore other procedures, such as <i>Harper</i> hearings
(<i>which are to be employed in the case of</i>
<i>dangerousness</i>) before considering involuntary medication
orders under <i>Sell." </i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20F.3d%201130&amp;summary=yes#jcite">Id. at 1137</a> (emphasis added).
Although we reversed for a procedural error in the
<i>Sell</i> proceedings, we noted that because of
Rivera-Guerrero's involuntary medication on dangerousness
grounds and confinement for more than the permissible period of
time, "on remand, conducting a <i>Sell</i> inquiry no longer
constitutes the appropriate procedure." <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20F.3d%201130&amp;summary=yes#jcite">Id. at 1143</a>.
We instructed the district court to order FMC-Springfield to
report on Rivera-Guerrero's medical status. "If the FMC reports
that Rivera-Guerrero has been rendered competent to stand trial
as a result of its administration of the medication, and the
district court accepts that assertion, then the district court
may proceed with the criminal trial. . . ." <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20F.3d%201130&amp;summary=yes#jcite">Id.
at 1144</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>United States v. Hernandez-Vasquez</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20f%203d%20908&amp;summary=yes#jcite">513 F.3d 908</a>
(9th Cir. 2008), we addressed a slightly different circumstance.
The government had charged Hernandez-Vasquez, like
Rivera-Guerrero, with illegal reentry. <i>See </i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20F.3d%20908&amp;summary=yes#jcite">id. at 911</a>.
After the district court found Hernandez-Vasquez incompetent,
he was transferred to FMC-Springfield where the government
requested that he be medicated to render him competent to stand
trial; in the alternative, the government asked that
Hernandez-Vasquez be evaluated for dangerousness. <i>See</i>
<i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20F.3d%20908&amp;summary=yes#jcite">id. at 912</a>. The district court conducted a <i>Sell</i>
hearing and granted the government's motion to medicate
Hernandez-Vasquez to render him competent for trial. <i>See</i>
<i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20F.3d%20908&amp;summary=yes#jcite">id</a>.</i> On appeal, we noted that "a <i>Sell</i> inquiry is
independent of the procedure that allows involuntary medication
of dangerous inmates under <i>Harper." </i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20F.3d%20908&amp;summary=yes#jcite">Id. at 913</a>. We
addressed the question of whether "the district court had an
obligation to apply <i>Harper</i> and make a dangerousness
inquiry before proceeding under <i>Sell</i>," and held that
"[i]f a district court does not conduct a dangerousness inquiry
under <i>Harper</i>, it should state for the record why it is
not doing so." <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20F.3d%20908&amp;summary=yes#jcite">Id. at 914</a>. We concluded that the
district court "should take care to separate the <i>Sell</i>
inquiry from the <i>Harper</i> dangerousness inquiry and not
allow the inquiries to collapse into each other." <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20F.3d%20908&amp;summary=yes#jcite">Id.
at 919</a>.
<span CLASS="page_no" data-cite="672 f 3d 750" data-cite-type="PrimaryFederalReporter" data-cite-pageno="750" data-primary-citation="672 F.3d 731">[*750]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We suppose that a close reading of these cases might yield a
conclusion that our statements regarding <i>Harper<span CLASS="page_no" data-cite="2012 bl 51594 p 16" data-cite-type="Bloomberg" data-cite-pageno="16" data-primary-citation="">[**16]</span> </i> are
dicta. But given the extensive nature of our discussions, our
lack of reservation about applying <i>Harper</i> to pretrial
detainees, and our instructions on remand to conduct "the
<i>Harper</i> dangerousness inquiry," <i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20166&amp;summary=yes#jcite">id</a>.</i>, there is
little doubt that we believe that the standards set forth in
<i>Harper</i> apply to inmates being held by the government,
whether they are awaiting trial or are serving a sentence of
incarceration. <i>See Ruiz-Gaxiola</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1E7A46003?jcsearch=623%20f%203d%20684&amp;summary=yes#jcite">623 F.3d at 689</a>
(referring to the magistrate judge ordering "the government to
conduct an administrative hearing pursuant to <i>Harper</i>"
prior to considering an involuntary medication order under
<i>Sell</i> for a pretrial detainee "[d]ue in part to our
admonition that `<i>Sell</i> orders are disfavored'").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Even if we were inclined to reweigh the factors considered by
the Supreme Court in <i>Harper</i> in the context of a
convicted prisoner, we would arrive at the conclusion that
<i>Harper</i> applies to pretrial detainees as well. Two
points are sufficient. First, we recognize that the most
important factor for determining the appropriate level of
scrutiny is the purpose of the involuntary medication, not the
inmate's criminal status. <i>See United States v.</i>
<i>Baldovinos</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13UO90003?jcsearch=434%20f%203d%20233&amp;summary=yes#jcite">434 F.3d 233</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13UO90003?jcsearch=434%20f%203d%20233&amp;summary=yes#jcite">240</a> (4th Cir. 2006) ("[T]he
Court indicated that the determination of which principles
apply &mdash; those of <i>Harper</i> or those of
<i>Sell</i> &mdash; depends on the purpose for which the
Government seeks to medicate the defendant."); <i>United</i>
<i>States v. Brandon</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X4851T?jcsearch=158%20f%203d%20947&amp;summary=yes#jcite">158 F.3d 947</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X4851T?jcsearch=158%20f%203d%20947&amp;summary=yes#jcite">957</a> (6th Cir. 1998)
("<i>Harper's</i> rationale is based upon the premise that if
the government's action focuses primarily on matters of prison
administration, then the action is proper if reasonably related
to a legitimate penological interest, even if it implicates
fundamental rights."). If the government seeks to medicate
involuntarily a pretrial detainee on trial competency grounds,
that is a matter of trial administration and the heightened
standard announced in <i>Sell</i> applies. <i>See Sell</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 183</a>, <cite>123 S.Ct. 2174</cite>. When dangerousness is a basis
for the involuntary medication, however, as is the case with
Loughner, the concerns are the orderly administration of the
prison and the inmate's medical interests. <i>See Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 222-25</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>; <i>Baldovinos</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13UO90003?jcsearch=434%20f%203d%20233&amp;summary=yes#jcite">434 F.3d at 240</a>; <i>Brandon</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X4851T?jcsearch=158%20f%203d%20947&amp;summary=yes#jcite">158 F.3d at 957</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Second, although we recognize that in certain contexts there
are important differences &mdash; differences of constitutional
magnitude &mdash; between pretrial detainees and convicted
detainees, <i>see Bell v. Wolfish</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9P3?jcsearch=441%20us%20520&amp;summary=yes#jcite">441 U.S. 520</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9P3?jcsearch=441%20us%20520&amp;summary=yes#jcite">537</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9P3?jcsearch=99%20supreme%20court%201861&amp;summary=yes#jcite">99 S.Ct. 1861</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9P3?jcsearch=60%20l%20ed%202d%20447&amp;summary=yes#jcite">60 L.Ed.2d 447</a> (1979) ("This Court has recognized a
distinction between punitive measures that may not
constitutionally be imposed prior to a determination of guilt
and regulatory restraints that may."); <i>Friedman v.</i>
<i>Boucher</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1BM0R6003?jcsearch=580%20f%203d%20847&amp;summary=yes#jcite">580 F.3d 847</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1BM0R6003?jcsearch=580%20f%203d%20847&amp;summary=yes#jcite">853-58</a> (9th Cir. 2009) (holding that
suspicionless, warrantless searches of pretrial detainees that
do not contribute to prison security are unconstitutional, and
distinguishing cases upholding similar searches of convicted
detainees), those differences largely disappear when the
context is the administration of a prison or detention
facility. As the Court stated in <i>Bell</i>,
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  [t]he fact of confinement as well as the legitimate
  goals and policies of the penal institution limits
  . . . retained constitutional rights. There must be a
  mutual accommodation <span CLASS="page_no" data-cite="2012 bl 51594 p 17" data-cite-type="Bloomberg" data-cite-pageno="17" data-primary-citation="">[**17]</span> between institutional needs and
  objectives and the provisions of the Constitution that
  are of general application. <i>This principle applies</i>
  <i>equally to pretrial detainees and convicted,</i>
  <i>prisoners.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9P3?jcsearch=441%20us%20520&amp;summary=yes#jcite">441 U.S. at 546</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9P3?jcsearch=99%20supreme%20court%201861&amp;summary=yes#jcite">99 S.Ct. 1861</a> (1979) (emphasis added)
(citations omitted) (internal
<span CLASS="page_no" data-cite="672 f 3d 751" data-cite-type="PrimaryFederalReporter" data-cite-pageno="751" data-primary-citation="672 F.3d 731">[*751]</span> 
quotation marks omitted); <i>see Bull v. City &amp; Cnty.</i>
<i>of San Francisco</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1CGKTA003?jcsearch=595%20f%203d%20964&amp;summary=yes#jcite">595 F.3d 964</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1CGKTA003?jcsearch=595%20f%203d%20964&amp;summary=yes#jcite">973-74</a> &amp; nn. 10, 11
(9th Cir. 2010) (en banc) ("We have never distinguished between
pre-trial detainees and prisoners in applying the
<i>Turner</i> test, but have identified the interests of
correction facility officials responsible for pretrial
detainees as being `penological' in nature."); <i>United</i>
<i>States v. Hearst</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X44UC4?jcsearch=563%20f%202d%201331&amp;summary=yes#jcite">563 F.2d 1331</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X44UC4?jcsearch=563%20f%202d%201331&amp;summary=yes#jcite">1345</a> n. 11 (9th Cir. 1977)
("All legitimate intrusive prison practices have basically
three purposes: the preservation of internal order and
discipline, the maintenance of institutional security against
escape or unauthorized entry, and the rehabilitation of the
prisoners. The first two interests are implicated regardless of
the status of the prisoner. The third, of course, applies only
to prisoners already convicted of a crime. Accordingly, a
pretrial detainee may assert his status as a shield against
intrusive practices aimed solely at rehabilitation but not
against practices aimed at security and discipline." (citations
omitted) (internal quotation marks omitted)). So long as
Loughner is a pretrial detainee, and lawfully held, his rights
are limited by the facility's legitimate goals and policies,
and his dangerousness to himself or to others may be judged by
the same standard as convicted detainees. <i>See Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 224</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a> ("We made quite clear that the
standard of review we adopted in <i>Turner</i> applies to all
circumstances in which the needs of prison administration
implicate constitutional rights.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finally, we observe that, post-<i>Sell</i>,<a HREF="#fn1200" name="fnref_fn1200">[fn12]</a> every court
of appeals to have considered the interplay between
<i>Harper</i> and <i>Sell</i> &mdash; a context that
necessarily implicates pretrial detainees only &mdash; has
similarly assumed that <i>Harper</i> is the appropriate
standard for measuring whether a pretrial detainee may be
involuntarily medicated because of dangerousness. <i>See</i>
<i>Grape</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1A7982003?jcsearch=549%20f%203d%20591&amp;summary=yes#jcite">549 F.3d at 599</a> ("We do not reach consideration of
the four-factor <i>Sell</i> test unless an inmate does not
qualify for forcible medication under <i>Harper</i>, as
determined at a <i>Harper</i> hearing generally held within
the inmate's medical center."); <i>United States v.</i>
<i>Green</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X19845A003?jcsearch=532%20f%203d%20538&amp;summary=yes#jcite">532 F.3d 538</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X19845A003?jcsearch=532%20f%203d%20538&amp;summary=yes#jcite">545</a> n. 5 (6th Cir. 2008) ("The
<i>Sell</i> standard applies when the forced medication is
requested to restore competency to a pretrial detainee and the
pre-trial detainee is not a danger to himself or others. When
the pretrial detainee is a potential danger to himself or
others, the <i>Harper</i> standard is used."); <i>United</i>
<i>States v. White</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13K1L6003?jcsearch=431%20f%203d%20431&amp;summary=yes#jcite">431 F.3d 431</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13K1L6003?jcsearch=431%20f%203d%20431&amp;summary=yes#jcite">435</a> (5th Cir. 2005);
<i>United States v. Morrison</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X12IL6C003?jcsearch=415%20f%203d%201180&amp;summary=yes#jcite">415 F.3d 1180</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X12IL6C003?jcsearch=415%20f%203d%201180&amp;summary=yes#jcite">1186</a> (10th
Cir. 2005) ("[T]he central role of dangerousness in the
<i>Sell</i> inquiry in this case calls out for proceeding
under <i>Harper</i> first."); <i>Evans</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X120096003?jcsearch=404%20f%203d%20227&amp;summary=yes#jcite">404 F.3d at 235</a>
n. 3 ("The Supreme Court has outlined different tests for when
the government may involuntarily medicate an individual,
depending on whether the medication is for purposes of prison
control or prisoner health on the one hand, <i>see</i>
<i>[Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 227</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>], or, on the
other hand, for the <span CLASS="page_no" data-cite="2012 bl 51594 p 18" data-cite-type="Bloomberg" data-cite-pageno="18" data-primary-citation="">[**18]</span> purpose of prosecuting an incompetent
defendant, <i>see Sell</i>[, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 166</a>,
<cite>123 S.Ct. 2174</cite>]."); <i>see also Morgan</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3OCSV?jcsearch=193%20f%203d%20252&amp;summary=yes#jcite">193 F.3d at 262-63</a>
(pre-<i>Sell</i> case holding that "[u]nder
<span CLASS="page_no" data-cite="672 f 3d 752" data-cite-type="PrimaryFederalReporter" data-cite-pageno="752" data-primary-citation="672 F.3d 731">[*752]</span> 
<i>Harper</i>, due process permits institutional medical
personnel to forcibly treat a pretrial detainee with
antipsychotic medication once they conduct the type of
administrative proceeding the State of Washington employed").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  If there was any remaining doubt in our cases about the proper
standard, we now hold that when the government seeks to
medicate a detainee &mdash; whether pretrial or post-conviction
&mdash; on the grounds that he is a danger to himself or
others, the government must satisfy the standard set forth in
<i>Harper.</i> "[T]he Due Process Clause permits the State to
treat a prison inmate who has a serious mental illness with
antipsychotic drugs against his will, if the inmate is
dangerous to himself or others and the treatment is in the
inmate's medical interest." <i>Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 227</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  3. The Standard Applied
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Having decided that <i>Harper</i> supplies the standard, we
can easily address Loughner's argument. Loughner argues that
FMC-Springfield applied the wrong standard. Based on the
assumption that <i>Riggins</i> governs here, Loughner claims
that FMC-Springfield failed to demonstrate that forcibly
medicating him was (1) medically appropriate and, (2)
"considering less intrusive alternatives, essential for the
sake of [Loughner]'s own safety or the safety of others."
<i>Riggins</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. at 135</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For the reasons we have explained, the <i>Riggins</i>
standard does not govern. We are satisfied that FMC-Springfield
used the proper standard from <i>Harper.</i> At the
<i>Harper III</i> hearing, Dr. Tomelleri heard the evidence
from Loughner's treating psychiatrist and psychologist and
concluded that Loughner was a danger to himself, and that
"[i]nvoluntary medication is . . . in the patient's best
medical interest." Dr. Tomelleri first noted that Loughner "has
a well-documented history of persistent manifestations of
schizophrenia" and that following discontinuation of a previous
medication order, Loughner's condition deteriorated. He further
explained that "[p]sychotropic medication is the treatment of
choice for conditions such as Mr. Loughner is experiencing" and
that "[d]iscontinuation of current medications is virtually
certain to result in an exacerbation of Mr. Loughner's illness
as it did when medication was discontinued in July [2011]."
Even though the facility was not required to demonstrate that
there were no less intrusive alternatives available or that
medication was "essential," <i>Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 226-27</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>, Dr. Tomelleri did note that other
measures were inadequate because they failed to "address the
fundamental problem" or "core manifestations of the mental
illness." Antipsychotics are "one of the most effective means
of treating and controlling a mental illness likely to cause
violent behavior"; the fact that there might be alternative
means for rendering Loughner temporarily harmless (minor
tranquilizers, seclusion and restraints), "do[es] not
demonstrate the invalidity of the [government]'s policy" of
treating the underlying mental disorder. <i>Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 226</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. We reject Loughner's claim that
<span CLASS="page_no" data-cite="2012 bl 51594 p 19" data-cite-type="Bloomberg" data-cite-pageno="19" data-primary-citation="">[**19]</span> FMC-Springfield failed to apply the appropriate substantive
standard.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
B. <i>Procedural Objections</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner raises a number of challenges to the procedures used
by FMC-Springfield to determine that he was a danger to himself
or others and should be involuntarily medicated. We begin with
a discussion of 28 C.F.R. &sect; 549.46, which sets forth BOP's
"[p]rocedures for involuntary administration of psychiatric
medication." Then we address Loughner's
<span CLASS="page_no" data-cite="672 f 3d 753" data-cite-type="PrimaryFederalReporter" data-cite-pageno="753" data-primary-citation="672 F.3d 731">[*753]</span> 
general or facial challenges to these regulations. We then
turn to Loughner's as-applied challenges to the <i>Harper</i>
<i>III</i> hearing held by FMC-Springfield.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  1. BOP's Regulation, 28 C.F.R. &sect; 549.46
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Like the regulation at issue in <i>Harper</i>, &sect; 549.46
requires that "[w]hen an inmate is unwilling or unable to
provide voluntary written informed consent for recommended
psychiatric medication, the inmate will be scheduled for an
administrative hearing." 28 C.F.R. &sect; 549.46(a). The
regulation requires twenty-four-hour written notice of the
hearing and a written "explanation of the reasons for the
psychiatric medication proposal." <i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/1?citation=28%20C.F.R.%20549.46(a)(2)&amp;summary=yes#jcite">Id</a>.</i>
&sect; 549.46(a)(2). The inmate has the right to appear, present
evidence, have a staff representative, request witnesses at the
hearing, and request that his witnesses be questioned by either
his staff representative or the hearing officer. If the inmate
does not request a staff representative, or requests a staff
representative with insufficient experience, the facility
administrator must appoint a qualified staff representative.
<i>See id.</i> &sect; 549.46(a)(3). The hearing officer must
be a psychiatrist who is not the attending psychiatrist and who
is not involved in the diagnosis or treatment of the inmate,
thus ensuring that there is an independent decision maker.
<i>See id.</i> &sect; 549.46(a)(4). The inmate's treating
psychiatrist must attend and present background information and
clinical data relative to the inmate's need for antipsychotic
medication. <i>See id.</i> &sect; 549.46(a)(6). The hearing
officer determines
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  whether involuntary administration of psychiatric
  medication is necessary because, as a result of the
  mental illness or disorder, the inmate is dangerous to
  self or others, poses a serious threat of damage to
  property affecting the security or orderly running of
  the institution, or is gravely disabled (manifested by
  extreme deterioration in personal functioning).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i>Id.</i> &sect; 549.46(a)(7). If the hearing officer
determines that medication is necessary, the inmate has the
right to appeal within twenty-four hours, and the staff
representative must assist in preparing and submitting the
appeal. <i>See id.</i> &sect; 549.46(a)(8). Unless there is a
"psychiatric emergency," no medications may be administered if
the inmate appeals the decision. <i>See id.</i>
&sect; 549.46(a)(9), (b)(1). The appeal will ordinarily be decided
within twenty-four hours. <i>See id.</i> &sect; 549.46(a)(9).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  These regulations are substantially equivalent to the
Washington procedures approved in <i>Harper. See Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 215-16</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. We notice two differences,
however, between the BOP's regulations and Washington's
procedures. First, the Washington policy contained a periodic
review requirement. <i>See <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/1?citation=28%20C.F.R.%20549.46(a)(3)&amp;summary=yes#jcite">id</a>.</i> at 216, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>.
Second, the Washington policy required that the <span CLASS="page_no" data-cite="2012 bl 51594 p 20" data-cite-type="Bloomberg" data-cite-pageno="20" data-primary-citation="">[**20]</span> hearing be held
before a three-person "special committee" comprised of a
psychiatrist, a psychologist, and the Associate Superintendent
of the facility. <i>See id.</i> at 215, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. It is
not clear that either of these procedures are constitutionally
required. <i>Harper</i> simply found them to be
constitutionally sufficient.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  These differences do not render &sect; 549.46 constitutionally
infirm. First, a periodic review requirement is unnecessary in
the context of pretrial detainees because a pretrial detainee's
status is by definition temporary &mdash; after the trial the
defendant will either become a convicted inmate or a free
person. Additionally, the involuntary medication order will
often be part of either a determination of competency, which is
limited to four months, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(1)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(1), or a
restoration to competency, which is limited to "an additional
<span CLASS="page_no" data-cite="672 f 3d 754" data-cite-type="PrimaryFederalReporter" data-cite-pageno="754" data-primary-citation="672 F.3d 731">[*754]</span> 
reasonable period of time," <i><cite>id</cite>.</i> <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">&sect; 4241(d)(2)</a>.
The involuntary medication order is limited precisely because
of the inmate's status, thus diminishing the need for periodic
review. <i>Cf. Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 216</a> n. 4,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a> (noting that the periodic review requirement of the
Washington policy was amended to require biweekly reports to
the Department of Corrections medical director and a new
hearing at the end of 180 days).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Second, unlike the procedures approved in <i>Harper</i>, BOP
provides for a single hearing officer, rather than the
three-person committee provided in Washington's policy.
<i>See</i> 28 C.F.R. &sect; 549.46(a)(4). We do not think a
multi-member committee is constitutionally compelled. Indeed,
the Court in <i>Harper</i> focused only on the fact that a
second psychiatrist &mdash; as a member of the special
committee &mdash; was reviewing the medications prescribed by
the inmate's treating psychiatrist. <i>See Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 222</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a> ("[T]he fact that the medication
must first be prescribed by a psychiatrist, and then approved
by a reviewing psychiatrist, ensures that the treatment in
question will be ordered only if it is in the prisoner's
medical interests. . . ."). BOP's decision to provide a
hearing conducted by a single non-treating psychiatrist is thus
consistent with the Court's analysis in <i>Harper.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We now turn to Loughner's challenges to <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1G2A50003?jcsearch=28%20C.F.R.%20%20549.46&amp;summary=yes#jcite">&sect; 549.46</a> generally
and then to his particular challenges to his <i>Harper</i>
<i>III</i> hearing.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  2. Loughner's General Challenges to 28 C.F.R. &sect; 549.46
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner raises three claims. First, he argues that, as a
pre-trial detainee, he is entitled to a judicial, rather than
an administrative, determination of his dangerousness and the
need for medication. Second, he argues that the government's
burden of proof is clear and convincing evidence. Third, he
argues that he is entitled to be represented at the hearing by
counsel. We think that <i>Harper</i> largely forecloses these
arguments.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                           a. Judicial hearing
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Court in <i>Harper</i> rejected the argument that an
involuntary medication decision based on dangerousness grounds
must be made by a judicial decision maker after a judicial
hearing. Indeed, the Court concluded that "an inmate's
interests are adequately protected, and perhaps better served,
by allowing the decision to medicate to be made by medical
professionals rather than a judge." <i>Id.</i> at 231,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Nevertheless, <span CLASS="page_no" data-cite="2012 bl 51594 p 21" data-cite-type="Bloomberg" data-cite-pageno="21" data-primary-citation="">[**21]</span> citing the "rhythmically insistent pulse of
<i>Sell's</i> refrain," the dissent argues that
"<i>Sell[]</i> and its progeny require <i>the district</i>
<i>court</i> to determine whether a pretrial detainee may be
involuntarily drugged on dangerousness grounds." Dissenting Op.
at 784. But the passage that the dissent relies on, and our
subsequent cases dealing with the <i>Sell/Harper</i>
distinction, is premised on the assumption that the involuntary
medication are being sought "solely for trial competence
purposes." <i>Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 180</a>, <cite>123 S.Ct. 2174</cite>. When
this is the case, <i>Sell</i> clearly mandates that the
district court, using a higher substantive standard, make the
involuntary medication determination. The dissent reads
<i>Sell</i> to mean that the district court, applying the
demanding standard of <i>Sell</i>, may consider whether there
might be alternative means (dangerousness) of justifying the
involuntary medication. Because the issue of dangerousness
could be raised before the court at that point, it would be the
district court that determines whether medication might be
justified on <i>Harper</i>-type grounds. The dissent thus
concludes that
<span CLASS="page_no" data-cite="672 f 3d 755" data-cite-type="PrimaryFederalReporter" data-cite-pageno="755" data-primary-citation="672 F.3d 731">[*755]</span> 
whenever "the government's ultimate aim is restoration of
competency" the "court must <i>itself</i> address the
involuntary medication issue." Dissenting Op. at 782.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The dissent reads too much into <i>Sell. Sell</i> tells us
that "[a] court need not consider whether to allow forced
medication for [trial competency purposes], if forced
medication is warranted for . . . the purposes set out in
<i>Harper." Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 181-82</a>, <cite>123 S.Ct. 2174</cite>. In
such a case, "the need to consider authorization on trial
competence grounds will likely disappear." <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20at%20181-82&amp;summary=yes#jcite">Id. at 183</a>,
<cite>123 S.Ct. 2174</cite>. When read in connection with the analysis in
<i>Harper, Sell</i> provides that a district court
<i>may</i> authorize involuntary medication on dangerousness
grounds, using the substantive standard outlined in
<i>Harper</i>, not that the district court <i>must</i> make
this determination. <i>Sell</i> thus incorporates
<i>Harper</i> into its structure, but nothing in
<i>Sell</i> requires the district court to revisit the
dangerousness inquiry de novo.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner offers a slightly different perspective. He argues
that there would be substantial added value to having judicial
decision makers and a judicial hearing in the pretrial context
because the administrative review is not very "probing," the
prison doctors are charged with conflicting goals, and the
medical expertise of the judicial decision maker would be
advanced by allowing the defense to present additional evidence
at a judicial hearing.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Nothing about Loughner's status as a pretrial detainee renders
administrative review more or less "probing," or affects the
medical expertise of a potential judicial decision maker.
<i>Harper</i> rejected these claims, and they are equally
unpersuasive when applied to pretrial detainees. <i>See</i>
<i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20at%20222-25&amp;summary=yes#jcite">id. at 233</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a> ("A State may conclude with
good reason that a judicial hearing will not be as effective,
as continuous, or as probing as administrative review using
medical decisionmakers.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The structural conflict of interest argument was also
considered and rejected in <i>Harper. See </i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20at%20222-25&amp;summary=yes#jcite">id. at 233-34</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a> (noting that prior cases <span CLASS="page_no" data-cite="2012 bl 51594 p 22" data-cite-type="Bloomberg" data-cite-pageno="22" data-primary-citation="">[**22]</span> involving similar
deprivations of liberty have approved the use of internal
decision makers (<i>citing Vitek v. Jones</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9UA?jcsearch=445%20us%20480&amp;summary=yes#jcite">445 U.S. 480</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9UA?jcsearch=445%20us%20480&amp;summary=yes#jcite">496</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9UA?jcsearch=100%20supreme%20court%201254&amp;summary=yes#jcite">100 S.Ct. 1254</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9UA?jcsearch=63%20l%20ed%202d%20552&amp;summary=yes#jcite">63 L.Ed.2d 552</a> (1980); <i>Parham v.</i>
<i>J.R.</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9QO?jcsearch=442%20us%20584&amp;summary=yes#jcite">442 U.S. 584</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9QO?jcsearch=442%20us%20584&amp;summary=yes#jcite">613-16</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9QO?jcsearch=99%20supreme%20court%202493&amp;summary=yes#jcite">99 S.Ct. 2493</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9QO?jcsearch=61%20l%20ed%202d%20101&amp;summary=yes#jcite">61 L.Ed.2d 101</a>
(1979); <i>Wolff v. McDonnell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8SD?jcsearch=418%20us%20539&amp;summary=yes#jcite">418 U.S. 539</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8SD?jcsearch=418%20us%20539&amp;summary=yes#jcite">570-71</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8SD?jcsearch=94%20supreme%20court%202963&amp;summary=yes#jcite">94 S.Ct. 2963</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8SD?jcsearch=41%20l%20ed%202d%20935&amp;summary=yes#jcite">41 L.Ed.2d 935</a> (1974))). In fact, the Court has
made clear that "it is only by permitting persons connected
with the institution to make these decisions that courts are
able to avoid `unnecessary intrusion into either medical or
correctional judgments.'" <i>Id.</i> at 235, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>
(quoting <i>Vitek</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9UA?jcsearch=445%20us%20480&amp;summary=yes#jcite">445 U.S. at 496</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9UA?jcsearch=100%20supreme%20court%201254&amp;summary=yes#jcite">100 S.Ct. 1254</a>). The
dissent disagrees, pointing to possible confusion in this
particular case as to what FMC-Springfield's role was in
administering involuntary medication, and arguing that courts
may be better situated to render objective decisions in the
pre-trial context. Dissenting Op. at 787-88. We maintain,
however, that the decision to medicate involuntarily a pretrial
detainee based on dangerousness grounds is a penological and
medical decision that should be made by the medical staff.
Although it is conceivable that a situation might arise in
which a conflict of interest exists, "we will not assume that
physicians will prescribe these drugs for reasons unrelated to
the medical needs of the patients." <i>Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 222</a> n. 8, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. Although the medical staff may
have an interest in curing the patient or restoring competency,
even when charged merely with determining if restoration is
possible, we trust that these professionals will act within the
pretrial detainee's and prison's best interests, within the
limits of their
<span CLASS="page_no" data-cite="672 f 3d 756" data-cite-type="PrimaryFederalReporter" data-cite-pageno="756" data-primary-citation="672 F.3d 731">[*756]</span> 
charge. Therefore, any conflict of interest argument should
be dealt with on a case-by-case basis and not deemed a bar to
leaving the involuntary medication decision to the prison
medical staff.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finally, Loughner contends that a judicial determination will
not be unduly burdensome because a pretrial detainee is already
subject to ongoing judicial proceedings. Additional judicial
proceedings, however, always have costs. Judicial
determinations of medical issues occasion unnecessary intrusion
into both medical and custodial judgments, <i>see </i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20at%20222-25&amp;summary=yes#jcite">id.
at 235</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>; <i>see also</i> Brief for Am.
Psychiatric Ass'n &amp; Am. Acad, of Psychiatry &amp; the Law
as Amici Curiae Supporting Affirmance ("APA Br.") at 24, and
"divert scarce prison resources, both money and the staffs
time, from the care and treatment of mentally ill inmates,"
<i>Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 232</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>; <i>see</i>
<i>Parham</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9QO?jcsearch=442%20us%20584&amp;summary=yes#jcite">442 U.S. at 606</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9QO?jcsearch=99%20supreme%20court%202493&amp;summary=yes#jcite">99 S.Ct. 2493</a>; APA Br. at 24-25
(discussing increase of judicial resources after Massachusetts
began requiring state courts to review involuntary medication
orders). This is so regardless of whether the inmate has
already been through the judicial process or is still in the
pretrial phase.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Due Process Clause requires that we measure the cost of
additional procedures against the risk of error in the existing
procedures and the private interest at stake. <i>Mathews v.</i>
<i>Eldridge</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X2N6JV?jcsearch=424%20us%20319&amp;summary=yes#jcite">424 U.S. 319</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X2N6JV?jcsearch=424%20us%20319&amp;summary=yes#jcite">335</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X2N6JV?jcsearch=96%20supreme%20court%20893&amp;summary=yes#jcite">96 S.Ct. 893</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X2N6JV?jcsearch=47%20l%20ed%202d%2018&amp;summary=yes#jcite">47 L.Ed.2d 18</a>
(1976). Thus, the mere fact that a party can design a set of
more expansive procedures does not entitle him to such process.
The fact that Loughner can conceive of <i>more</i> process
does not entitle him to it as the process that is <i>due.</i>
Loughner has made no argument beyond his own comfort level to
demonstrate the superiority of judicially <span CLASS="page_no" data-cite="2012 bl 51594 p 23" data-cite-type="Bloomberg" data-cite-pageno="23" data-primary-citation="">[**23]</span> directed hearings
over medically directed hearings. He has offered no explanation
for why there is an unacceptable risk of error "by allowing the
decision to medicate to be made by medical professionals rather
than a judge." <i>Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 231</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Thus, the Due Process Clause does not require a judicial
determination or a judicial hearing before a facility
authorizes involuntarily medication.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                b. Clear, Cogent, and Convincing Standard
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner next argues that because he is a pretrial detainee,
the Due Process Clause requires that the determination to
medicate forcibly be made by clear and convincing evidence.
<i>Harper</i> held that a "clear, cogent, and convincing"
standard "is neither required nor helpful when medical
personnel are making the judgment." <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20at%20231&amp;summary=yes#jcite">Id. at 235</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. Because it is the type of decision to be made and
not a person's status as a pre-trial inmate that is relevant to
this factor, we reject the contention that the Due Process
Clause requires a heightened standard of proof.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                      c. Representation by Counsel
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner argues that a pretrial detainee is entitled to counsel
at the involuntary medication hearing. This argument is largely
an outgrowth of his argument for a judicial hearing. In any
event, we disagree that Loughner is entitled to counsel in a
BOP administrative hearing.<a HREF="#fn1300" name="fnref_fn1300">[fn13]</a> It is not an inmate's trial
posture that governs the need for lawyers; instead, it is
<span CLASS="page_no" data-cite="672 f 3d 757" data-cite-type="PrimaryFederalReporter" data-cite-pageno="757" data-primary-citation="672 F.3d 731">[*757]</span> 
the nature of the judgment required. The decision to
medicate involuntarily based on dangerousness grounds is a
quintessential medical judgment, and in rejecting the necessity
of counsel, <i>Harper</i> noted that "`[i]t is less than
crystal clear why <i>lawyers</i> must be available to
identify possible errors in <i>medical</i> judgment.'"
<i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20at%20231&amp;summary=yes#jcite">Id. at 236</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a> (quoting <i>Walters v.</i>
<i>Nat'l Ass'n of Radiation Survivors</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CB5G?jcsearch=473%20us%20305&amp;summary=yes#jcite">473 U.S. 305</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CB5G?jcsearch=473%20us%20305&amp;summary=yes#jcite">330</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CB5G?jcsearch=105%20supreme%20court%203180&amp;summary=yes#jcite">105 S.Ct. 3180</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CB5G?jcsearch=87%20l%20ed%202d%20220&amp;summary=yes#jcite">87 L.Ed.2d 220</a> (1985)). <i>Harper</i> then
defined what would be sufficient representation: "the provision
of an independent lay adviser who understands the psychiatric
issues involved is sufficient protection." <i>Id.</i> We
agree that this is the only requirement in the pretrial context
as well.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  3. Loughner's As-applied Challenges to His <i>Harper III</i>
Hearing
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We next address whether the <i>Harper III</i> hearing, under
which Loughner is currently being forcibly medicated, complied
with the procedural protections of 28 C.F.R. &sect; 549.46.
Loughner argues that even if <i>Harper</i> applies, his
rights were violated, for four reasons: First, the decision
maker failed to demonstrate that he was dangerous; second,
FMC-Springfield failed to specify the course of treatment, that
is, the types or dosages of drugs that may be administered to
him; third, the BOP decision makers were not actually
independent; and, finally, Loughner was not provided meaningful
representation at the hearings.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although no statute affirmatively grants an inmate the right to
obtain judicial review of a Harper-dangerousness hearing, the
court that authorized commitment in the first place pursuant to
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d) has jurisdiction over the involuntary
medication order, and we have appellate jurisdiction under the
collateral order doctrine. In reviewing the order, we recognize
that "deference . . . <span CLASS="page_no" data-cite="2012 bl 51594 p 24" data-cite-type="Bloomberg" data-cite-pageno="24" data-primary-citation="">[**24]</span> is owed to medical professionals who have
the full-time responsibility of caring for mentally ill inmates
. . . and who possess, as courts do not, the requisite
knowledge and expertise to determine whether the drugs should
be used in an individual case." <i>Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 230</a> n. 12, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. Giving such deference, we review
Loughner's involuntary medication order to ensure the decision
is not arbitrary. <i>See Morgan</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3OCSV?jcsearch=193%20f%203d%20252&amp;summary=yes#jcite">193 F.3d at 263</a> ("[S]uch
a determination is subject to judicial review for
arbitrariness.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                        a. Dangerousness Finding
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner maintains that FMC-Springfield never determined that
medication was necessary to mitigate any danger that he posed
to himself. In the Justification section of the Involuntary
Medication Report that followed the <i>Harper III</i> hearing
on September 15, Dr. Tomelleri cited Loughner's deterioration
after the discontinuation of antipsychotics authorized by
<i>Harper I.</i> Loughner "expressed feelings of depression
and hopelessness, complained of a radio talking to him
inserting thoughts into his mind, . . . engaged in yelling,
crying, [and] rocking back and forth for prolonged periods of
time, made statements such as that he wanted to die, [and]
requested to be given an injection to be killed." His sleep
schedule became erratic, including a 50-hour period without
sleep. His food intake was poor and he lost weight, and he
would pace or spin in circles for hours without interruption.
Since involuntary medication resumed, Loughner's agitation has
decreased, his sleep has improved, and his communication with
staff is progressing, but he is still restless and paces and
cries frequently. Dr. Tomelleri concluded that "[p]sychotropic
medication is the treatment of choice for conditions such as
Mr. Loughner is experiencing," and rejected the alternatives.
<span CLASS="page_no" data-cite="672 f 3d 758" data-cite-type="PrimaryFederalReporter" data-cite-pageno="758" data-primary-citation="672 F.3d 731">[*758]</span> 
Psychotherapy, he wrote, would "not address the fundamental
problem"; minor tranquilizers are useful to reduce anxiety and
agitation and were being used for that purpose; and seclusion
and restraints are "merely protective temporary measures with
no direct effect on the core manifestations of the mental
illness." Rejecting the argument that Loughner is no longer a
danger to himself, Dr. Tomelleri stated that "[d]iscontinuation
of current medications is virtually certain to result in an
exacerbation of Mr. Loughner's illness as it did when
medication was discontinued in July."<a HREF="#fn1400" name="fnref_fn1400">[fn14]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner attempts to recharacterize his current danger to
himself as being caused by his depression, which he attributes
to the effects of the antipsychotic drugs because they are
making him more lucid. Loughner thus alleges that the
antipsychotics are not in his medical interest, but offers no
medical opinion or other evidence to counter Dr. Tomelleri's
determination. By contrast, Dr. Ballenger testified before the
district court that Loughner's depression, borne of his
"remorse of what happened," is "logical" and his
"self-realization [was] an indication that the medication is
helping" and "a very strong indication that his psychosis is
better." We must leave such medical judgments to medical staff
and professionals. <span CLASS="page_no" data-cite="2012 bl 51594 p 25" data-cite-type="Bloomberg" data-cite-pageno="25" data-primary-citation="">[**25]</span> <i>See Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 230</a> n. 12,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. Based on the substantial evidence in the
record, we conclude that FMC-Springfield did not act
arbitrarily in finding Loughner to be a danger to himself and
that antipsychotic medication was in his best interest.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                          b. Medication Regimen
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner next contends that the <i>Harper III</i> hearing
violated the Due Process Clause because no specific, future
course of treatment was identified and no limitations were
placed upon the types or dosages of drugs that could be
administered to him. He further faults FMC-Springfield staff
for modifying his medication without first seeking "`due
process' authorization," and the hearing psychiatrist for
relying on the current medication regimen rather than a
proposed future plan.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner's complaints may be contrary to his own medical
interests. Loughner relies on three cases for the proposition
that the government must specify his drug regimen in advance:
<i>Hernandez-Vasquez</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20f%203d%20908&amp;summary=yes#jcite">513 F.3d 908</a>; <i>Evans</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X120096003?jcsearch=404%20f%203d%20227&amp;summary=yes#jcite">404 F.3d 227</a>; and <i>United States v. Williams</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X6COPO?jcsearch=356%20f%203d%201045&amp;summary=yes#jcite">356 F.3d 1045</a>
(9th Cir. 2004). All involved persons who were ordered
involuntarily medicated, either to render them competent to
stand trial, <i>see Hernandez-Vasquez</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20f%203d%20908&amp;summary=yes#jcite">513 F.3d at 912</a>;
<i>Evans</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X120096003?jcsearch=404%20f%203d%20227&amp;summary=yes#jcite">404 F.3d at 236</a>, or as a condition of
supervised release, <i>see Williams</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X6COPO?jcsearch=356%20f%203d%201045&amp;summary=yes#jcite">356 F.3d at 1047</a>. In
each of these cases, the defendant or probationer had not been
found to be a danger to himself or others. <i>See</i>
<i>Hernandez-Vasquez</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20f%203d%20908&amp;summary=yes#jcite">513 F.3d at 915</a>; <i>Evans</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X120096003?jcsearch=404%20f%203d%20227&amp;summary=yes#jcite">404 F.3d at 235</a> n. 3; <i>Williams</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X6COPO?jcsearch=356%20f%203d%201045&amp;summary=yes#jcite">356 F.3d at 1057</a>. The
difference between <i>Harper</i> and <i>Sell</i> is
critical here. When an inmate is involuntarily medicated
because he is a danger to himself or others, he is being
treated for reasons that are in his and the institution's best
interests; the concern is primarily penological and medical,
and only secondarily legal. But when the government seeks to
medicate an inmate involuntarily to render him competent to
stand trial, the inmate is being treated because of the
<i>government's</i> trial interests, not the prison's
interests or the inmate's medical interests;
<span CLASS="page_no" data-cite="672 f 3d 759" data-cite-type="PrimaryFederalReporter" data-cite-pageno="759" data-primary-citation="672 F.3d 731">[*759]</span> 
the concern is primarily a legal one and only secondarily
penological or medical. Hence, the Supreme Court has emphasized
that resorting to a <i>Sell</i> hearing is appropriate only
if there is no other legitimate reason for treating the inmate.
<i>See Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 181-82</a>, <cite>123 S.Ct. 2174</cite>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner's treating psychiatrist is addressing Loughner's
serious and immediate medical needs and, accordingly, must be
able to titrate his existing dosages to meet his needs, and to
change medications as necessary, as other treatments become
medically indicated. No one who is being treated for a serious
medical condition would benefit from a court order that
restricted the drugs and the dosages permissible; mental
illness cannot always be treated with such specificity.<a HREF="#fn1500" name="fnref_fn1500">[fn15]</a>
We are not the dispensary and should let the doctors conduct
their business.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Washington policy approved in <i>Harper</i> required that
the treatment plan be proposed by the treating psychiatrist and
then approved by a reviewing psychiatrist. The purpose of this
scheme, however, was not to limit the prison personnel's future
course of treatment; it was to ensure that treatment "will be
ordered only if it is in the prisoner's medical interests."
<span CLASS="page_no" data-cite="2012 bl 51594 p 26" data-cite-type="Bloomberg" data-cite-pageno="26" data-primary-citation="">[**26]</span> <i>Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 222</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>.
<i>Harper</i> did not envision a process in which medical
professionals were limited to a treatment plan set out in the
original hearing. Rather, the Court recognized that treatment
of a mental illness is a dynamic process. <i>See </i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20at%20222-25&amp;summary=yes#jcite">id.
at 232-33</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a> ("Under the Policy, the hearing
committee reviews on a regular basis the staffs choice of both
the type and dosage of drug to be administered, and can order
appropriate changes."). Loughner's suggestion that
FMC-Springfield abused its authority by increasing the dosages
and changing the types of prescribed medication ignores the
realities of psychiatric medicine and overlooks the fact that
BOP's doctors have an ethical duty to do what is in the best
interest of the patient. <i>See </i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20at%20222-25&amp;summary=yes#jcite">id. at 222</a> n. 8,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a> ("[W]e will not assume that physicians will
prescribe these drugs for reasons unrelated to the medical
needs of the patients; indeed, the ethics of the medical
profession are to the contrary.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finally, even if specificity of the treatment were required,
the Involuntary Medication Report from the <i>Harper III</i>
hearing lists Loughner's then-current medication regimen as 3
mg of risperidone, twice a day; 300 mg of buproprion XL, daily;
1 mg of benztropine, twice a day; 1 mg of clonazepam, twice a
day, and 2 mg at bedtime. The report also states: "There is a
documented treatment plan on patient's chart," and the box is
checked indicating that Dr. Tomelleri considered and/or
reviewed a treatment proposal and justification. Additionally,
Dr. Pietz's August 22, 2011, progress report describes
Loughner's psychiatric treatment as of that day, and we note
that it is substantially the same as the treatment plan on
September 15 3 mg of risperidone, twice a
<span CLASS="page_no" data-cite="672 f 3d 760" data-cite-type="PrimaryFederalReporter" data-cite-pageno="760" data-primary-citation="672 F.3d 731">[*760]</span> 
day; 300 mg of buproprion XL, daily; 1 mg benztropine,
twice a day; 1 mg lorazepam (anti-anxiety), three times a day,
at bedtime, and as needed. Both his treating psychiatrist, Dr.
Sarrazin, and the hearing officer, Dr. Tomelleri, have opined
that Loughner requires medication. The district court heard
additional testimony from Dr. Ballenger that Loughner's
medication regimen was a standard approach to his schizophrenia
and other medical conditions. Loughner has offered no evidence
to the contrary, and we hold that there was no due process
violation relating to the medication regimen.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                     c. Independent Decision Makers
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner argues that FMC-Springfield doctors were charged with
competing responsibilities and that the decision makers were
not independent. Independence of the decision maker is required
by 28 C.F.R. &sect; 549.46(a)(4), however, and the hearing in
this case was conducted by Dr. Tomelleri, a psychiatrist who is
not currently involved in the diagnosis or treatment of
Loughner. The decision to medicate Loughner was upheld by the
Associate Warden, who agreed with Dr. Tomelleri's findings,
conclusions, and diagnosis. The bare fact that the involuntary
medication decision was made at FMC-Springfield, by
BOP-employed doctors, is insufficient to demonstrate a conflict
without proof of actual bias. <i>See Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 233-34</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. BOP is charged with caring for those
who have been committed to a detention facility; <span CLASS="page_no" data-cite="2012 bl 51594 p 27" data-cite-type="Bloomberg" data-cite-pageno="27" data-primary-citation="">[**27]</span> it is not a
prosecuting arm of the government and has no particular
interest in the continued incarceration of those inmates.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court found "no evidence that the FMC
[-Springfield] staff is in any way an ally of the Government
prosecution team," Order on Def's Mot. to Enjoin Medication 5,
and elaborated this point during the hearing:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I just don't see any evidence whatsoever that the
  findings &mdash; the determination made by
  FMC[-Springfield] to take this action was colored in
  any way by considerations of how it's going to affect
  the pending charges. . . . [The] professional staff,
  including the professional psychologists and
  psychiatrists, are calling things as they see them and
  they're acting on the basis of observation and
  judgment and experience and training.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
Hr'g on Mot. to Enjoin Tr. 50, June 29, 2011.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We are also not persuaded that FMC-Springfield is in league
with the prosecution team. It was, after all, FMC-Springfield
doctors who found Loughner incompetent to stand trial in the
first place, a conclusion instinctively contrary to a
prosecutor's interests. Moreover, we can take notice of the
fact that the same doctors involved in Loughner's treatment
have had to make these judgments in other cases, and the
judgments do not always favor the prosecution. For example, in
<i>Grape</i>, Dr. Pietz and Dr. Sarrazin opined that Grape
was not competent to stand trial. <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1A7982003?jcsearch=549%20f%203d%20591&amp;summary=yes#jcite">549 F.3d at 594-95</a>. At a
<i>Harper</i> hearing, Dr. Tomelleri found that, although
Grape was a potential danger to others, he could be managed
without resort to involuntary medication. <i>See </i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1A7982003?jcsearch=549%20F.3d%20at%20594-95&amp;summary=yes#jcite">id.
at 595</a>. That finding forced the prosecution to ask for a
<i>Sell</i> hearing, which has a much more demanding burden
of proof, to medicate Grape in order to restore him to trial
competency. <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1A7982003?jcsearch=549%20F.3d%20at%20594-95&amp;summary=yes#jcite">Id. at 594-95</a>. We can find no evidence
that FMC-Springfield staff was biased or lacked independence.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The dissent argues that a conflict of interest may have existed
because whereas the currently operative commitment order
charges the medical staff with restoring Loughner to
competency, the initial order
<span CLASS="page_no" data-cite="672 f 3d 761" data-cite-type="PrimaryFederalReporter" data-cite-pageno="761" data-primary-citation="672 F.3d 731">[*761]</span> 
charged FMC-Springfield only with determining whether
restoration was possible. Dissenting Op. at 787-88. The dissent
cites language from Loughner's Notice of Medication Hearing and
Advisement of Rights form as evidence that there may have been
a "confusion of roles . . . with respect to FMC-Springfield's
involuntary medication decision in this case." <i>Id.</i>
at 788. This form was filled out prior to the first involuntary
medication decision by Loughner's treating psychologist, Dr.
Pietz, who participated in the <i>Harper</i> hearings, and
stated that Loughner "was referred to this facility to restore
competency." Therefore, the argument proceeds, in making the
initial decision to medicate involuntarily Loughner on
dangerousness grounds, the medical staff may have been clouded
by their interest in actually restoring him to competency.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Dr. Pietz, however, was not a key decision maker in the
involuntary medication determination.
28 C.F.R. &sect; 549.46(a)(6) requires the treating psychiatrist to attend the
hearing and present data and background information
demonstrating <span CLASS="page_no" data-cite="2012 bl 51594 p 28" data-cite-type="Bloomberg" data-cite-pageno="28" data-primary-citation="">[**28]</span> the patient's need for antipsychotic medication;
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1G2A50003?jcsearch=28%20C.F.R.%20%20549.46(a)(7)&amp;summary=yes#jcite">&sect; 549.46(a)(7)</a> vests the presiding psychiatrist, who must
not be currently involved in the detainee's treatment or
diagnosis, with the authority to determine whether treatment
with antipsychotic medication is necessary because of an
inmate's dangerousness; <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1G2A50003?jcsearch=28%20C.F.R.%20%20549.46(a)(9)&amp;summary=yes#jcite">&sect; 549.46(a)(9)</a> vests the
institution's mental health division administrator with
authority to resolve any appeal from the presiding
psychiatrist's decision. There is no evidence that these
decision makers shared Dr. Pietz's possibly mistaken
understanding of the reasons for Loughner's commitment and
their concomitant statutory obligations. Therefore, the
district court did not clearly err in finding that
FMC-Springfield did not operate under a conflict of interest.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                         d. Staff Representative
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner argues that his appointed staff representative, John
Getchell, did not adequately represent his interests at the
<i>Harper III</i> hearing. He claims that in all three of the
hearings, Getchell "failed to seek out or present any
witnesses, cross-examine or challenge the prison's witnesses,
or advocate in any other meaningful way against forced
medication." Instead, Loughner contends, Getchell's sole
efforts were to relay to the administrative hearing officer
Loughner's witness request and continued objection to
involuntary medication. Loughner further contends that the
inadequacy of his staff representative deprived him of his
substantive and procedural due process, and that he should have
been afforded "[a] proper adversarial hearing, before a judge,"
and with representation of counsel. The government does not
dispute Loughner's factual assertions, but argues that
Getchell's representation satisfied due process.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Due process does not require that a pretrial detainee be
represented by counsel. The Supreme Court has held that
providing a lay adviser who understands the psychiatric issues
involved provides sufficient procedural protection. The Court
has not defined further the required qualifications of the
personal representative, except to hold that it need not be an
attorney. <i>See Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 236</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>.
Following the procedures outlined in <i>Harper</i>,
28 C.F.R. &sect; 549.46 requires that the facility provide the inmate with
a staff representative for the hearing. If the inmate does not
request a staff representative, or requests one with
"insufficient experience or education," FMC-Springfield "must
appoint a <i>qualified</i> staff representative."
28 C.F.R. &sect; 549.46(a)(3) (emphasis added).
<span CLASS="page_no" data-cite="672 f 3d 762" data-cite-type="PrimaryFederalReporter" data-cite-pageno="762" data-primary-citation="672 F.3d 731">[*762]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although the Supreme Court has only held that it is sufficient
that the representative "understand[] the psychiatric issues
involved," <i>Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 236</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>, we
have some concerns with the adequacy of Loughner's
representation. Loughner's representative, Getchell, is an
LCSW. We do not doubt the ability of an LCSW to understand
psychological issues in general, particularly those related to
counseling and psychotherapy. What is less clear is whether an
LCSW has the background necessary to challenge either the
diagnosis or the medical regimen prescribed by a psychiatrist.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Our concerns <span CLASS="page_no" data-cite="2012 bl 51594 p 29" data-cite-type="Bloomberg" data-cite-pageno="29" data-primary-citation="">[**29]</span> may stem from some confusion over the nature of
<i>Harper</i> hearings. Although the Court characterized
Washington's policy in <i>Harper</i> as "an adversary
hearing," <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 235</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>, BOP's regulations
create something of a hybrid between an adversarial hearing and
an inquisitorial hearing. The expectations of advocates
participating in those respective hearings are quite different.
The adversarial mode is party driven, as each side has the
opportunity to present its best case, and the judge or hearing
officer makes a decision based on the evidence the parties have
mustered. Advocates take an active role, whereas the judge
remains a passive participant. By contrast, in the
inquisitorial model more familiar to continental systems, the
judge takes a far more active role in directing the case and
developing the evidence, whereas the advocate takes a passive
role. <i>See McNeil v. Wisconsin</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC2N?jcsearch=501%20us%20171&amp;summary=yes#jcite">501 U.S. 171</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC2N?jcsearch=501%20us%20171&amp;summary=yes#jcite">181</a> n. 2,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC2N?jcsearch=111%20supreme%20court%202204&amp;summary=yes#jcite">111 S.Ct. 2204</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC2N?jcsearch=115%20l%20ed%202d%20158&amp;summary=yes#jcite">115 L.Ed.2d 158</a> (1991) ("What makes a system
adversarial rather than inquisitorial is not the presence of
counsel . . . but rather, the presence of a judge who does not
(as an inquisitor does) conduct the factual and legal
investigation himself, but instead decides on the basis of
facts and arguments pro and con adduced by the parties.");
<i>see also</i> Stephan Landsman, <i>A Brief Survey of the</i>
<i>Development of the Adversary System</i>, 44 Ohio St. L.J. 713,
714-15, 724 (1983); Jeffrey S. Wolfe &amp; Lisa B. Proszek,
<i>Interaction Dynamics in Federal Administrative Decision</i>
<i>Making: The Role of the Inquisitorial Judge and the Adversarial</i>
<i>Lawyer</i>, 33 Tulsa L.J. 293, 313-15 (1997). Although the
adversarial model is more familiar, we have examples of
inquisitorial proceedings, particularly in agencies charged
with administering benefits programs, such as social security
or veterans' benefits. <i>See Sims v. Apfel</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X48SLJ?jcsearch=530%20us%20103&amp;summary=yes#jcite">530 U.S. 103</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X48SLJ?jcsearch=530%20us%20103&amp;summary=yes#jcite">110-11</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X48SLJ?jcsearch=120%20supreme%20court%202080&amp;summary=yes#jcite">120 S.Ct. 2080</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X48SLJ?jcsearch=147%20l%20ed%202d%2080&amp;summary=yes#jcite">147 L.Ed.2d 80</a> (2000) ("Social
Security proceedings are inquisitorial rather than
adversarial."); <i>Nat'l Ass'n of Radiation Survivors</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CB5G?jcsearch=473%20us%20305&amp;summary=yes#jcite">473 U.S. at 309-11</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CB5G?jcsearch=105%20supreme%20court%203180&amp;summary=yes#jcite">105 S.Ct. 3180</a> (explaining that the
Veterans' Administration benefits system is not an "adversary
mode").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The <i>Harper</i> hearing bears some characteristics of both
systems. At first glance, the <i>Harper</i> hearing is
decidedly adversarial because the purpose is to determine if
the inmate can be medicated against his will. Unlike agency
hearings to determine an applicant's eligibility for federal
largesse, the <i>Harper</i> hearing pits the inmate against
his prison doctor in a clash over his best interests. Beyond
this obvious difference, however, it is less clear that the
hearing has been structured in either a plainly adversarial or
plainly inquisitorial fashion. The hearing officer is not a
judge but a doctor charged with confirming or rejecting the
medical judgment of a colleague. That makes the hearing officer
not just a neutral decision maker, but a decision maker who has
been selected precisely because of his own expertise in the
field. As in an inquisitorial system, the hearing officer
conducts the proceeding and directs the development of the
evidence. <i>See</i> 28 C.F.R. &sect; 549.46(a)(4), <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1G2A50003?jcsearch=28%20C.F.R.%20%20549.46(a)(7)&amp;summary=yes#jcite">(7)</a>.
<span CLASS="page_no" data-cite="672 f 3d 763" data-cite-type="PrimaryFederalReporter" data-cite-pageno="763" data-primary-citation="672 F.3d 731">[*763]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In a <i>Harper</i> hearing, the government is not represented
by counsel, but by the inmate's own treating psychiatrist or
psychologist who is there to testify <span CLASS="page_no" data-cite="2012 bl 51594 p 30" data-cite-type="Bloomberg" data-cite-pageno="30" data-primary-citation="">[**30]</span> as to why, in her
judgment, the inmate's own interests, as well as BOFs
institutional interests, require that the inmate be
involuntarily medicated. The treating psychiatrist has no
interest in the outcome of the hearing other than to present
and defend her own diagnosis and recommendation. Importantly,
she is not directing the case in the sense that we would expect
from the government's advocate in a purely adversarial
proceeding. For his part, the inmate may present evidence,
request his own witnesses, and ask that any witnesses be
questioned. BOP's regulations provide, somewhat ambiguously,
that witnesses may be questioned either "by the staff
representative or by the person conducting the hearing."
<i><cite>Id</cite>.</i> <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1G2A50003?jcsearch=28%20C.F.R.%20%20549.46(a)(3)&amp;summary=yes#jcite">&sect; 549.46(a)(3)</a>. The staff representative also
"assist[s] the inmate in preparing and submitting the appeal."
<i><cite>Id</cite>.</i> <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1G2A50003?jcsearch=28%20C.F.R.%20%20549.46(a)(8)&amp;summary=yes#jcite">&sect; 549.46(a)(8)</a>. The acts required of the staff
representative do not necessarily speak in terms of advocacy,
but require that the staff representative facilitate the
inmate's presentation at the hearing and any appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The role of the inmate's staff representative changes &mdash;
and perhaps dramatically &mdash; as we characterize the
<i>Harper</i> hearing as adversarial or inquisitorial. If it
is adversarial, then we would expect the staff representative
to assist the inmate to present any evidence or request
witnesses who would challenge his treating psychiatrist's
assessment that he is a danger to himself or others and the
recommendation that the inmate be medicated against his will.
Indeed, in some circumstances, we might assume that the staff
representative should vigorously represent the inmate's desire
not to be medicated. On the other hand, if the <i>Harper</i>
hearing is largely inquisitorial in nature, then the hearing
officer has the primary duty to develop the evidence to his own
satisfaction, and the staff representative is there to
facilitate the presenting of evidence or witnesses for the
inmate.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On balance, although the question is a curious one, the
<i>Harper</i> hearing is about countermanding the desires of
the inmate in an area in which he "possesses a significant
liberty interest in avoiding the unwanted administration of
antipsychotic drugs." <i>Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 221</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. Within our traditions, and in the absence of
clearer direction in the regulations, we consider the
<i>Harper</i> hearing to be adversarial.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Based on that premise, we question whether any representative
appointed by BOP who is not qualified to make medical diagnoses
or prescribe medication &mdash; or, at the least, qualified by
training to know what medications are typically called for to
treat serious mental illnesses &mdash; can meet the inmate's
treating psychiatrist on a level playing field. We thus
question whether Getchell, as Loughner's representative, was
placed in a situation where his training did not qualify him to
challenge Loughner's treating psychiatrist. In other words, in
the American adversarial tradition, we wonder whether, in a
contest to be decided by a hearing officer who is a
psychiatrist, the hearing really pits adversaries and advocates
prepared to challenge <span CLASS="page_no" data-cite="2012 bl 51594 p 31" data-cite-type="Bloomberg" data-cite-pageno="31" data-primary-citation="">[**31]</span> each other fairly. We do not mean to
suggest that a <i>Harper</i> hearing requires that counsel be
present, lest "[t]he role of the hearing [officer] itself . . .
may become more akin to that of a judge at a trial, and less
attuned to the [medical] needs of the individual." <i>Gagnon</i>
<i>v. Scarpelli</i> <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8FO?jcsearch=411%20us%20778&amp;summary=yes#jcite">411 U.S. 778</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8FO?jcsearch=411%20us%20778&amp;summary=yes#jcite">787-88</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8FO?jcsearch=93%20supreme%20court%201756&amp;summary=yes#jcite">93 S.Ct. 1756</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8FO?jcsearch=36%20l%20ed%202d%20656&amp;summary=yes#jcite">36 L.Ed.2d 656</a> (1973). But it may suggest a more demanding role
for the staff representative.
<span CLASS="page_no" data-cite="672 f 3d 764" data-cite-type="PrimaryFederalReporter" data-cite-pageno="764" data-primary-citation="672 F.3d 731">[*764]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Here, Getchell's failure to present any affirmative evidence or
question any of the evidence in support of involuntary
medication may indicate that his representation was unqualified
or procedurally defective.<a HREF="#fn1600" name="fnref_fn1600">[fn16]</a> <i>See Morgan</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3OCSV?jcsearch=193%20f%203d%20252&amp;summary=yes#jcite">193 F.3d at 265-66</a> (noting that the staff representative's lack of
"meaningful participation" during the administrative hearing
supported the inference that the staff representative lacked
"sufficient education and experience" as required by the
regulations); <i>United States v. Humphreys</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X287DJ?jcsearch=148%20f%20supp%202d%20949&amp;summary=yes#jcite">148 F.Supp.2d 949</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X287DJ?jcsearch=148%20f%20supp%202d%20949&amp;summary=yes#jcite">953</a> (D.S.D. 2001) (finding that the staff
representative did not meet the requirements of due process
because she presented no evidence; testified against the
defendant, stating that she believed he had a mental illness;
and may have filed a disciplinary report against the defendant
when he first arrived at FMC-Rochester). Or, it may simply
indicate that Getchell had nothing to say because the evidence
was overwhelming that Loughner required medication and that his
prescriptions were standard protocol. We cannot determine the
answers to these questions from this record. If we were
deciding this matter based on the <i>Harper III</i> hearing
alone, we might well send the case back for further proceedings
or a new <i>Harper</i> hearing.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The record in this case, however, is far more complete because
the district court held an extensive hearing following
<i>Harper III. See</i> Order Den. Stay 2, Oct. 3, 2011
(referring to "the lengthy and, at times, tedious hearing").
Thus, we think that any error that may have resulted from the
staff representative's lack of advocacy in the <i>Harper</i>
<i>III</i> hearing was harmless. Three <i>Harper</i> hearings
all reached the same conclusion: Loughner is a danger and needs
to be medicated.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The <i>Harper III</i> hearing was followed by a district
court hearing where each party had the opportunity to call
witnesses. The government called Dr. Pietz, Loughner's treating
psychologist, and Dr. Ballenger, a clinical psychiatrist and
independent expert. At the hearing before the district court in
late September 2011, Dr. Pietz testified to her daily contact
with Loughner, beginning in March 2011. She testified
concerning Loughner's behavior, her conversations with him, and
his contacts with other FMC-Springfield staff. Dr. Ballenger
provided a written statement and testified before the district
court. Dr. Ballenger has more than forty years experience,
having served as a professor at the University of Virginia
Medical Center and Chairman of the Department of Psychiatry and
Behavioral Sciences at the Medical University of South
Carolina. He has authored or co-authored almost 400
peer-reviewed articles and 16 books, most of which deal with
psychopharmacology. Dr. Ballenger did not examine Loughner or
perform <span CLASS="page_no" data-cite="2012 bl 51594 p 32" data-cite-type="Bloomberg" data-cite-pageno="32" data-primary-citation="">[**32]</span> a comprehensive review of his treatment records, but he
had reviewed Loughner's progress notes and had spoken to
Loughner's treating psychiatrist, Dr. Sarrazin. He provided
general background on first-and second-generation
antipsychotic medications and their effectiveness and
side-effects. Dr. Ballenger testified regarding the drugs and
dosages prescribed for Loughner, and he affirmed that the
regimen was "the logical routine" and the dosages were "highly
appropriate." He confirmed that the combination of drugs
Loughner's
<span CLASS="page_no" data-cite="672 f 3d 765" data-cite-type="PrimaryFederalReporter" data-cite-pageno="765" data-primary-citation="672 F.3d 731">[*765]</span> 
psychiatrist had prescribed presented "no problems of using
them together."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although the district court attempted to keep both sides
"focus[ed] on the issue of the day" &mdash; i.e., the extension
of commitment under <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2) &mdash; the
district court also addressed the adequacy of the <i>Harper</i>
<i>III</i> hearing. Thus, at the hearing, Loughner had the
opportunity to challenge the assessments of his doctors, and to
present evidence that the dangerousness finding at his
<i>Harper</i> hearings was arbitrary. Loughner's counsel
cross-examined both Dr. Pietz and Dr. Ballenger. His counsel
called no witnesses, but produced graphs and charts compiled
from Loughner's own FMC-Springfield medical records.
Ultimately, the government's presentation was nearly
unchallenged by Loughner's counsel. Indeed, over the course of
months, and numerous hearings before the district court,
Loughner has never presented any witnesses or other evidence
that calls into question his diagnosis or treatment. The
evidence before the district court thus fully supported the
judgment reached at the <i>Harper</i> hearings.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Additionally, in making the finding that there was "a
substantial probability that within a reasonable period of time
. . . Mr. Loughner can be restored to competency," <i>see</i>
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2), the district court relied on
Loughner's "ongoing treatment" at FMC-Springfield. Because his
"ongoing treatment" necessarily encompassed the involuntary
medication of Loughner, a current, valid involuntary medication
order must exist. Thus, Loughner effectively had two chances to
attack the existing <i>Harper</i> order during the hearing
regarding the extension of his commitment: by either attacking
the <i>Harper</i> order directly or as a challenge to the
<cite>&sect; 4241</cite> determination. But Loughner called no witnesses,
introduced no new evidence, and did not allege that the doctors
chose a course that was medically inappropriate. Any deficiency
in Getchell's representation in Loughner's case was cured in
the district court's subsequent hearing.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                               * * * * * *
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We conclude that Loughner was provided with the substance and
procedure demanded by the Due Process Clause before the
government involuntarily medicated him. It is clear that
Loughner has a severe mental illness, that he represents a
danger to himself or others, and that the prescribed medication
is appropriate and in his medical interest. There was no
arbitrariness in the district court's order denying the motion
to enjoin Loughner's emergency treatment. He may be
involuntarily medicated.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                  IV. COMMITMENT TO RESTORE COMPETENCY
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We next <span CLASS="page_no" data-cite="2012 bl 51594 p 33" data-cite-type="Bloomberg" data-cite-pageno="33" data-primary-citation="">[**33]</span> turn to Loughner's appeal of the district court's
extension of his commitment. This is a separate inquiry and,
although the issues are related, we must keep the issues
distinct. The dissent, however, argues that the involuntary
medication and commitment decisions are one and the same. See
Dissenting Op. at 784-85. Because "the court . . . must decide
whether Loughner is to be medically treated so as to be
restored to competency" and because that decision "depends on
the availability of involuntary medication," the dissent argues
that the district court may not rely on a previous involuntary
medication order, but instead must make an independent decision
as to whether the medication is justified and unlikely to
infringe on Loughner's fair trial rights. <i>Id.</i>
at 781-82. But these determinations must be kept separate.
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2) requires a court to decide whether
"there is a substantial probability that . . . [the detainee]
will attain the capacity to permit the proceedings to go
forward." Although
<span CLASS="page_no" data-cite="672 f 3d 766" data-cite-type="PrimaryFederalReporter" data-cite-pageno="766" data-primary-citation="672 F.3d 731">[*766]</span> 
the court will necessarily have to consider the preexisting
treatment that will lead to such attainment, the basis for that
treatment, when it is involuntary medication, is
28 C.F.R. &sect; 549.46. This is a completely separate authorization, and
one that the Supreme Court has indicated may be made in an
administrative hearing. We therefore address whether, given the
currently operative involuntary medication order, the district
court properly extended Loughner's commitment pursuant to
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">&sect; 4241(d)(2)</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Under <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d), if a court finds that a
defendant's mental disease renders him "mentally incompetent to
the extent that he is unable to understand the nature and
consequences of the proceedings against him or to assist
properly in his defense," the court shall commit the defendant
for up to four months to determine if there is a "substantial
probability" that he will be restored to competency.
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(1)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(1). After such time, the court shall commit the
defendant "for an additional reasonable period of time until"
he is fit to proceed to trial, "if the court finds that there
is a substantial probability that within such additional period
of time he will attain the capacity to permit the proceedings
to go forward." <i><cite>Id</cite>.</i> <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">&sect; 4241(d)(2)</a>; <i>see also</i>
<i>Jackson v. Indiana</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C87L?jcsearch=406%20us%20715&amp;summary=yes#jcite">406 U.S. 715</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C87L?jcsearch=406%20us%20715&amp;summary=yes#jcite">738</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C87L?jcsearch=92%20supreme%20court%201845&amp;summary=yes#jcite">92 S.Ct. 1845</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C87L?jcsearch=32%20l%20ed%202d%20435&amp;summary=yes#jcite">32 L.Ed.2d 435</a> (1972).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In challenging the extension of his commitment, Loughner raises
three claims. First, he contends that the district court's
order extending his commitment is flawed because the court
failed to demand a particularized course of treatment from
FMC-Springfield. Second, he argues that the district court did
not consider whether the antipsychotic medications would render
his trial unfair. Third, he maintains that the district court
clearly erred in finding that there is a "substantial
probability" that Loughner will regain competency. We will
consider each in turn.<a HREF="#fn1700" name="fnref_fn1700">[fn17]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
A. <i>Particularized Course of Treatment</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner argues that the district court failed to consider the
medical appropriateness of his treatment regimen and, without
considering that regimen, could not assess the likelihood of
Loughner being restored to competency.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We think <span CLASS="page_no" data-cite="2012 bl 51594 p 34" data-cite-type="Bloomberg" data-cite-pageno="34" data-primary-citation="">[**34]</span> Loughner has failed to distinguish between the reasons
for which he may be medicated pursuant to <i>Harper</i>
&mdash; reasons that predominantly have to do with the prison's
and his own medical interests &mdash; and the reasons for which
he may be medicated pursuant to <i>Sell</i> &mdash; which
involve the government's interests. Loughner is being medicated
for his serious mental illness irrespective of whether he can
concomitantly be restored to competency in order to stand
trial. The purpose of the district court's hearing was to
determine whether, in light of his existing treatment, there is
a "substantial probability that within [the] additional period
of time he will attain the capacity to permit the proceedings
to go forward." <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2). If his current
regimen is sufficient to determine that there is a substantial
probability that he can be rendered competent, then he can be
"hospitalize[d] . . . in a suitable facility." <i><cite>Id</cite>.</i>
<span CLASS="page_no" data-cite="672 f 3d 767" data-cite-type="PrimaryFederalReporter" data-cite-pageno="767" data-primary-citation="672 F.3d 731">[*767]</span> 
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)&amp;summary=yes#jcite">&sect; 4241(d)</a>. If, however, the treatment for his
dangerousness will not concomitantly render him
trial-competent, then additional medication could be forced
upon him only if it is in the government's (rather than his
own) interests, and in such case the government would have to
proceed under <i>Sell</i>, As the Court explained in
<i>Sell</i>, "[a] court need not consider whether to allow
forced medication for [trial competency purposes], if forced
medication is warranted for a <i>different</i> purpose. . . .
If a court authorizes medication on these alternative grounds,
the need to consider authorization on trial competence grounds
will likely disappear." <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 181</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">183</a>, <cite>123 S.Ct. 2174</cite>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We agree with Loughner that the existing involuntary medication
decision is important to the overall outcome of the
<cite>&sect; 4241(d)(2)</cite> proceeding because it "likely affect[s] both the
scope and term of a <cite>&sect; 4241(d)(2)</cite> order." <i>United States</i>
<i>v. Magassouba</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X19IV6M003?jcsearch=544%20f%203d%20387&amp;summary=yes#jcite">544 F.3d 387</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X19IV6M003?jcsearch=544%20f%203d%20387&amp;summary=yes#jcite">418</a> n. 27 (2d Cir. 2008).
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)&amp;summary=yes#jcite">Section 4241(d)</a>, however, is a commitment statute, not an
involuntary medication statute, and a <cite>&sect; 4241(d)(2)</cite>
extension of commitment for purposes of competency restoration
does not alter the legitimacy of the decision to medicate
involuntarily Loughner under <i>Harper.</i> The court must
therefore consider only whether his ongoing treatment is likely
to restore competency, not whether it is medically appropriate.
The medical appropriateness of Loughner's treatment was
addressed in his <i>Harper</i> hearing, and we have approved
that treatment. <i>See <cite>supra</cite></i> Part III.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In any event, the district court heard "what medications the
defendant is receiving, what <i>dosages</i> of those
medications he is receiving, and <i>when</i> during the day
he is receiving those dosages." Order Den. Stay 4-5. Although
the district court assumed that the "present medication regimen
will continue with only minor modifications," <i></i><cite>id.
at 5</cite>, the district court heard testimony that Loughner's
medication regimen has changed in the months that he has been
committed to FMC-Springfield, and his treating psychologist,
Dr. Pietz, testified that his medication might continue to
change. Dr. Ballenger testified that the medication currently
administered to Loughner was "highly appropriate" but that if
Loughner does not fully respond <span CLASS="page_no" data-cite="2012 bl 51594 p 35" data-cite-type="Bloomberg" data-cite-pageno="35" data-primary-citation="">[**35]</span> to the medication, it would be
"a very appropriate strategy" to increase the dosages, even
doubling some. But the administration of antipsychotic drugs is
a fluid process and must be adjusted depending on how the
patient reacts and why, if any, side effects are experienced.
<i>See</i> APA Br. at 26 ("[T]he choice whether and how to
medicate an inmate is not a one-time decision; it involves a
process of monitoring and, for many patients, adjustments in
medication and dosage."); <i>see also Indiana v. Edwards</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X193JHU003?jcsearch=554%20us%20164&amp;summary=yes#jcite">554 U.S. 164</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X193JHU003?jcsearch=554%20us%20164&amp;summary=yes#jcite">176</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X193JHU003?jcsearch=128%20supreme%20court%202379&amp;summary=yes#jcite">128 S.Ct. 2379</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X193JHU003?jcsearch=171%20l%20ed%202d%20345&amp;summary=yes#jcite">171 L.Ed.2d 345</a> (2008)
("Mental illness itself is not a unitary concept. It varies in
degree. It can vary over time. It interferes with an
individual's functioning at different times in different
ways."). Requiring FMC-Springfield to submit with particularity
the exact course of treatment over several months is
impractical and unnecessary, and would ignore the concerns
expressed in <i>Harper</i> that <i>medical</i> decisions
should not be made by judges. <i>See Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 232</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a> (" The mode and procedure of medical
diagnostic procedures is not the business of judges. . . .'"
(quoting <i>Parham</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9QO?jcsearch=442%20us%20584&amp;summary=yes#jcite">442 U.S. at 607</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9QO?jcsearch=99%20supreme%20court%202493&amp;summary=yes#jcite">99 S.Ct. 2493</a>));
<i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20at%20232&amp;summary=yes#jcite">id. at 231</a> n. 12, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a> (stating that
deference should be given to medical professionals in making
medication decisions because courts do not have the necessary
<span CLASS="page_no" data-cite="672 f 3d 768" data-cite-type="PrimaryFederalReporter" data-cite-pageno="768" data-primary-citation="672 F.3d 731">[*768]</span> 
knowledge or expertise).<a HREF="#fn1800" name="fnref_fn1800">[fn18]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court found that Loughner was being lawfully
medicated pursuant to <i>Harper</i> and that there was a
substantial probability that his existing treatment will
restore him to competency to stand trial. In the process, the
court considered Loughner's existing regimen but did not
undertake to micromanage his treatment or otherwise limit his
course of treatment. <i>See Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 231</a>
n. 12, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>; <i>Hernandez-Vasquez</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20f%203d%20908&amp;summary=yes#jcite">513 F.3d at 916-17</a>. The Due Process Clause does not demand more.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
B. <i>Side Effects and Fair Trial Rights</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner argues that when forced medication is the means
employed by BOP to seek restoration of competency, the district
court must engage in a predictive analysis of whether side
effects are substantially unlikely to render a trial unfair
before the defendant can be committed under <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">&sect; 4241(d)(2)</a>.
Specifically, Loughner argues that the district court must
predict whether the antipsychotic medication is substantially
unlikely to alter his demeanor in a manner that will prejudice
his reactions and presentation in the court-room, and render
him unable or unwilling to assist counsel. Loughner's concerns
are well-taken, but premature. As the district court
recognized, Loughner will have a full and fair opportunity to
raise his concerns before he goes to trial. See Order on
<i>Sell</i> Hr'g 8. To demand that the district court answer
such questions at this juncture blurs the distinction between a
defendant who is being medicated under <i>Harper</i> and one
the government seeks to medicate under <i>Sell.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Before a defendant can be committed for evaluation of his
competence, the district court must find that the defendant "is
unable to understand the nature and consequences of the
proceedings against him or to assist properly in his defense."
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d). The premise for granting the
government's motion for a competency examination of Loughner at
FMC-Springfield in March <span CLASS="page_no" data-cite="2012 bl 51594 p 36" data-cite-type="Bloomberg" data-cite-pageno="36" data-primary-citation="">[**36]</span> 2011 was "reasonable cause to believe"
that he was not competent to understand trial procedures or to
assist in his defense. <i><cite>Id</cite>.</i> <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(a)&amp;summary=yes#jcite">&sect; 4241(a)</a>. That belief
was confirmed shortly after Loughner was committed. Before
granting an extension of commitment for the purpose of
restoration, the district court must find that there is a
substantial probability that the pretrial detainee "will attain
the capacity to permit the proceedings to go forward."
<i><cite>Id</cite>.</i> <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">&sect; 4241(d)(2)</a>. Once these findings are made,
the court must then commit the defendant for a reasonable
period of time until trial may proceed. <i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">Id</a>.</i> The
statute itself therefore contemplates that the "capacity" that
the district court is required to predict is the ability to
understand the nature and consequences of the proceedings and
to assist in his defense &mdash; in other words, competency.
<i>See United States v. Marks</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X192TCA003?jcsearch=530%20f%203d%20799&amp;summary=yes#jcite">530 F.3d 799</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X192TCA003?jcsearch=530%20f%203d%20799&amp;summary=yes#jcite">814</a> (9th
Cir. 2008) ("The substantive standard for determining competence
to stand trial is whether the defendant had sufficient present
ability to consult with his lawyer with a reasonable degree of
rational understanding, and a rational as well as factual
understanding of the proceedings against him." (internal
quotation marks omitted)); <i>see also Edwards</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X193JHU003?jcsearch=554%20U.S.%20164&amp;summary=yes#jcite">554 U.S. at 174</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X193JHU003?jcsearch=128%20supreme%20court%202379&amp;summary=yes#jcite">128 S.Ct. 2379</a> (explaining that the Supreme Court's
"mental competency" cases have defined
<span CLASS="page_no" data-cite="672 f 3d 769" data-cite-type="PrimaryFederalReporter" data-cite-pageno="769" data-primary-citation="672 F.3d 731">[*769]</span> 
"competency" in terms of "the capacity to understand the
nature and object of the proceedings against him, to consult
with counsel, and to assist in preparing his defense")
(emphasis omitted) (quoting <i>Drope v. Missouri</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8U5?jcsearch=420%20us%20162&amp;summary=yes#jcite">420 U.S. 162</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8U5?jcsearch=420%20us%20162&amp;summary=yes#jcite">171</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8U5?jcsearch=95%20supreme%20court%20896&amp;summary=yes#jcite">95 S.Ct. 896</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8U5?jcsearch=43%20l%20ed%202d%20103&amp;summary=yes#jcite">43 L.Ed.2d 103</a> (1975)); Order
Extending Restoration Commitment 2 n. 1 (finding that
competency and capacity are equivalent).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>Sell</i> requires, among other things, that the government
demonstrate not only that involuntary medication is "likely to
render the defendant competent to stand trial," but that
"administration of the drugs is substantially unlikely to have
side effects that will interfere significantly with the
defendant's ability to assist counsel in conducting a trial
defense." <i>Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 181</a>, <cite>123 S.Ct. 2174</cite>;
<i>see also </i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20at%20181-82&amp;summary=yes#jcite">id. at 185</a>, <cite>123 S.Ct. 2174</cite> ("Whether a
particular drug will tend to sedate a defendant, interfere with
communication with counsel, prevent rapid reaction to trial
developments, or diminish the ability to express emotions are
matters important in determining the permissibility of
medication to restore competence. . . ."). That predictive
judgment is required where the government seeks to medicate the
defendant for no reason other than to render him competent. As
we have pointed out, Loughner is being medicated involuntarily
because he is a danger to himself or others, irrespective of
whether the medications may cause side effects that interfere
with his ability to assist counsel in his defense. A district
court's judgement on side effects is both premature and
irrelevant at this stage. <i>See</i> Order Den. Stay 3 ("It
was obviously premature at this stage of the competency
restoration process for the Court to determine whether there
are side effects of the defendant's medication that will
prevent the Court from making a finding of competency in the
future.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Because Loughner remains <span CLASS="page_no" data-cite="2012 bl 51594 p 37" data-cite-type="Bloomberg" data-cite-pageno="37" data-primary-citation="">[**37]</span> under medical treatment for his mental
illness, the district court properly focused on whether his
treatment might also restore him to competency. The district
court acknowledged that Loughner's concerns "will be fully
addressed if there is a future competency hearing." Order on
<i>Sell</i> Hr'g 8. We agree that such concerns are important
and that Loughner should have an opportunity to raise these
issues. We also agree that the district court need not address
Loughner's concerns before deciding to extend his commitment to
determine whether he can be restored to competency.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
C. <i>Substantial Probability of Restoration of</i>
<i>Competency</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner contends that the district court applied the wrong
legal standard in granting the extension of commitment, arguing
that the "substantial probability" of restoration must be
proven by clear and convincing evidence. First, we agree with
the district court that a second layer of proof is not required
and that the statute itself provides the requisite burden of
proof &mdash; the government must prove there is a "substantial
probability" that Loughner will regain competency. <i>See</i>
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)(A)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2)(A).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Next, in defining that standard, the district court noted that
"a `substantial' probability is any probability worth taking
seriously." Order Extending Restoration Commitment 3. To
demonstrate this proposition, the court used an analogy: "For
example, a 40 percent chance of rain is enough of a reason to
leave the house with a raincoat, or cancel plans to spend a day
outside; it wouldn't be unreasonable to label that chance `a
substantial <i>probability,</i>" even if rain is not
substantially <i>probable." <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)(A)&amp;summary=yes#jcite">Id</a>.</i> The district court then
looked to Ninth Circuit precedent, finding that "`courts have
generally construed
<span CLASS="page_no" data-cite="672 f 3d 770" data-cite-type="PrimaryFederalReporter" data-cite-pageno="770" data-primary-citation="672 F.3d 731">[*770]</span> 
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">&sect; 4241(d)(2)</a> to allow extensions for a reasonable
period of time only when the individual is <i>likely</i> to
attain competency within a reasonable time.'" <i></i><cite>Id. at 4</cite>
(emphasis added) (quoting <i>Rivera-Guerrero</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20f%203d%201130&amp;summary=yes#jcite">426 F.3d at 1143</a>) (some internal quotation marks omitted). The district
court's determination that "substantial probability" means
"likely" (and not necessarily "more likely than not") was based
on both a fair reading of the statute and the guidance of our
precedent and, therefore, we agree.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner further challenges the district court's finding that
there was a "substantial probability" that Loughner can be
restored to competency as clear error. He raises three
objections to the district court's <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">&sect; 4241(d)(2)</a> finding:
(1) that his past improvement does not support an inference
that his condition will continue to improve to the point of
competency, (2) that expert opinion regarding the amount of
time required for restoration was unsupported by any specific
data and impermissibly relied on generalities, and (3) that the
district court improperly relied on Dr. Ballenger's testimony
because it equated functional competency with trial competency.
After reviewing the evidence, we are not "left with the
definite and firm conviction that a mistake has been
committed." <i>Ruiz-Gaxiola</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1E7A46003?jcsearch=623%20f%203d%20684&amp;summary=yes#jcite">623 F.3d at 693</a> (citations
omitted) (internal quotation marks omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  1. Past Improvement
<span CLASS="page_no" data-cite="2012 bl 51594 p 38" data-cite-type="Bloomberg" data-cite-pageno="38" data-primary-citation="">[**38]</span> </p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner argues that because a response to medication will
eventually plateau, some additional indication beyond past
improvement is required to establish a probability that his
condition will continue to improve to the point of competency.
In concluding that Loughner was likely to continue improving,
however, the district court did not rely solely on Loughner's
past improvement. The court based its finding on Loughner's
positive response to the antipsychotic drugs, including the
lack of significant side effects; Dr. Pietz's testimony
regarding Loughner's progress and potential for further
progress; the experience of Dr. Ballenger, corroborating the
"optimistic viewpoint and prognosis" of Dr. Pietz; and his own
observations of Loughner's improvement. Regardless, past
experience is often the best predication of future performance,
and the district court did not clearly err in basing its
determination of the likelihood of competency restoration on
readily available evidence of Loughner's reaction to
antipsychotic medication already administered, and the views of
the medical experts who testified.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  2. Time Required for Restoration to Competency
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner next disputes the district court's finding that
restoration would be accomplished in four months, and the basis
for Dr. Pietz's opinion that Loughner could be restored to
competency within eight months.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In her progress report on September 7, 2011, Dr. Pietz opined
that Loughner remained incompetent to stand trial. She
requested an extension of his commitment because she believed
that Loughner would improve and reach competency to stand
trial. Dr. Pietz could not predict how much additional time was
required, but she noted that "[h]istorically, most defendants
reach competency within 8 months of their commitment," and
recommended that Loughner's commitment be extended for four
months. At the extension hearing, Dr. Pietz clarified that "the
eight months goes to when we start to medicate [him]." In
coming to the eight-month figure, Dr. Pietz relied on her
experience restoring defendants to competency over twenty-one
years, her colleagues' experience, a book, and several
articles that were presented to
<span CLASS="page_no" data-cite="672 f 3d 771" data-cite-type="PrimaryFederalReporter" data-cite-pageno="771" data-primary-citation="672 F.3d 731">[*771]</span> 
the district court. She did not have, however, any formal
data from which she based her figure of eight months. Dr. Pietz
further explained that she recommended an extension of
commitment for four months because, based on her understanding
of the statute and her experience, extensions are granted in
four-month increments, with the possibility of a second
extension if necessary. <i>See</i> <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d).
Based on the testimony that he heard from Dr. Pietz, a review
of the records in this case, and his own experience, Dr.
Ballenger confirmed that it is "highly likely" that Loughner
will get clinically better in "two to six, eight more months."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court found that Dr. Pietz is credible,
experienced, and qualified to make the judgments required of
her during the commitment hearing. The court further credited
Dr. Pietz's day-to-day personal contact with Loughner, as well
as her "<span CLASS="page_no" data-cite="2012 bl 51594 p 39" data-cite-type="Bloomberg" data-cite-pageno="39" data-primary-citation="">[**39]</span> barometer on whether he's made progress[and] whether
he'll continue to make marked progress." Status Hr'g Tr. 275.
Additionally, Dr. Pietz's opinion was supported by the
testimony of Dr. Ballenger, an "experienced and
well-credentialed psychiatrist."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court did not rely exclusively on the experts. At
the hearing, the district judge found that "measurable progress
toward restoration has been made," <i>id.</i>, and offered his
own observation of Loughner's progress:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I watched Mr. Loughner today as I have in the other
  proceedings. His demeanor, while all the
  characterizations are correct about flat affect and
  all, has been distinctly different than in other
  proceedings. . . . The smirk, what we referred to as
  affect, is gone. He's appeared to pay attention to the
  proceedings today. In earlier proceedings, the court
  notes that he wasn't particularly paying attention. He
  was looking down, looking away, didn't seem connected
  at all. Today, in my lay view, he does appear to be
  more connected to the proceedings, appears to be
  paying attention to what's going on.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i>Id.</i> at 276-77. After admitting that he is "not a
physician," the district court judge concluded that "everything
I observe about [Loughner] seems to connect with the expert
testimony that I've heard; that there is reason to be
optimistic, that he will recover and be able to assist his
lawyers in defending him against this case." <i>Id.</i>
at 277.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Next, the district court determined the appropriate length of
the commitment extension. The court considered Dr. Pietz's
request for an additional eight months, as modified from her
original request for four months, based on her prior
understanding of the statute and case law. Recognizing that
"[i]t's for me to determine what is a reasonable period of
time," the district judge explained that he could not "at this
point [predict] that it would be four months or eight months."
<i>Id.</i> at 278. The court also noted that it was
established that if Dr. Pietz or the physicians at
FMC-Springfield determined that Loughner was restored to
competency before the end of the four-month extension, the
court would be notified. Thus, following another district court
decision, the district court set a four-month period, with the
possibility of granting another extension if necessary. <i>See</i>
<i>United States v. Rodriguez-Lopez</i>, No. CR 08-2447,
<cite>2010 WL 4339282</cite>, at *8 (D.N.M. Sept. 22, 2010) ("Section 4241 provides
insight into the measure of a reasonable `additional period of
time' by establishing that an initial reasonable period is `not
to exceed four months.' The statute appears to contemplate one
four-month term followed by another four-month term." (citation
omitted)).
<span CLASS="page_no" data-cite="672 f 3d 772" data-cite-type="PrimaryFederalReporter" data-cite-pageno="772" data-primary-citation="672 F.3d 731">[*772]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court based its &sect; 4241(d)(2) determination on
the credible testimony of both Dr. Pietz and Dr. Ballenger; a
reading of all the evidence in the record, including contrary
evidence presented by Loughner; and the district judge's own
observations. Loughner did not offer any evidence that he could
not be restored to competency within four months. We find that
the district court considered proper evidence before it and did
not clearly err in determining that there <span CLASS="page_no" data-cite="2012 bl 51594 p 40" data-cite-type="Bloomberg" data-cite-pageno="40" data-primary-citation="">[**40]</span> was a substantial
probability that Loughner would be restored to competency
within four months.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  3. Trial Competency and Clinical Competency
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner finally argues that the district court erred in
accepting Dr. Ballenger's testimony as a proxy for competency
restoration. <i>See Riggins</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. at 141</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a> (Kennedy, J., concurring) ("The avowed purpose of the
[involuntary] medication is not functional competence, but
competence to stand trial."). In the oral ruling on September
28, the district court acknowledged that clinical competence
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  is a proxy, that is a parallel of what's going on
  here. Restoration in the case of someone in a clinical
  setting, for all intents and purposes, is the same
  goal that we have in this case, which is to get
  somebody functioning again as a human being who
  understands, appreciates, and assists in the context
  of the criminal case with the defense of his case.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
Status Hr'g Tr. 276.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although restoration in the clinical setting may not be "the
same goal" as restoration for trial competency, Dr. Ballenger's
testimony was certainly relevant for determining the likelihood
of restoration, generally, of signs of an improvement in mental
disease (and thus whether Loughner's condition has improved
thus far), and the likelihood of restoration given Loughner's
current treatment regimen. Thus, the district court did not
clearly err in relying on Dr. Ballenger's testimony to support
a finding that there was a substantial probability that
Loughner would attain the capacity to permit the proceedings to
go forward.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                               * * * * * *
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court did not commit legal error in its commitment
rulings, and its finding that there is a substantial
probability that Loughner will be restored to competency in the
foreseeable future is supported by the evidence and not clearly
erroneous. Loughner may be committed pursuant to the district
court's order and subject to its supervision.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                              V. CONCLUSION
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The judgment in No. <cite>11-10504</cite> is AFFIRMED. Because the
<i>Harper III</i> hearing supercedes the prior
<i>Harper</i> hearings and the emergency medication order,
appeals No. <cite>11-10339</cite> and No. <cite>11-10432</cite> are DISMISSED as moot.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn*00" name="fn*00">[fn*]</a></span> Appeal No. 11-10339 was argued and submitted on August
30, 2011. Appeal No. 11-10504 was argued and submitted on
November 1, 2011. Appeal No. 11-10432 was submitted, without
argument, on February 27, 2012.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> The regulation was amended effective August 12, 2011.
<i>See</i> <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/1?citation=76%20federal%20register%2040229&amp;summary=yes#jcite">76 Fed.Reg. 40229</a>, <cite>2011 WL 2648228</cite> (Aug. 12,
2011). The former <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1G2A50003?jcsearch=28%20C.F.R.%20%20549.46&amp;summary=yes#jcite">&sect; 549.43</a> is now contained in
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1G2A50003?jcsearch=28%20C.F.R.%20%20549.46&amp;summary=yes#jcite">&sect; 549.46</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn200" name="fn200">[fn2]</a></span> <i>Riggins v. Nevada</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. 127</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=118%20l%20ed%202d%20479&amp;summary=yes#jcite">118 L.Ed.2d 479</a> (1992).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn300" name="fn300">[fn3]</a></span> <i>Sell v. United States</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. 166</a>,
<cite>123 S.Ct. 2174</cite>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=156%20l%20ed%202d%20197&amp;summary=yes#jcite">156 L.Ed.2d 197</a> (2003).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn400" name="fn400">[fn4]</a></span> The current regulation is located at
28 C.F.R. &sect; 549.46(b)(1).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn500" name="fn500">[fn5]</a></span> Dr. Pietz explained at the September 28th hearing that
she initially limited her extension request to four months
because, in her experience, judges ordinarily granted
extensions in four-month increments.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn600" name="fn600">[fn6]</a></span> On February 8, 2012, the district court extended
Loughner's commitment for the purpose of competency restoration
to June 7, 2012. Dr. Pietz reported to the district court that
Loughner remains incompetent to stand trial but that he has
made substantial progress. The government and Loughner filed a
Joint Notice in which they indicated that they had no further
evidence to present.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The extension of the commitment for competency restoration does
not moot the issues in this appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn700" name="fn700">[fn7]</a></span> In No. <cite>11-10339</cite>, Loughner appeals from the district
court's denial of his motion challenging the June 14
involuntary medication decision, <i>Harper I.</i> Because
<i>Harper I</i> is no longer operative, but the bulk of the
legal arguments in that appeal apply also to the <i>Harper</i>
<i>III</i> appeal, we have consolidated the cases and will
consider the briefs, records, and arguments from both appeals
as applied to the September 1 5 <i>Harper III</i> hearing
&mdash; the currently operative involuntary medication order.
No. <cite>11-10339</cite> is therefore dismissed as moot.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In No. <cite>11-10432</cite>, Loughner appeals from the district court's
denial of a prompt post-deprivation hearing after the emergency
medication decision of July 18, 2011. Because that involuntary
medication order is no longer operative, and because there is
no relief that can be granted by this court, that appeal is
dismissed as moot.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn800" name="fn800">[fn8]</a></span> We note that although Loughner cites <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEIMUA003?jcsearch=28%20usc%201292&amp;summary=yes#jcite">28 U.S.C. &sect; 1292</a>
as an alternative basis for jurisdiction, and initially filed a
motion to enjoin in the district court, the parties appear to
have addressed the issues as though this was a direct appeal
from the involuntary medication order and not an appeal from a
denial of a motion for an injunction. <i>See</i>
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEIMUA003?jcsearch=28%20U.S.C.%20%201292(a)(1)&amp;summary=yes#jcite">28 U.S.C. &sect; 1292</a>(a)(1) (providing appellate jurisdiction for denial
of an injunction). Because direct appellate review through the
collateral order doctrine does not add another layer of review,
and because this result is urged by Loughner and acceded to by
the government, we have proceeded in that manner. <i>Cf.</i>
<i>Winter v. Natural Res. Defense Council, Inc.</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X19TK96003?jcsearch=555%20us%207&amp;summary=yes#jcite">555 U.S. 7</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X19TK96003?jcsearch=555%20us%207&amp;summary=yes#jcite">32</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X19TK96003?jcsearch=129%20supreme%20court%20365&amp;summary=yes#jcite">129 S.Ct. 365</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X19TK96003?jcsearch=172%20l%20ed%202d%20249&amp;summary=yes#jcite">172 L.Ed.2d 249</a> (2008) (reviewing an
injunction for abuse of discretion). We also note that it is
not necessary for a defendant to go the route of an injunction
to have the administrative <i>Harper</i> order reviewed in
the district court. The district court's authority to review
pretrial orders naturally extends to a review of pretrial
medication orders.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn900" name="fn900">[fn9]</a></span> The dissent argues that we have addressed "the questions
before us in the wrong order" because the "commitment decision
is the currently operative one." Dissenting Op. at 781
(emphasis omitted). Contrary to this claim, however,
determining whether the involuntary medication order is
currently operative &mdash; i.e., is not substantively or
procedurally deficient &mdash; is a necessary predicate to
determining whether Loughner's commitment for the purpose of
competency restoration is justified. This is so because, as we
explain, if Loughner must be involuntarily medicated because he
is a danger to himself or others, then he will be medicated
irrespective of whether that treatment will restore him to
competency. <i>See Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 181-82</a>,
<cite>123 S.Ct. 2174</cite>. We therefore first address whether Loughner's current
involuntary medication order comports with constitutional
requirements, and then address the extension of his commitment
for the purposes of competency restoration.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1000" name="fn1000">[fn10]</a></span> We note that some of the Court's concerns in
<i>Harper</i> have been lessened to some extent by
significant pharmacological advances. The drugs at issue in
<i>Harper</i> &mdash; Trialafon, Haldol, Prolixin, Taractan,
Loxitane, Mellaril, and Navane, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 214</a> n. 1,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a> &mdash; were first-generation antipsychotics. As Dr.
Ballenger explained at Loughner's commitment hearing, the
"almost miraculous promise of second-generation[medications] is
people still get well, but with markedly less" side effects:
the frequency of tardive dyskinesia is "[a] fifth or one-tenth
of what it was before"; neuroleptic malignant syndrome is
"vanishingly rare"; extrapryamidal effects (Parkinson-like
disorders) that had an incidence rate of 75% with Haldol occur
"very rarely," at the same level as with a placebo; and
"akathisia is also markedly less frequent." <i>See Grape</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1A7982003?jcsearch=549%20f%203d%20591&amp;summary=yes#jcite">549 F.3d at 596</a> (citing testimony from a FMC-Springfield
psychiatrist that "[t]hese side effects, especially neuroleptic
malignant syndrome, EPS or stiffness, and tardive dyskinesia,
which could be permanent, are less common in second-generation
antipsychotics than in first-generation medicines such as
haloperidol"); <i>United States v. Evans</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X120096003?jcsearch=404%20f%203d%20227&amp;summary=yes#jcite">404 F.3d 227</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X120096003?jcsearch=404%20f%203d%20227&amp;summary=yes#jcite">233-34</a> (4th Cir. 2005) (discussing the involuntary medication
report's conclusion that "second-generation, or atypical
antipsychotic medications" have a reduced risk of side
effects).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1100" name="fn1100">[fn11]</a></span> Furthermore, in <i>Sell</i>, the Court observed that
FMC-Springfield and the magistrate judge held dangerousness
hearings "applying standards roughly comparable to those set
forth here and in <i>Harper." Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 183</a>,
<cite>123 S.Ct. 2174</cite>. The magistrate judge approved Sell's medication on
dangerousness grounds. Although the district court found that
conclusion clearly erroneous, the court of appeals agreed, and
the government did not appeal the finding, the Supreme Court
noted that "[i]f anything, the record before us . . . suggests
the contrary," before proceeding on the "hypothetical
assumption" that Sell was not dangerous. <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20at%20183&amp;summary=yes#jcite">Id.
at 184-85</a>, <cite>123 S.Ct. 2174</cite>. If the Court had any remaining doubts
about the nature of the hearings, it had ample opportunity to
renew its disclaimer in <i>Riggins</i> or otherwise question
the standards used by FMC-Springfield and the magistrate
judge.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1200" name="fn1200">[fn12]</a></span> We note that in <i>Weston</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3F9L5?jcsearch=206%20f%203d%209&amp;summary=yes#jcite">206 F.3d 9</a>, a
pre-<i>Sell</i> decision, the panel questioned whether, in
light of <i>Riggins, Harper</i> applied to pretrial
detainees. <i>Compare </i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3F9L5?jcsearch=206%20F.3d%209&amp;summary=yes#jcite">id. at 14</a> (Henderson, J.,
concurring) ("[T]he applicable standards for reviewing an
institution's medical/safety determination appear to me, at
least, to be the same for a detainee as for a convicted
inmate."), <i>with </i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3F9L5?jcsearch=206%20F.3d%209&amp;summary=yes#jcite">id. at 17</a> (Rogers, J., concurring)
("The Supreme Court may ultimately articulate a standard for
pretrial detainees that is different from the one applied in
<i>Harper</i> to a prison inmate. . . ."). So far as we can
determine, the DC. Circuit has not revisited the question
after <i>Sell.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1300" name="fn1300">[fn13]</a></span> We have some additional concerns with how, short of
having legal counsel, a detainee's interests are represented at
the dangerousness hearing. These are addressed <i>infra</i>
at Part III.B.3.d.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1400" name="fn1400">[fn14]</a></span> Dr. Tomelleri noted that, during the hearing, Loughner
complained of "drowsiness" and said that his treating
psychiatrist would modify his medications to address this side
effect.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1500" name="fn1500">[fn15]</a></span> We have recognized that such specificity is appropriate
when an inmate is not a danger to himself or to others and is
being medicated pursuant to <i>Sell. See</i>
<i>Hemandez-Vasquez</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20f%203d%20908&amp;summary=yes#jcite">513 F.3d at 916-17</a>;
<i>Rivera-Guerrero</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20f%203d%201130&amp;summary=yes#jcite">426 F.3d at 1140</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20f%203d%201130&amp;summary=yes#jcite">1142</a>. Even as we
have expressed concern "not to grant physicians unlimited
discretion in their efforts to restore a defendant to
competency for trial," we have also stated that we will not
"micromanage the decisions of medical professionals" and must
"give physicians a reasonable degree of flexibility."
<i>Hernandez-Vasquez</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20f%203d%20908&amp;summary=yes#jcite">513 F.3d at 916-17</a>. Noting "that
instances in which an order for involuntary medication would be
appropriate under <i>Sell</i> `may be rare,'" we advised that
it may be better "if the facts warrant, to find another legal
basis for involuntary medication." <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20F.3d%20at%20916-17&amp;summary=yes#jcite">Id. at 916</a> (quoting
<i>Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 180</a>, <cite>123 S.Ct. 2174</cite>).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1600" name="fn1600">[fn16]</a></span> The government points out that one of Loughner's
attorneys, Anne Chapman, acted as a witness by submitting a
written statement raising factual and legal arguments against
involuntary medication. A written statement, however, may not
necessarily cure a procedural defect because it does not afford
the opportunity to respond to evidence or arguments put forward
at the hearing.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1700" name="fn1700">[fn17]</a></span> We review the district court's legal conclusions de novo
and its factual findings for clear error. <i>See</i>
<i>Ruiz-Gaxiola</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1E7A46003?jcsearch=623%20f%203d%20684&amp;summary=yes#jcite">623 F.3d at 693</a>. We review a district
court's competency determination for clear error.
<i>Friedman</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X6BFA3?jcsearch=366%20f%203d%20975&amp;summary=yes#jcite">366 F.3d at 980</a>; <i>United States v.</i>
<i>Gastelum-Almeida</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XF7HB3?jcsearch=298%20f%203d%201167&amp;summary=yes#jcite">298 F.3d 1167</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XF7HB3?jcsearch=298%20f%203d%201167&amp;summary=yes#jcite">1171</a> (9th Cir. 2002). "A
trial court's factual finding is clearly erroneous when,
although there is evidence to support it, the reviewing court
on the entire evidence is left with the definite and firm
conviction that a mistake has been committed."
<i>Ruiz-Gaxiola</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1E7A46003?jcsearch=623%20f%203d%20684&amp;summary=yes#jcite">623 F.3d at 693</a> (internal quotation
marks omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1800" name="fn1800">[fn18]</a></span> The district court noted that there was no "evidence
that the FMC[-Springfield] staff is medicating the defendant
under <i>Harper</i> just to avoid a more stringent
<i>Sell</i> hearing. . . . The FMC[-Springfield] staff has no
<i>obligation</i> to restore the defendant to competency, and
indeed, the staff is free to report to the Court that the
defendant cannot be restored or has not been restored within
the time allowed." Order on <i>Sell</i> Hr'g 6 n. 3, Oct. 27,
2011.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  WALLACE, Senior Circuit Judge, concurring in all but
Part III.B.3.d. of Judge BYBEE's opinion and concurring in the
judgment:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I concur in the opinion and judgment and I join the
excellent analysis in all sections except Part III.B.3.d. I do
not join in the negative speculation that Loughner's staff
representative, John Getchell, was unqualified or that
Getchell's performance was procedurally defective.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Judge Bybee suggests that Getchell, a Licensed Clinical Social
Worker, might not "understand[] the psychiatric issues
involved" in medicating Loughner sufficiently to satisfy
<i>Washington v. Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. 210</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">236</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=108%20l%20ed%202d%20178&amp;summary=yes#jcite">108 L.Ed.2d 178</a> (1990) and qualify as a staff
representative under 28 C.F.R. &sect; 549.46(a)(3). <i>See</i>
<span CLASS="page_no" data-cite="672 f 3d 773" data-cite-type="PrimaryFederalReporter" data-cite-pageno="773" data-primary-citation="672 F.3d 731">[*773]</span> 
Opinion at 762. This suggestion is made with nothing in the
record to support it.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  But a more basic question is why is this suggestion in the
opinion at all? The sufficiency of Getchell's understanding was
never raised by Loughner. <i>See Smith v. Marsh</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3AUVN?jcsearch=194%20f%203d%201045&amp;summary=yes#jcite">194 F.3d 1045</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3AUVN?jcsearch=194%20f%203d%201045&amp;summary=yes#jcite">1052</a> (9th Cir. 1999) ("[O]n appeal, arguments not raised
by a party in its opening brief are deemed waived").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Furthermore, I do not join in viewing the dearth of record on
Getchell's qualifications to support <span CLASS="page_no" data-cite="2012 bl 51594 p 41" data-cite-type="Bloomberg" data-cite-pageno="41" data-primary-citation="">[**41]</span> the possibility of sending
this case back to the district court. Instead, I would view it
as a reason to affirm because it means that Loughner has not
met his burden to show the arbitrariness of the Bureau of
Prison's decision. <i>See</i> Part III.B.3 (describing
standard of review).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Judge Bybee also suggests that Getchell's representation might
have been procedurally defective because he did not present
affirmative evidence or question any of the evidence in support
of involuntary medication. <i>See</i> Opinion at 763-64. This
suggestion that Getchell's performance was flawed for not
acting more like an advocate follows from Judge Bybee's
labeling a <i>Harper</i> hearing as "adversarial."
<i>See</i> Opinion at 763. I disagree with his analysis on
this issue because, whatever label is given to <i>Harper</i>
hearings, <i>Harper</i> itself requires no more than "the
provision of an independent lay adviser who understands the
psychiatric issues involved." <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 236</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>.
There is no record evidence this standard was not met. There is
nothing in <i>Harper</i> giving the adviser a duty to act as
an advocate in the traditional adversarial sense. Nor does
28 C.F.R. &sect; 549.46 require the staff representative to seek
affirmatively to develop evidence in the inmate's favor.
<i>See</i> 28 C.F.R. &sect; 549.46(a)(3) (inmate may
"<i>request</i> that witnesses be questioned by the staff
representative") (emphasis added). The standard for this
administrative hearing has been set by Congress. Supreme Court
cases have not expanded this standard. Why should this court
tamper with it?
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The basis of the tampering is questionable. I disagree with
Judge Bybee's categorization of a <i>Harper</i> hearing as
"adversarial" rather than "inquisitorial" to the extent the
categorization is used to support a due process requirement for
a staff representative to act as an adversarial advocate. As he
recognized, "[w]hat makes a system adversarial rather than
inquisitorial is not the presence of counsel . . . but rather,
the presence of a judge who does not (as an inquisitor does)
conduct the factual and legal investigation himself, but
instead decides on the basis of facts and arguments pro and con
adduced by the parties." <i>McNeil v. Wisconsin</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC2N?jcsearch=501%20us%20171&amp;summary=yes#jcite">501 U.S. 171</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC2N?jcsearch=501%20us%20171&amp;summary=yes#jcite">181</a>, n. 2, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC2N?jcsearch=111%20supreme%20court%202204&amp;summary=yes#jcite">111 S.Ct. 2204</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC2N?jcsearch=115%20l%20ed%202d%20158&amp;summary=yes#jcite">115 L.Ed.2d 158</a> (1991). In
Loughner's <i>Harper</i> hearings, the presiding
psychiatrist, Dr. Tomelleri, acted as an inquisitor. Dr.
Tomelleri interviewed and observed Loughner and used the
interviews as a basis for his decisions. Loughner could have
requested that any other witnesses be questioned by the Dr.
Tomelleri. <i>See</i> 28 C.F.R. &sect; 549.46(a)(3).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  That a <i>Harper</i> hearing involves overcoming a person's
desires with respect to a significant liberty interest does not
require that the proceeding be an adversarial hearing with an
advocate-representative. <i>In Wolff v. McDonnell</i>, the
Supreme Court did not impose a right to counsel in connection
with prison disciplinary proceedings, even where good time
credits are at stake, because "[t]he insertion of counsel into
the disciplinary process would inevitably give the proceedings
a more adversary cast and tend to reduce their utility as a
means to further correctional goals."
<span CLASS="page_no" data-cite="672 f 3d 774" data-cite-type="PrimaryFederalReporter" data-cite-pageno="774" data-primary-citation="672 F.3d 731">[*774]</span> 
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8SD?jcsearch=418%20us%20539&amp;summary=yes#jcite">418 U.S. 539</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8SD?jcsearch=418%20us%20539&amp;summary=yes#jcite">570</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8SD?jcsearch=94%20supreme%20court%202963&amp;summary=yes#jcite">94 S.Ct. 2963</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C8SD?jcsearch=41%20l%20ed%202d%20935&amp;summary=yes#jcite">41 L.Ed.2d 935</a> (1974). In
<i>Parham v. J.R.</i>, the Supreme Court did not require a
hearing when a <span CLASS="page_no" data-cite="2012 bl 51594 p 42" data-cite-type="Bloomberg" data-cite-pageno="42" data-primary-citation="">[**42]</span> staff physician determines whether a child may
be voluntarily committed to a state mental institution by his
parents. <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9QO?jcsearch=442%20us%20584&amp;summary=yes#jcite">442 U.S. 584</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9QO?jcsearch=99%20supreme%20court%202493&amp;summary=yes#jcite">99 S.Ct. 2493</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9QO?jcsearch=61%20l%20ed%202d%20101&amp;summary=yes#jcite">61 L.Ed.2d 101</a> (1979).
The Court permitted the use of "informal traditional medical
investigative techniques," in part, because "[w]hat is best for
a child is an individual medical decision that must be left to
the judgment of physicians in each case." <i>Id.</i>
at 607-08, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9QO?jcsearch=99%20supreme%20court%202493&amp;summary=yes#jcite">99 S.Ct. 2493</a>. The Court was also concerned that an
adversarial hearing might pose a danger "for significant
intrusion into the parent-child relationship" and might
"exacerbate whatever tensions already exist between the child
and the parents" to the detriment of "the successful long-range
treatment of the patient." <i>Id.</i> at 610, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9QO?jcsearch=99%20supreme%20court%202493&amp;summary=yes#jcite">99 S.Ct. 2493</a>.
Similar concerns are present in this case: a <i>Harper</i>
hearing is aimed at reaching a medical judgment, <i>see</i>
Part III.B.2.C, and to require the hearing to become more
adversarial might well intrude into the doctor-patient
relationship to the detriment of Loughner's long-range
treatment.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The basis for recasting the role of the staff representative
into an attorney-like advocate appears to come from a
"home-town" preference or, as Judge Bybee puts it: "[w]ithin
our traditions." Opinion at 763. There are two problems with
this approach. First, the vast majority of countries use the
"inquisitorial" or "civil" trial practices to ascertain truth.
We are used to our hometown process, but that does not make the
vast majority of court systems wrong or inadequate.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Second, there is no argument in Judge Bybee's opinion that the
inquisitorial method is unconventional. Indeed, he identifies
areas of significant importance where the inquisitorial or
civil method is effectively used in our country. <i>See</i>
Opinion at 762.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In any event, this case does not give us free rein to design
from scratch whatever procedures we think would be best for the
Bureau of Prisons to follow. Instead, we are required to give
substantial deference to the penological regulations already in
existence. <i>See Bell v. Wolfish</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9P3?jcsearch=441%20us%20520&amp;summary=yes#jcite">441 U.S. 520</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9P3?jcsearch=441%20us%20520&amp;summary=yes#jcite">547</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9P3?jcsearch=99%20supreme%20court%201861&amp;summary=yes#jcite">99 S.Ct. 1861</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9P3?jcsearch=60%20l%20ed%202d%20447&amp;summary=yes#jcite">60 L.Ed.2d 447</a> (1979) ("Prison administrators . . .
should be accorded wide-ranging deference in the adoption and
execution of policies and practices that in their judgment are
needed to preserve internal order and discipline and to
maintain institutional security"). Judge Berzon's dissent never
acknowledges this principle, and none of the cases she relies
on actually hold that due process requires more than compliance
with existing regulations. <i>See United States v.</i>
<i>Morgan</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3OCSV?jcsearch=193%20f%203d%20252&amp;summary=yes#jcite">193 F.3d 252</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3OCSV?jcsearch=193%20f%203d%20252&amp;summary=yes#jcite">253</a> (4th Cir. 1999) (remanding for
factual findings as to whether the staff representative had the
education and experience required by regulation); <i>United</i>
<i>States v. Humphreys</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X287DJ?jcsearch=148%20f%20supp%202d%20949&amp;summary=yes#jcite">148 F.Supp.2d 949</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X287DJ?jcsearch=148%20f%20supp%202d%20949&amp;summary=yes#jcite">953</a> (D.S.D. 2001)
(requiring a representative "that will more fully comply with
the due process requirements of <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1G2A50003?jcsearch=28%20C.F.R.%20%20549.46&amp;summary=yes#jcite">section 549.43</a>"); <i>United</i>
<i>States v. Weston</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3M9V3?jcsearch=55%20f%20supp%202d%2023&amp;summary=yes#jcite">55 F.Supp.2d 23</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3M9V3?jcsearch=55%20f%20supp%202d%2023&amp;summary=yes#jcite">26-27</a> (D.D.C. 1999)
(remanding to Bureau of Prisons because of non-compliance with
a court order and prison regulations). There is no reason to
depart from the regulations and impose additional requirements
on the conduct of a staff representative.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Here, the standards of <i>Harper</i> and
28 C.F.R. &sect; 549.46 have been met. Getchell explained Loughner's rights <span CLASS="page_no" data-cite="2012 bl 51594 p 43" data-cite-type="Bloomberg" data-cite-pageno="43" data-primary-citation="">[**43]</span> to
him and presented him the opportunity to answer any questions
about the process; Getchell was present at the <i>Harper</i>
hearings; Getchell encouraged Loughner to participate despite
his initial reluctance; and twice
<span CLASS="page_no" data-cite="672 f 3d 775" data-cite-type="PrimaryFederalReporter" data-cite-pageno="775" data-primary-citation="672 F.3d 731">[*775]</span> 
Getchell appealed on Loughner's behalf. There is no
evidence that Getchell was unable or unwilling to provide any
assistance requested by Loughner or his attorneys at the time
of the <i>Harper III</i> hearing. Not one piece of evidence is
before this court that Getchell was unqualified to perform the
task identified in the governing statute. No wonder Loughner
did not raise that issue on appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I need not get to the harmless error analysis, but I agree that
any imagined error would be harmless. Thus, I join in that
holding. My division from Judge Bybee is that no error was
shown and any consideration of an imagined error would be
inappropriate. Because <i>Harper</i> and
28 C.F.R. &sect; 549.46 do not provide a right for the type of
advocate-representative that Loughner now seeks, there was no
Constitutional deficiency in Getchell's performance.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  BERZON, Circuit Judge, dissenting:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Viewed realistically, what the majority holds is that the
district court correctly abdicated to Loughner's prison
physicians the responsibility to determine whether he is to be
restored to trial competency through involuntary medication.
The form of the majority opinion obscures that holding, as it
addresses first the quite separate question of the standards
and procedures applicable to the mid-commitment decision to
medicate a pretrial detainee for reasons of dangerousness. But
that is not where we are now in this case. Instead, we are,
principally, reviewing the district court's decision as to
<i>whether</i> Loughner is to be committed to a federal
medical facility for purposes of restoration of competency to
stand trial, a goal that, all agree, could be accomplished only
through psychotropic medication, which Loughner refuses to take
voluntarily. As I cannot agree that Loughner may be so
committed without a judicial determination as to the propriety
of involuntary medication and because, even on the majority's
approach, I see several deficiencies in the administrative
proceedings conducted by the medical center's physicians
&mdash; I respectfully dissent.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                              <b>I. Background</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I begin by highlighting certain aspects of the relevant
proceedings crucial to the resolution of this case.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>A. The first Harper proceeding</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As the nation is well aware, Jared Loughner, a seriously
disturbed young man, shot at Congresswoman Gabrielle Giffords
and her entourage outside a Tucson supermarket on January 8,
2011, profoundly injuring her and killing Federal District
Judge John Roll and five others. He was indicted for numerous
criminal offenses relating to the shooting. Finding that
Loughner presented a danger to the community, the district
court ordered him committed to the federal government's custody
for confinement at a corrections facility pending trial. Two
months later, the district court granted the government's
motion for a competency examination <span CLASS="page_no" data-cite="2012 bl 51594 p 44" data-cite-type="Bloomberg" data-cite-pageno="44" data-primary-citation="">[**44]</span> and, pursuant to
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU2E003?jcsearch=18%20usc%204247&amp;summary=yes#jcite">18 U.S.C. &sect; 4247</a>, committed Loughner to the United States Medical
Center for Federal Prisoners in Springfield, Missouri
(FMC-Springfield) for evaluation. There, a Bureau of Prisons
staff psychologist, Dr. Christina Pietz, and an independent
psychiatrist, Dr. Matthew Carroll, examined Loughner and issued
forensic reports to the district court. Doctor Pietz observed
in her report that Loughner "was polite, cooperative, and
forthcoming" during their initial interview and that he was,
"[f]or the most part . . . cooperative with correctional staff"
during the examination period. Both Dr. Pietz and Dr. Carroll
diagnosed Loughner with schizophrenia and concluded that he
was,
<span CLASS="page_no" data-cite="672 f 3d 776" data-cite-type="PrimaryFederalReporter" data-cite-pageno="776" data-primary-citation="672 F.3d 731">[*776]</span> 
at that time, incompetent to stand trial.<a HREF="#fn101" name="fnref_fn101">[fn1]</a> The district
court agreed and ordered Loughner committed to the Attorney
General's custody for a four-month period of hospitalization at
FMC-Springfield, to "determine whether there is a substantial
probability that in the foreseeable future he will attain the
capacity to permit the proceedings to go forward."
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(1)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(1).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  At FMC-Springfield, Loughner's physicians prescribed
psychotropic medication, but Loughner refused to take it. The
facility therefore decided to conduct an administrative
proceeding to determine whether Loughner should be
involuntarily medicated. On June 2, Dr. Pietz, now Loughner's
treating psychologist, provided Loughner a Notice of Medication
Hearing and Advisement of Rights form. The form explained that
Loughner was diagnosed with "undifferentiated schizophrenia"
and that the proposed treatment was "anti-psychotic
medication." Under the heading "Reason for Treatment," the form
stated: "Mr. Loughner suffers from a mental illness and refused
to take the medication prescribed to him. He was referred to
this facility to restore competency."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On June 14, the prison conducted an administrative involuntary
medication hearing ("<i>Harper I</i> "), pursuant to the
procedures outlined in the then-current federal regulation,
28 C.F.R. &sect; 549.43, and <i>Washington v. Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. 210</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=108%20l%20ed%202d%20178&amp;summary=yes#jcite">108 L.Ed.2d 178</a> (1990). Doctor Carlos
Tomelleri, a prison psychiatrist not involved in Loughner's
diagnosis and treatment, presided over the proceedings. The
hearing's other participants included Loughner, his staff
representative John Getchell (a prison employee who is a
licensed social worker), Dr. Robert Sarrazin (chief of
psychiatry at FMC-Springfield and Loughner's treating
psychiatrist), and Dr. Pietz.<a HREF="#fn201" name="fnref_fn201">[fn2]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The hearing did not go well. Loughner barricaded himself behind
his bed and refused to participate in the proceeding. There is
no evidence in the record to suggest that Getchell made any
statements or inquiries on Loughner's behalf at the hearing.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In his post-hearing involuntary medication report, Dr.
Tomelleri concluded that the involuntary administration of
psychotropic medication was justified on the ground that
Loughner was dangerous to others. Doctor Tomelleri noted that
Loughner had several times thrown plastic chairs against a
metal grill, behind which was Dr. Pietz, and at a wall; had
tried to throw toilet paper at a camera; had spat and "lunged"
at one of his <span CLASS="page_no" data-cite="2012 bl 51594 p 45" data-cite-type="Bloomberg" data-cite-pageno="45" data-primary-citation="">[**45]</span> attorneys (a characterization the defense
disputes); continued to suffer from auditory hallucinations;
laughed inappropriately; made poor eye contact; and repeatedly
yelled the word "No!" Comparing the relative merits of
psychotropic medication and other, less intrusive treatment
options, Dr. Tomelleri wrote:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Treatment with psychotropic medication is universally
  accepted as the choice for conditions such as Mr.
  Loughner's. Other measures, such as psychotherapy, are
  not practicable and do not address
<span CLASS="page_no" data-cite="672 f 3d 777" data-cite-type="PrimaryFederalReporter" data-cite-pageno="777" data-primary-citation="672 F.3d 731">[*777]</span> 
  the fundamental problem. Minor tranquilizers
  (benzodiazepines) are useful in reducing agitation,
  but have no direct effect on the core manifestations
  of the mental disease. Seclusion and restraints are
  merely temporary protective measures with no direct
  effect on mental disease.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
Dr. Tomelleri concluded that involuntary medication was
justified but neither identified the proposed medication
regimen nor established any limits on what medication might be
administered.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner appealed the authorization of involuntary medication.
On the appeal form, he wrote: "You can't make me take any drug!
I know it's cruel punishment," and added profane comments.
Getchell confirmed that Loughner wished to appeal the decision
of the hearing psychiatrist and that he desired to submit the
incoherent, profanity-laced statement; Getchell made no effort
to develop actual arguments in support of the appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The prison's Associate Warden for Health Services ("the
warden") upheld Dr. Tomelleri's authorization of involuntary
medication. The warden concluded that Loughner was dangerous to
others because he "engag[ed] in conduct, like throwing chairs,
that is either intended or reasonably likely to cause physical
harm to another or cause significant property damage." He
further informed Loughner that "medication is the best
treatment for your symptoms," and that "[m]inor tranquilizers,
seclusion or restraints are only temporary in nature and have
no direct effect on your symptoms or illness."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On June 21, Dr. Sarrazin filled out an administrative note
indicating that Loughner was to be treated twice daily, for 30
days, with 0.5 mg oral solutions of Risperidone.<a HREF="#fn301" name="fnref_fn301">[fn3]</a> That same
day, defense counsel first became aware of the involuntary
medication decision. Soon thereafter, defense counsel filed a
motion in the district court seeking to enjoin Loughner's
involuntary medication. Proffering testimony from a former
Bureau Of Prisons official and a forensic psychiatrist with a
background in prison administration and involuntary medication
decisions, defense counsel argued that Loughner's status as a
pretrial detainee entitled him to an evidentiary hearing before
the court as a prerequisite to involuntary medication, and that
the prison had not sufficiently justified the need for
psychotropic drugs over less-intrusive alternatives.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court held that Loughner was entitled neither to a
judicial evidentiary hearing on the involuntary medication
issue nor to the heightened substantive standards advocated <span CLASS="page_no" data-cite="2012 bl 51594 p 46" data-cite-type="Bloomberg" data-cite-pageno="46" data-primary-citation="">[**46]</span> by
the defense. Instead, the court adopted the approach of
<i>United States v. Morgan</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3OCSV?jcsearch=193%20f%203d%20252&amp;summary=yes#jcite">193 F.3d 252</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3OCSV?jcsearch=193%20f%203d%20252&amp;summary=yes#jcite">262-63</a> (4th
Cir. 1999), and reviewed the prison's <i>Harper I</i>
determination for arbitrariness. Finding "no evidence that the
FMC staff is in any way an ally of the Government prosecution
team," and pointedly noting that <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d) did
not charge FMC-Springfield's staff "with the
<i>obligation</i> to restore [Loughner] to competency," the
court concluded that "the procedures followed by the FMC staff
at the <cite>&sect; 549.43</cite> hearing, and the finding of the presiding
independent psychiatrist, were not arbitrary." The court
further concluded that the procedural protections afforded
Loughner satisfied <i>Harper's</i> due process requirements.
<span CLASS="page_no" data-cite="672 f 3d 778" data-cite-type="PrimaryFederalReporter" data-cite-pageno="778" data-primary-citation="672 F.3d 731">[*778]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>B. The Emergency Medication Proceeding</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On July 1, a motions panel of this Court granted Loughner's
motion for a temporary stay of involuntary medication pending
appeal. On July 12, the panel continued the stay, with the
clarification that it applied specifically to psychotropic
medication and that other measures (such as involuntarily
administered tranquilizers) remained available. In response to
this Court's stay orders, FMC-Springfield immediately stopped
administering Loughner's psychotropic medication.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Loughner's condition deteriorated significantly after the
sudden withdrawal of medication. On July 8, FMC-Springfield
placed him on suicide watch. Ten days later, FMC-Springfield
doctors determined that he was a severe danger to himself and
authorized psychotropic medication on an emergency basis, a
decision this Court was also asked to stay but did not. On
August 11, the defense filed a motion seeking to enjoin the
emergency administration of psychotropic medication, which the
district court denied.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>C. The Second Harper Proceeding</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On August 25, FMC-Springfield conducted a second
<i>Harper</i> hearing ("<i>Harper II</i> "), pursuant to
28 C.F.R. &sect; 549.46, the newly promulgated replacement for
28 C.F.R. &sect; 549.43. <i>See</i> <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/1?citation=76%20federal%20register%2040229&amp;summary=yes#jcite">76 Fed.Reg. 40229-02</a>,
<cite>2011 WL 2648228</cite> (Aug. 12, 2011). Doctor Tomelleri again concluded that
involuntary psychotropic medication was justified, this time
based on the threat Loughner's behavior posed to his own
safety. On administrative appeal from the <i>Harper II</i>
involuntary medication order, the warden determined that the
<i>Harper II</i> proceeding was invalid because the
administrative hearing officer had failed to obtain a
pre-hearing witness statement from Loughner's requested witness
(defense counsel Anne Chapman).<a HREF="#fn401" name="fnref_fn401">[fn4]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>D. The Third Harper Proceeding</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On September 15, 2011, FMC-Springfield conducted its third
<i>Harper</i> hearing ("<i>Harper III</i>"). Doctor
Tomelleri, again presiding, concluded that involuntary
psychotropic medication was justified on the basis of the
danger Loughner posed to himself. In reaching this result, Dr.
Tomelleri noted that Loughner's condition deteriorated
significantly after involuntary medication was discontinued in
July, and observed that, although many of Loughner's psychotic
symptoms had abated after medication resumed, he continued to
exhibit signs of restlessness, guilt, and suicidal ideation.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Doctor Tomelleri determined that psychotropic medication was
justified <span CLASS="page_no" data-cite="2012 bl 51594 p 47" data-cite-type="Bloomberg" data-cite-pageno="47" data-primary-citation="">[**47]</span> because "[d]iscontinuation . . . is virtually certain
to result in an exacerbation of Mr. Loughner's illness as it
did when medication was discontinued in July." Echoing, nearly
verbatim, the justification asserted in the <i>Harper I</i>
and <i>Harper II</i> proceedings, he added that
"[p]sychotropic medication is the treatment of choice for
conditions such as Mr. Loughner is experiencing," and rejected
"[o]ther measures, such as psychotherapy, [because they] do not
address the fundamental problem." He further noted that
"[s]eclusion and restraints are merely protective temporary
measures with no direct effect on the core manifestations of
the mental illness." As in the <i>Harper I</i> proceeding,
Dr. Tomelleri did not specify any limits on the types or
dosages medications that might be involuntarily administered
<span CLASS="page_no" data-cite="672 f 3d 779" data-cite-type="PrimaryFederalReporter" data-cite-pageno="779" data-primary-citation="672 F.3d 731">[*779]</span> 
or describe the proposed future treatment plan. He did,
however, list Loughner's current medication regimen, and
indicated that a treatment plan could be found on Loughner's
chart. On appeal, the warden determined that Loughner had been
afforded his due process rights and, rejecting alternatives
because they would "not impact the underlying cause or relieve
the symptoms of [Loughner's] mental illness," upheld Dr.
Tomelleri's involuntary medication order.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  After his administrative appeal was denied, Loughner filed an
emergency motion in the district court to enjoin his
involuntary medication under the <i>Harper III</i> order. In
addition to reiterating his previous arguments, Loughner argued
that his staff representative had provided inadequate
representation and that the Bureau of Prisons had not
established that antipsychotic medication was needed to treat
his dangerousness to self. The district court briefly addressed
Loughner's motion at the <cite>&sect; 4241(d)(2)(A)</cite> commitment hearing
conducted on September 28, 2011, and in the ensuing written
opinion.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>E. Request for Commitment Pursuant to</i>
<i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/1?citation=18%20usc%204241&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2)(A</i>)
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In her August 22 and September 7 progress reports to the
district court, Dr. Pietz summarized Loughner's hospital
course, described his current mental status and psychiatric
treatment, and provided her opinions as to the probability that
he could be restored to competency for trial and as to the
likely length of treatment toward that end. Doctor Pietz
concluded that Loughner would likely be restored to competency
"in the near future." The government accordingly asked the
district court to commit Loughner for the purpose of restoring
his trial competency, pursuant to
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)(A)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2)(A). Loughner filed a motion objecting to commitment
under <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">&sect; 4241(d)(2)</a> and asking the court to "engage in a
predictive analysis not unlike that developed in <i>Sell [v.</i>
<i>United States</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. 166</a>, <cite>123 S.Ct. 2174</cite>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=156%20l%20ed%202d%20197&amp;summary=yes#jcite">156 L.Ed.2d 197</a> (2003)] and its progeny, in which the court must not only
assess the substantial likelihood of competency restoration but
also consider the potential side effects caused by the drugs
used to restore competency."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>F. The September 28 Hearing</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On September 1, the district court issued an order scheduling
Loughner's &sect; 4241(d)(2)(A) commitment hearing. The order
stated that "the scope of the hearing will be limited to the
<span CLASS="page_no" data-cite="2012 bl 51594 p 48" data-cite-type="Bloomberg" data-cite-pageno="48" data-primary-citation="">[**48]</span> question of whether an additional period of time should be
granted to actually restore the defendant to competency." The
court also conducted a telephonic status conference in advance
of the commitment hearing. During the telephonic conference,
Dr. Pietz informed the court that Loughner wished to attend the
commitment hearing. The court concluded that Loughner had a
right to attend the hearing, pursuant to
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU2E003?jcsearch=18%20U.S.C.%20%204247(d)&amp;summary=yes#jcite">18 U.S.C. &sect; 4247</a>(d), and accordingly "require[d] that [Loughner] be present
for the extension hearing."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On September 28, the district court conducted the
<cite>&sect; 4241(d)(2)(A)</cite> commitment hearing. In addition to the district
judge and counsel for both parties, Loughner, Dr. Pietz, and
Dr. Ballenger (a clinical psychiatrist and expert witness for
the government) convened at the Tucson courthouse for the
proceedings. At the outset, the court reiterated its intention
to restrict the evidentiary aspect of the hearing to the
commitment issue, even though other matters &mdash;
specifically, the defense's recently submitted motion to stay
Loughner's involuntary medication under the <i>Harper III</i>
order &mdash; were pending.
<span CLASS="page_no" data-cite="672 f 3d 780" data-cite-type="PrimaryFederalReporter" data-cite-pageno="780" data-primary-citation="672 F.3d 731">[*780]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As the majority describes in fuller detail, Dr. Pietz and Dr.
Ballenger testified at length about Loughner's progress and his
prospects for restoration through involuntary medication.
During the hearing, the court persistently emphasized that
"[t]he limited focus here is whether an extension is likely
&mdash; substantially probable to restore him." So stating, the
court repeatedly prevented defense counsel from cross-examining
Doctors Pietz and Ballenger regarding Loughner's diagnosis and
the propriety of the drugs prescribed for treating his
dangerousness. Although defense counsel argued that "[t]he
restoration depends upon the treatment that's going to be
given," the court reiterated that "[t]he question here is
whether he's likely to be restored with an extended commitment
to Springfield."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  At the conclusion of the hearing, the district court determined
that Loughner was likely to be restored to competency within a
reasonable period of time, assuming he continued to receive
involuntary medication. It accordingly held that Loughner's
commitment should be extended by four months, pursuant to
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2). The court emphasized that it was
recommitting Loughner for the express purpose of restoration:
"I'm now committing him for the purpose of restoration. No more
evaluation. It changes today with this ruling. He's being
committed for another four months for the purpose of
restoration." It also expressed a concern that the procedural
and substantive standards applicable under <i>Sell</i> when
the government seeks to medicate involuntarily a pretrial
detainee for purposes of restoration to competency were
implicated by the court's decision to extend Loughner's
commitment for the express purpose of restoration. "I'm
committing him at a time that I know that they're continuing to
treat him with medication that he declines to take," the court
stated, "I think this is a very different situation from what
has existed to this point. I'm now telling them to continue <span CLASS="page_no" data-cite="2012 bl 51594 p 49" data-cite-type="Bloomberg" data-cite-pageno="49" data-primary-citation="">[**49]</span> to
restore him. I think we're right up against <i>Sell.</i>" The
court concluded that a <i>Sell</i> judicial hearing, or at
least some acknowledgment of the <i>Sell</i> issue, needed to
take place, but stated that it was postponing the matter to a
later date.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Before the hearing adjourned, defense counsel reminded the
court of its pending motion to stay Loughner's involuntary
medication. The court emphasized that it was "not being
stubborn," but stated that it continued to believe that the
Bureau of Prisons should determine the propriety of Loughner's
involuntary medication so long as the purpose of medication
related to his dangerousness, even if it was an essential
predicate for the court's commitment decision. Reaffirming its
reliance on <i>Morgan</i>, the court stated it would review
the prison's <i>Harper III</i> determination only for
arbitrariness and for compliance with 28 C.F.R. &sect; 549.46
and <i>Harper.</i> The court concluded that there was "no
arbitrariness in the third <i>Harper</i> hearing and that the
medication going forward, at least of today, is authorized
pursuant to the <i>Harper</i> case." Loughner appealed.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  While Loughner's appeal was pending, the district court issued
an order holding that Loughner is not entitled to a judicial
<i>Sell</i> hearing regarding the propriety of pretrial
involuntary medication where the ultimate goal is restoration
of competency. The court acknowledged that it was "shifting the
aim of [Loughner's] commitment from evaluation to restoration,"
but reasoned that "the Supreme Court, in <i>Sell</i>,
contemplated that a pretrial detainee could be incidentally
restored to trial competency by being medicated on
dangerousness grounds under <i>Harper.</i>" The court
accordingly concluded that Loughner was not entitled to further
<i>procedural</i> protections, because the prison "doctors
have
<span CLASS="page_no" data-cite="672 f 3d 781" data-cite-type="PrimaryFederalReporter" data-cite-pageno="781" data-primary-citation="672 F.3d 731">[*781]</span> 
made a <i>medical</i> determination in this case
justifying the need for medicating Mr. Loughner under
<i>Harper</i>, which the Court has reviewed and has concluded
was not arbitrary."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                       <b>II. The Commitment Decision</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The majority first labors to determine whether this case is
governed by <i>Harper</i> or by <i>Sell</i>, and settles on
the former with regard to the
pretrial-medication-for-dangerousness question. The majority
then proceeds to treat that prior medication decision as a
background event that the district court did not need to
revisit itself when deciding whether to commit Loughner to
FMC-Springfield for restoration of competency. But the
majority's analysis goes off course proceeding in this fashion,
in two ways: The majority addresses the questions before
<i>us</i> in the wrong order, as the commitment decision is
the currently operative one. And it seeks to sort the issues we
face into a preexisting "box" &mdash; that is, either
<i>Harper</i> or <i>Sell</i> &mdash; when, in fact, this
case presents us with somewhat novel questions.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Specifically, we must decide whether a district court may rely
on a prior administrative authorization to medicate
involuntarily a pretrial detainee based on dangerousness to
self, issued while the detainee was under an earlier commitment
order, to justify a new commitment for the express <span CLASS="page_no" data-cite="2012 bl 51594 p 50" data-cite-type="Bloomberg" data-cite-pageno="50" data-primary-citation="">[**50]</span> purpose of
restoration of competency pursuant to
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)(A)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2)(A). The question is a difficult one, for it requires
us to weigh the interests and values at stake in two separate,
but related, proceedings, conducted for different reasons.
Reviewing those interests, together with the principles gleaned
from <i>Sell</i> and our post-<i>Sell</i> cases, I conclude
that a court may not commit a pretrial detainee for the purpose
of restoring his trial competency through involuntary
medication without itself deciding that involuntary medication
is both justified on some properly applicable ground and
unlikely to infringe the detainee's fair trial rights.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Because of the way it structures its opinion, however, the
majority does not squarely confront the now-dispositive
question. Instead, the majority cleaves the issue of Loughner's
involuntary medication from the question of his commitment for
restoration, even though the commitment decision was entirely
dependent on continuing the involuntary medication during the
entirety of Loughner's treatment for restoration of competency
at FMC-Springfield. In other words, the majority holds that it
was proper to commit Loughner to FMC-Springfield for
restoration of competency because, <i>if</i> so committed,
the earlier administrative decision to medicate him for
dangerousness to himself could be relied upon, and if thus
medicated, Loughner would likely become competent to stand
trial. The logical flaw here is obvious: One cannot decide
whether Loughner <i>should</i> be committed to restore
competency by assuming an administrative medication decision
that rested on the premise that he is already an inmate of the
institution and needs to be medicated while there.<a HREF="#fn501" name="fnref_fn501">[fn5]</a>
<span CLASS="page_no" data-cite="672 f 3d 782" data-cite-type="PrimaryFederalReporter" data-cite-pageno="782" data-primary-citation="672 F.3d 731">[*782]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Further, to justify its analysis, the majority holds that
<i>whenever</i> dangerousness is the ground for involuntary
medication &mdash; whether pre-or post-trial, and whether with
the ultimate aim is restoration to competency or not &mdash;
<i>Harper</i> governs entirely as to <i>both</i> the
substantive and procedural safeguards. Why that should be so,
we are not told. In particular, we are not told why the
question of the propriety of involuntary medication on
dangerousness grounds can be relegated to an administrative
proceeding when: (1) it is the court that must decide whether
Loughner is to be medically treated so as to be restored to
competency; and (2) its decision in that regard depends on the
availability of involuntary medication.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>A.</i> Sell <i>and its Progeny</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  To my mind, <i>Sell</i> goes <i>almost</i> all of the way
toward establishing that where, as here, the involuntary
medication decision is embedded in a pretrial judicial decision
concerning restoration of competency, the court must decide
whether the defendant is to be involuntarily medicated.
<i>Sell</i> does not address the precise situation here, in
which there was a previous mid-commitment administrative
involuntary medication decision.<a HREF="#fn601" name="fnref_fn601">[fn6]</a> But it does establish the
proposition that a court must <i>itself</i> address the
involuntary medication issue when, as here, the government's
ultimate aim is restoration of competency, <span CLASS="page_no" data-cite="2012 bl 51594 p 51" data-cite-type="Bloomberg" data-cite-pageno="51" data-primary-citation="">[**51]</span> and the court is
deciding the propriety of treatment toward that end. Because
the relevant passage from <i>Sell</i> is singularly important
to the correct disposition of this case, and is brushed aside
by the majority, I quote it at length:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We emphasize that the <i>court</i> applying these
  standards is seeking to determine whether involuntary
  administration of drugs is necessary significantly to
  further a particular governmental interest, namely,
  the interest in rendering the defendant competent to
  stand trial. A <i>court</i> need not consider
  whether to allow forced medication for that kind of
  purpose,
<span CLASS="page_no" data-cite="672 f 3d 783" data-cite-type="PrimaryFederalReporter" data-cite-pageno="783" data-primary-citation="672 F.3d 731">[*783]</span> 
  if forced medication is warranted for a different
  purpose, such as the purposes set out in
  <i>Harper</i> related to the individual's
  dangerousness, or purposes related to the individual's
  own interests where refusal to take drugs puts his
  health gravely at risk. There are often strong reasons
  for a <i>court</i> to determine whether forced
  administration of drugs can be justified on these
  alternative grounds before turning to the trial
  competence question.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  . . .
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  [C]ourts typically address involuntary medical
  treatment as a civil matter, and justify it on these
  alternative, <i>Harper</i>-type grounds. Every State
  provides avenues through which, for example, a doctor
  or institution can seek appointment of a guardian with
  the power to make a decision authorizing medication
  &mdash; when in the best interests of a patient who
  lacks the mental competence to make such a decision.
  And <i>courts</i>, in civil proceedings, may
  authorize involuntary medication where the patient's
  failure to accept treatment threatens injury to the
  patient or others. If a <i>court</i> authorizes
  medication on these alternative grounds, the need to
  consider authorization on trial competence grounds
  will likely disappear. Even if a <i>court</i>
  decides medication cannot be authorized on the
  alternative grounds, the findings underlying such a
  decision will help to inform expert opinion and
  judicial decisionmaking in respect to a request to
  administer drugs for trial competence purposes.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i>Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 181-83</a>, <cite>123 S.Ct. 2174</cite> (emphases
added) (citations omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The rhythmically insistent pulse of <i>Sell's</i> refrain
&mdash; "A court need not consider. . . . There are often
strong reasons for a court to determine. . . . [C]ourts
typically address. . . . If a court authorizes. . . . Even if
a court decides. . . ." &mdash; repeatedly reinforces the
command that a <i>court</i>, "asked to approve forced
administration of drugs for purposes of rendering a defendant
competent to stand trial," should <i>itself</i> begin by
determining whether the drugs may be justified on alternative,
<i>Harper</i>-type <i>substantive</i> grounds. <i>See </i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20at%20181-83&amp;summary=yes#jcite">id.
at 183</a>, <cite>123 S.Ct. 2174</cite>. In other words, <i>Sell</i> recognized
that the substantive reasons for an involuntary medication
order and the applicable procedural protections are not
necessarily tied together in discrete packages. Instead, where
an ultimate judicial decision concerning medical treatment
toward restoration of competency turns on involuntary
medication, the court can vary the substantive ground for
ordering involuntary medication, but must <i>itself</i>
determine whether <span CLASS="page_no" data-cite="2012 bl 51594 p 52" data-cite-type="Bloomberg" data-cite-pageno="52" data-primary-citation="">[**52]</span> involuntary medication is appropriate on
<i>some</i> proper basis.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>Sell</i> does not stand alone in this regard. Its
predecessor, <i>Riggins v. Nevada</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. 127</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=118%20l%20ed%202d%20479&amp;summary=yes#jcite">118 L.Ed.2d 479</a> (1992), stated that the government
"certainly would have satisfied due process if the prosecution
had demonstrated, <i>and the District Court had found</i>,
that treatment with antipsychotic medication was medically
appropriate and, considering less intrusive alternatives,
essential for the sake of Riggins' own safety or the safety of
others." <i>Id.</i> at 135, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a> (emphasis added)
(citations omitted). Although this sentence from
<i>Riggins</i> does not, as Loughner maintains, adopt as a
holding the requirement of a no-less-intrusive-alternative
finding, it does presage <i>Sell's</i> insistence that,
whatever the substantive standard is, the pertinent finding,
even as to medication for dangerousness, be made by a court,
where that finding is an alternative to medication for trial
competency purposes and restoration is the likely result.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Justice Kennedy's concurrence in <i>Riggins</i> reinforces
this point, explicitly rejecting
<span CLASS="page_no" data-cite="672 f 3d 784" data-cite-type="PrimaryFederalReporter" data-cite-pageno="784" data-primary-citation="672 F.3d 731">[*784]</span> 
the analytical bifurcation of involuntary medication and
trial-related proceedings. "I cannot accept the premise . . .
that the involuntary medication order comprises some separate
procedure, unrelated to the trial and foreclosed from inquiry
or review in the criminal proceeding itself," Justice Kennedy
wrote, "To the contrary, the allegations pertain to the State's
interference with the trial." <i>Riggins</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. at 139</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a> (Kennedy, J., concurring in the judgment).
Similarly, I cannot, especially in light of <i>Sell</i>,
accept the proposition that the involuntary medication order
can be a separate, administrative procedure, even though the
judicial commitment proceeding is part of the overall criminal
prosecution and concerns whether Loughner can be restored to
competency to stand trial through involuntary medication.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Our own cases similarly suggest that a court, asked to
authorize restoration of a pretrial detainee to trial
competency through mandatory administration of drugs, must
itself determine whether medication can be justified on
dangerousness grounds. In <i>United States v.</i>
<i>Hernandez-Vasquez</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20f%203d%20908&amp;summary=yes#jcite">513 F.3d 908</a> (9th Cir. 2008), we stated
that "the <i>district court</i>, in an ordinary case, should
refrain from proceeding with the <i>Sell</i> inquiry before
examining dangerousness and other bases to administer
medication forcibly," and added that the <i>court</i> should
state its reasons for not proceeding under <i>Harper</i> if
it chose to advance directly to the <i>Sell</i> analysis.
<i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20F.3d%20908&amp;summary=yes#jcite">Id. at 914</a> (emphasis added). Moreover, we cautioned
that, "[o]n remand, the district court. . . . should take care
to separate the <i>Sell</i> inquiry from the <i>Harper</i>
dangerousness inquiry and not allow the inquiries to collapse
into each other" &mdash; an instruction that would have made
little sense if we had expected the prison to conduct the
<i>Harper</i> hearing. <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20F.3d%20908&amp;summary=yes#jcite">Id. at 919</a>; <i>see also</i>
<i>United States v. Rivera-Guerrero</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20f%203d%201130&amp;summary=yes#jcite">426 F.3d 1130</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20f%203d%201130&amp;summary=yes#jcite">1138</a> n. 4
(9th Cir. 2005) (stating that "<i>the district court</i>
should have conducted a <i>Harper</i> dangerousness hearing
instead of proceeding under <i>Sell</i>") (emphasis
added).<a HREF="#fn701" name="fnref_fn701">[fn7]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Thus, where the government <span CLASS="page_no" data-cite="2012 bl 51594 p 53" data-cite-type="Bloomberg" data-cite-pageno="53" data-primary-citation="">[**53]</span> has asked the district court to
authorize the detainee's restoration through involuntary
medication, <i>Sell</i> and its progeny require <i>the</i>
<i>court</i> to determine whether a pretrial detainee may be
involuntarily drugged on dangerousness grounds, if that appears
to be a feasible alternative to involuntary medication on
restoration grounds alone. That is, of course, precisely what
has happened here.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>B. The Interwoven Medication and Commitment Decisions</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Apart from brushing aside <i>Sell</i> and our related cases
with regard to the need for a <i>judicial</i> decision
whenever the ultimate aim is restoration of competency, the
majority attempts to distinguish this case from <i>Sell</i>
by separating the involuntary medication decision from the
decision that Loughner could be restored to competency within a
reasonable period of time if committed for treatment at
FMC-Springfield. But the two issues cannot be disentangled in
this manner.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)(A)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2)(A) focuses the commitment for
treatment inquiry on the
<span CLASS="page_no" data-cite="672 f 3d 785" data-cite-type="PrimaryFederalReporter" data-cite-pageno="785" data-primary-citation="672 F.3d 731">[*785]</span> 
likelihood of the detainee's restoration after the
treatment. Obviously, a judge cannot meaningfully decide
whether restoration to trial competency as a result of
treatment is likely without knowing what treatment is
contemplated. And equally obviously, where the treatment
contemplated is the administration of involuntary psychotropic
medication, the detainee's prospects for restoration depend on
the propriety of an order authorizing involuntary medication.
Thus, as the majority acknowledges, the "involuntary medication
decision is important to the overall outcome of the
<cite>&sect; 4241(d)(2)</cite> proceeding because it `likely affect[s] both the
scope and term of a <cite>&sect; 4241(d)(2)</cite> order.'" Majority Op.
at 767 (quoting <i>United States v. Magassouba</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X19IV6M003?jcsearch=544%20f%203d%20387&amp;summary=yes#jcite">544 F.3d 387</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X19IV6M003?jcsearch=544%20f%203d%20387&amp;summary=yes#jcite">418</a> n. 27 (2d Cir. 2008)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  What the majority does not acknowledge, however, is that the
involuntary medication order itself depends on the detainee's
commitment. Certainly, a defendant would not be subject to
involuntary medication were he released from government
custody. Were he instead simply transferred from a mental
health treatment facility to an ordinary pretrial detention
center, changes to the circumstances of his confinement would
necessitate a new involuntary medication proceeding to
determine whether the inmate poses a danger to himself or
others in the context of his new confinement.<a HREF="#fn801" name="fnref_fn801">[fn8]</a> Thus, the
district court's decision to extend Loughner's commitment for
the purpose of effecting his restoration both required and
enabled the administration of involuntary medication. Under
these circumstances, the prior administrative involuntary
medication decision, made while Loughner was already committed
to FMC-Springfield for a limited period and for a different
purpose than is now at issue, cannot simply be <i>assumed</i>
valid and treated as a background condition of the commitment
decision.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>C. The Reasons for Requiring Judicial Authorization of</i>
<i>Involuntary Medication</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I would therefore view the <cite>&sect; 4241(d)(2)(A)</cite> commitment
proceeding as functionally indistinguishable from the
involuntary medication <span CLASS="page_no" data-cite="2012 bl 51594 p 54" data-cite-type="Bloomberg" data-cite-pageno="54" data-primary-citation="">[**54]</span> decision in <i>Sell.</i> And, as I
have shown, <i>Sell</i> and our later cases could not be more
clear in directing that, where restoration of trial competency
is the ultimate goal, any decision to medicate involuntarily a
pretrial detainee, even on dangerousness grounds, must be made
in a judicial proceeding. As <i>Sell</i> does not elaborate
on why that is so in any detail, I do so now, with particular
attention to the circumstances we face. I conclude that, at the
point at which a decision must be made concerning the
detainee's commitment for restoration of competency to stand
trial, the relative advantages of judicial involvement in the
involuntary medication decision and concern for the impact
psychotropic medication may have on the detainee's fair trial
rights both counsel in favor of requiring the district court
itself to resolve the involuntary medication issue, whether on
dangerousness or other
<span CLASS="page_no" data-cite="672 f 3d 786" data-cite-type="PrimaryFederalReporter" data-cite-pageno="786" data-primary-citation="672 F.3d 731">[*786]</span> 
grounds. I review each of these considerations in turn.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
            i. The Benefits and Costs of Judicial Involvement
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In deciding that a convicted, incarcerated prisoner is not
entitled to a judicial hearing regarding the involuntary
medication decision, <i>Harper</i> expressed significant
concern over "the fact that requiring judicial hearings will
divert scarce prison resources, both money and the staffs time,
from the care and treatment of mentally ill inmates."
<i>Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 232</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. The Court
also reasoned that these additional costs were not justified,
given the specifically medical nature of the inquiry and the
absence of any reason to doubt the administrative
decisionmaker's impartiality. <i>See </i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20U.S.%20at%20232&amp;summary=yes#jcite">id. at 233-35</a> &amp;
n. 13, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. In the quite different context of a
judicial decision concerning pre-trial treatment for
restoration of competency, focused on the detainee's prospects
for restoration of capacity to stand trial, there are several
important purposes served by, and few reasons for avoiding,
judicial resolution of the involuntary medication for
dangerousness issue.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  First, unlike the <i>Harper</i> context, in which the inmate
has been convicted and is incarcerated for the term of his
sentence, the marginal costs of judicial inquiry into the
involuntary medication issue are minimal. A judicial hearing is
required anyway for purposes of determining the propriety of
treatment for restoration of competency.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Here, for example, the district judge, counsel for both
parties, Loughner's treating psychologist (Dr. Pietz), a
government expert witness with a background in clinical
psychiatry (Dr. Ballenger), and Loughner himself were all
present in the court-room for the district court's September 28
commitment hearing. Concomitantly, the issues pertaining to
Loughner's commitment for restoration (e.g., his likely
reaction to psychotropic drugs, the need to continue medication
throughout the extended commitment period, and so on) are
closely related to the issues pertaining to whether he may be
medicated involuntarily for dangerousness to self or others.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  If Loughner's attorneys had been permitted to inquire at the
September 28 hearing into the propriety of <span CLASS="page_no" data-cite="2012 bl 51594 p 55" data-cite-type="Bloomberg" data-cite-pageno="55" data-primary-citation="">[**55]</span> forced medication on
dangerousness grounds, they could conceivably have established
that such medication was not justified, and so treatment on
that ground would not be the basis for any conclusion that
Loughner could, if committed, be restored to competency in a
reasonable period of time. The marginal difficulty of requiring
the court to explore whether Loughner's involuntary medication
is justified on dangerousness grounds, in addition to
determining whether that medication, if administered, will
likely restore his trial competency, would be immeasurably less
than for a convicted prisoner, as to whom no legal proceedings
at all are ongoing, much less proceedings focused on matters
closely related to, and dependent upon, the involuntary
medication determination.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Nor would requiring judicial determination in the present
context encroach on the prerogative of the prison's medical
staff. Like the criminal defendant in <i>Riggins</i> and the
pretrial detainee in <i>Sell</i>, Loughner was already in the
midst of government-initiated judicial proceedings that dealt
explicitly with legal issues relating to his involuntary
medication (i.e., whether the medication is likely to restore
him to the capacity to permit the proceedings to go forward).
<i>See Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 175</a>, <cite>123 S.Ct. 2174</cite>;
<i>Riggins</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. at 139</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a> (Kennedy, J.,
concurring in the judgment). Because the government has itself
opened the door to judicial proceedings
<span CLASS="page_no" data-cite="672 f 3d 787" data-cite-type="PrimaryFederalReporter" data-cite-pageno="787" data-primary-citation="672 F.3d 731">[*787]</span> 
relating to involuntary medication, its professed concerns
about judicial encroachment on matters of prison administration
carry significantly less weight.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, where, as for the commitment decision, the question
of the propriety of medication for dangerousness is embedded in
an inquiry into the likelihood of restoration of competency,
the district court is no worse placed, and in some respects
better placed, than the prison's medical staff to render an
objective and impartial decision. For one thing,
FMC-Springfield's physicians are, like most physicians,
professionally disposed to favor medical treatment. The
district court recognized as much when it acknowledged that
Loughner's physicians may be overly optimistic in forecasting
his prospects for restoration through involuntary medication.
"They're doctors," the court observed, "They want to help and
heal people."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Doctor Tomelleri's involuntary medication orders bear out the
district court's observation. The <i>Harper I, Harper II</i>,
and <i>Harper III</i> orders repeatedly rejected
less-intrusive measures, such as seclusion and physical
restraints, because they have "no direct effect on mental
illness," and justified the use of psychotropic medication on
the grounds that only the psychotropic drugs "address the
fundamental problem." Doctor Tomelleri's preoccupation with
treating Loughner's underlying mental illness, although
professionally appropriate, could have significantly clouded
his judgment as to whether the drastic measure of involuntary
psychotropic medication was justified under the temporary
detention circumstances.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This skew may well have <span CLASS="page_no" data-cite="2012 bl 51594 p 56" data-cite-type="Bloomberg" data-cite-pageno="56" data-primary-citation="">[**56]</span> influenced the original involuntary
medication decision, which was premised on dangerousness to
others. At that point, Loughner's manifestations of
dangerousness consisted of throwing some plastic chairs against
a metal grill and a wall, throwing some toilet paper at a
camera, and spitting and "lunging" at his attorneys (a
characterization the attorneys dispute, but as to which there
has been no evidentiary hearing). Although very likely
manifestations of serious mental illness, these incidents do
not appear to have endangered anyone and would be most
unlikely, I would think, to have triggered involuntary
psychotropic medication &mdash; as opposed to physical security
measures &mdash; in most incarceration contexts. <i>See</i>
<i>Weston</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3F9L5?jcsearch=206%20f%203d%209&amp;summary=yes#jcite">206 F.3d at 13</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Further, Loughner's FMC-Springfield physicians in particular
are, unlike physicians in other jail and prison settings,
charged with additional duties that could color their
medication for dangerousness decision. FMC-Springfield was
previously charged with treating Loughner as necessary "to
determine whether there is a substantial probability" that he
can be restored to competency, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(1)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(1), and
is now charged with treating Loughner for the express purpose
of restoring him to competency. <i>See</i>
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)(A)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2)(A). Where, as here, the detention facility's medical
staff perceive involuntary medication as "the only option for
restoring [the detainee] to competency," the institutional
responsibility to restore competency if possible is likely to
color the medical staffs deliberations regarding involuntary
medication on any grounds.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Indeed, there is some indication that this confusion of roles
occurred with respect to FMC-Springfield's involuntary
medication decisions in this case. For example, Loughner's
Notice of Medication Hearing and Advisement of Rights form,
filled out by Dr. Pietz, stated: "Reason for Treatment: Mr.
Loughner suffers from a mental illness and refused to take the
medication prescribed to him. He was referred to this facility
to restore competency."
<span CLASS="page_no" data-cite="672 f 3d 788" data-cite-type="PrimaryFederalReporter" data-cite-pageno="788" data-primary-citation="672 F.3d 731">[*788]</span> 
Contrary to the district court's observation that
Loughner's prison physicians "remain free to find that he
cannot be, or has not been restored," the language of
Loughner's notice form suggests Dr. Pietz believed that
Loughner was sent to FMC-Springfield "to restore competency"
(which was not true; the commitment was for evaluation, <i>see</i>
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(1)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(1)) and that the purpose of involuntary
medication was to restore Loughner's competency for trial,
<i>not</i> to treat dangerousness.<a HREF="#fn901" name="fnref_fn901">[fn9]</a> Such instances
support the conclusion that the district court may be better
placed than the prison's administrative decisionmakers to
render an objective decision on the involuntary medication of a
pretrial detainee for purposes of dangerousness to self.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although the majority suggests otherwise, Majority Op.
at 755-56 (citing <i>Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 233-34</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>), this particular structural conflict theory did not come
into play in <i>Harper.</i> In the postconviction context,
the prison's administrative decisionmakers did not confront any
statutory restoration obligations that could potentially
interfere <span CLASS="page_no" data-cite="2012 bl 51594 p 57" data-cite-type="Bloomberg" data-cite-pageno="57" data-primary-citation="">[**57]</span> with the "necessary independence to provide an inmate
with a full and fair hearing." <i>See Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 233</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The majority also suggests that the courts are ill-suited for
making medical judgments about a detainee's medication
treatment and should avoid doing so wherever possible. Majority
Op. at 755. Courts are not institutionally disabled from
deciding such questions. As <i>Sell</i> recognized, they
"typically address involuntary medical treatment as a civil
matter, and justify it on these alternative,
<i>Harper</i>-type grounds." <i>Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 182</a>,
<cite>123 S.Ct. 2174</cite>; <i>see also, e.g., Kulas v. Valdez</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X37TA4?jcsearch=159%20f%203d%20453&amp;summary=yes#jcite">159 F.3d 453</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X37TA4?jcsearch=159%20f%203d%20453&amp;summary=yes#jcite">455-56</a> (9th Cir. 1998). For example, the criteria
courts must apply in determining whether a federal criminal
defendant may be civilly committed strongly resemble the
criteria applied by the Bureau of Prisons' administrative
decisionmakers in <i>Harper</i> proceedings. <i>Compare</i>
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU2C003?jcsearch=18%20U.S.C.%20%204246(d)&amp;summary=yes#jcite">18 U.S.C. &sect; 4246</a>(d) <i>with</i> 28 C.F.R. 549.46(a)(7).
Indeed, the district court's decision to extend Loughner's
commitment itself involved a medical judgment as to the
likelihood that Loughner's current regimen of psychotropic
medication will successfully induce his restoration within the
authorized period. If we can trust the court's acumen to
determine, after an evidentiary hearing at which experts
appear, that a certain medication regimen is likely to restore
Loughner's capacity to stand trial, there is no reason
simultaneously to distrust that same court's ability to
ascertain whether that same medication is needed to make him
less dangerous to himself or others.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                  ii. The Concern for Fair Trial Rights
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Central to the holding in <i>Sell</i> was the understanding
that the side-effects associated with psychotropic medication
may severely prejudice a defendant's right to receive a fair
trial. Here, for example, Dr. Pietz testified that Loughner has
developed a flat, emotionless aspect since resuming
psychotropic medication. The district court further observed
that Loughner "did appear to be tired" at the commitment
proceeding and "did appear to close his eyes from time to time
today and
<span CLASS="page_no" data-cite="672 f 3d 789" data-cite-type="PrimaryFederalReporter" data-cite-pageno="789" data-primary-citation="672 F.3d 731">[*789]</span> 
maybe a little sleepy or nod off." This "sedation-like
effect" may result in "serious prejudice" during trial
proceedings "if medication inhibits [Loughner's] capacity to
react and respond to the proceedings and to demonstrate remorse
or compassion." <i>Riggins</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. at 143-44</a>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a> (Kennedy, J., concurring in the judgment). "The tendency
of psychotropic medication to flatten or deaden emotional
responses" could prove particularly damaging if the government
seeks the death penalty, as it very well might in this case,
because "the jury would then be especially sensitive to
[Loughner's] character and any demonstrations of remorse (or
lack thereof)." <i>Weston</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3F9L5?jcsearch=206%20f%203d%209&amp;summary=yes#jcite">206 F.3d at 20</a> (Tatel, J.,
concurring).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Even the <i>intended</i> effects of psychotropic drugs may
infringe Loughner's fair trial rights. Assuming Loughner will
put on an insanity defense, manifestations in court of how his
mind works may well be his own best evidence. Because
psychotropic medication chemically alters the brain, it
"deprives the jury of the opportunity to observe the defendant
in the delusional state he was in at the time of the crime."
<i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3F9L5?jcsearch=206%20F.3d%20at%2020&amp;summary=yes#jcite">Id. at 21</a> (Tatel, J., concurring). <span CLASS="page_no" data-cite="2012 bl 51594 p 58" data-cite-type="Bloomberg" data-cite-pageno="58" data-primary-citation="">[**58]</span> The government's
decision to restore Loughner's trial competency may therefore
prevent him from putting on his chosen defense, by altering the
material evidence for that defense. <i>See Riggins</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. at 139</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">142</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a> (Kennedy, J., concurring in
the judgment).<a HREF="#fn1001" name="fnref_fn1001">[fn10]</a> Thus, both the intended and unintended
effects of psychotropic medication can conceivably deprive a
criminal defendant of his right to a fair trial.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  There is no point in restoring a defendant's trial competency,
through commitment to a medical facility and involuntary
administration of psychotropic medication, if the means
necessary to effect restoration will so infringe the
defendant's fair trial rights as to render the trial itself
unconstitutional. That is why <i>Sell</i> requires a court to
find, <i>before</i> ordering involuntary medication on trial
competency grounds, that the involuntary medication to be
administered is both substantially likely to render the
defendant competent to stand trial <i>and</i> substantially
unlikely to create side-effects that would render his trial
unfair. <i>See Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 181</a>, <cite>123 S.Ct. 2174</cite>
(citing <i>Riggins</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. at 142-45</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>
(Kennedy, J., concurring in the judgment)). Only then, the
Court observed, will the medication sufficiently advance the
trial-related interests put forward to justify depriving the
defendant of his liberty to reject medical treatment. <i>See</i>
<i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20at%20181-82&amp;summary=yes#jcite">id</a>.</i> And, although the Court did not expressly so state, the
possible impact of involuntary medication on the ultimate trial
explains <i>Sell's</i> repeated insistence on the need for a
<i>court</i> to determine the need for involuntary medication
on grounds of dangerousness where restoration of trial
competency is the government's ultimate goal. <i>See id.</i>
at 181-83, <cite>123 S.Ct. 2174</cite>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Given the particular circumstances of this case &mdash; namely,
a commitment proceeding governed by
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)(A)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2)(A) &mdash; there is the same need for a judicial
determination as to how the psychotropic drugs will likely
impact Loughner's fair trial rights, even though dangerousness
to self is the immediate reason for his involuntary medication.
To commit Loughner for the purpose of restoration,
<span CLASS="page_no" data-cite="672 f 3d 790" data-cite-type="PrimaryFederalReporter" data-cite-pageno="790" data-primary-citation="672 F.3d 731">[*790]</span> 
the court must conclude that there is a "substantial
probability" that he "will attain the capacity to permit the
proceedings to go forward" during the commitment period.
<i>See</i> <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)(A)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2)(A). Thus, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241&amp;summary=yes#jcite">&sect; 4241</a>
requires the court to focus on whether Loughner's commitment is
likely to advance the prosecution's trial-related interests.
Pretrial commitment for restoration of competency will likely
not "permit the [trial] proceedings to go forward" if Loughner
can only be restored through means likely to render any
resulting trial unfair. So the district court may only commit
Loughner for restoration of trial competency if it concludes
that the psychotropic means through which his restoration is to
be accomplished are substantially unlikely to infringe his fair
trial rights.<a HREF="#fn1101" name="fnref_fn1101">[fn11]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Of course, at the time of the <cite>&sect; 4241(d)(2)(A)</cite> commitment
hearing, there may not be sufficient evidence to support the
conclusion that involuntary psychotropic medication will render
the trial unfair. But that should not excuse the district court
from its responsibility <span CLASS="page_no" data-cite="2012 bl 51594 p 59" data-cite-type="Bloomberg" data-cite-pageno="59" data-primary-citation="">[**59]</span> to evaluate the evidence that is
available according to its own best lights, providing "both the
defendant, whose right to present a defense may be infringed by
involuntary medication, and the government, whose eventual
prosecution of the defendant may be foreclosed because of the
infringement," with the best available "premedication
resolution of the Sixth Amendment issue." <i>Weston</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3F9L5?jcsearch=206%20f%203d%209&amp;summary=yes#jcite">206 F.3d at 14</a>. If the district court concludes that there is
insufficient evidence to reach a final conclusion on the impact
involuntary medication will have on the defendant's fair trial
rights, it could simply defer the issue until some later,
pre-trial date. <i>See </i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3F9L5?jcsearch=206%20F.3d%20at%2014&amp;summary=yes#jcite">id. at 21</a> (Tatel, J., concurring).
The government would then, however, bear the risk that the
court might bar criminal prosecution if it subsequently
concludes that the drugs have infringed the defendant's fair
trial rights. Regardless of whether the court had sufficient
evidence to resolve Loughner's fair trial rights concerns at
the time of the commitment hearing, however, the inquiry is
not, as the majority asserts, "premature and irrelevant at this
stage." Majority Op. at 769.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>D. Conclusion</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In short, I would hold that a district court asked to commit a
pretrial detainee for the purpose of restoring his trial
competency through involuntary medication must itself determine
whether involuntary medication is justified. In doing so, it
should first consider, as in <i>Sell</i>, whether the
medication is justified on grounds of dangerousness to self or
others. If the court concludes that involuntary medication is
justified, it may then proceed to determine whether involuntary
medication is likely to restore the detainee's capacity to such
a point that trial may proceed. But I would require the court
to determine, as part of that inquiry, whether the contemplated
treatment is substantially unlikely to infringe the detainee's
fair trial rights. I cannot agree with the majority's
conclusion that the district court could authorize
<span CLASS="page_no" data-cite="672 f 3d 791" data-cite-type="PrimaryFederalReporter" data-cite-pageno="791" data-primary-citation="672 F.3d 731">[*791]</span> 
Loughner's commitment under <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)(A)&amp;summary=yes#jcite">&sect; 4241(d)(2)(A)</a> on the bare
determination that the medication he is currently receiving is
likely to restore his purely cognitive trial competency,
meaning the ability to appreciate the course of the proceedings
and confer with counsel, with no consideration of either the
medication's propriety or its potential effect on his fair
trial rights.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                  <b>III. The Involuntary Medication Order</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Because I conclude that the district court was obligated itself
to decide anew the involuntary medication issue in conjunction
with its <cite>&sect; 4241(d)(2)(A)</cite> commitment determination, I
consider the propriety of the prison's <i>Harper III</i>
involuntary medication order moot in all relevant respects. I
nevertheless proceed to review the deficiencies I see in those
proceedings, for two reasons.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  First, in reviewing the administrative involuntary medication
order, I wish to clarify the substantive standards and
associated requirements I believe must be applied by the
district court in deciding whether involuntary medication is
justified on dangerousness grounds.
<span CLASS="page_no" data-cite="2012 bl 51594 p 60" data-cite-type="Bloomberg" data-cite-pageno="60" data-primary-citation="">[**60]</span> </p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Second, I disagree with the majority's conclusion that the
<i>Harper III</i> involuntary medication order otherwise
satisfies the demands of substantive and procedural due
process. Setting aside my conviction that the procedural
posture of this case requires a court to adjudicate the merits
of Loughner's involuntary medication, I agree that a
mid-commitment medication decision on dangerousness grounds
need not be made by a judge. Where an otherwise proper judicial
commitment decision has already been made, either for a certain
period or indefinitely, it is appropriate to regard direct
judicial intervention, even pretrial, as both unnecessary and
burden-some. Moreover, in that circumstance, the penological
and liberty interests are similar, in many respects, to those
that pertain post-conviction. But despite that basic procedural
agreement, I would hold that the <i>Harper III</i> involuntary
medication order cannot stand, given its substantive and
procedural shortcomings.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>A. Substantive Due Process</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                 i. Modifications to the <i>Harper</i> Standard
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I agree with the majority's conclusion that involuntary
medication may be justified even if it is not necessarily the
least restrictive alternative. The so-called "<i>Riggins</i>
standard," put forth by Loughner to justify the least
restrictive alternative requirement, simply does not exist;
<i>Riggins</i> rejected the opportunity to "finally prescribe
such substantive standards." <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=504%20us%20127&amp;summary=yes#jcite">504 U.S. at 136</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CC57?jcsearch=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>.
In light of <i>Sell's</i> command to determine whether
medication is justified on <i>Harper-type</i> grounds prior
to deciding whether medication is justified to restore
competency, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 183</a>, <cite>123 S.Ct. 2174</cite>, I do not dispute
the application of <i>Harper's</i> substantive standard,
broadly construed, to the decision to medicate a pretrial
detainee for dangerousness to self or others.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>Harper's</i> substantive due process standard was,
however, expressly predicated on the particular circumstances
of a convicted prisoner's confinement. <i>See Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 222</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. It must therefore be modified to
accommodate the pretrial context of Loughner's confinement.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>Harper</i> identified three general factors as
particularly important to assessing the constitutional validity
of a prison regulation authorizing the use of involuntary
medication: (1) the existence of a valid, rational connection
between the prison regulation and the legitimate governmental
interest put forward to justify it; (2) the impact
accommodation of the asserted
<span CLASS="page_no" data-cite="672 f 3d 792" data-cite-type="PrimaryFederalReporter" data-cite-pageno="792" data-primary-citation="672 F.3d 731">[*792]</span> 
constitutional right would have on guards and other
inmates, and on the allocation of prison resources generally;
and (3) the availability of "ready" alternatives.
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 224-25</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. The pre-trial context of Loughner's
confinement significantly affects our application of these
factors, in at least two respects.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  First, Loughner's status as a pretrial detainee narrows the
scope of the government's legitimate interests in restricting
his constitutional rights. Where the government seeks to
medicate involuntarily a convicted prisoner, its legitimate
long-term correctional interests countervail, to a degree, the
prisoner's liberty interest in <span CLASS="page_no" data-cite="2012 bl 51594 p 61" data-cite-type="Bloomberg" data-cite-pageno="61" data-primary-citation="">[**61]</span> avoiding the intended,
mind-altering effects of psychotropic medication. The federal
sentencing standards, for example, recognize that "correctional
treatment," including appropriate medical care, can be
legitimately imposed on a convicted defendant. <i>See</i>
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHTO0003?jcsearch=18%20U.S.C.%20%203553(a)(2)(D)&amp;summary=yes#jcite">18 U.S.C. &sect; 3553</a>(a)(2)(D); <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHTOK003?jcsearch=18%20U.S.C.%20%203563(b)(9)&amp;summary=yes#jcite">18 U.S.C. &sect; 3563</a>(b)(9). When
the government seeks to medicate a convicted prisoner on
dangerousness grounds, these treatment interests provide a
modicum of justification for preferring long-term, systemic
correction, through involuntary psychotropic medication, of the
mental illness causing the convict's dangerousness, over
temporary interventions that will not alleviate the condition
causing the dangerousness. <i>See Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 225</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The government may not, however, assert such correctional
interests as a justification for restricting the constitutional
rights of a pretrial detainee. We have recognized that "[a]ll
legitimate intrusive prison practices have basically three
purposes: the preservation of internal order and discipline,
the maintenance of institutional security against escape or
unauthorized entry, and the rehabilitation of the prisoners."
<i>United States v. Hearst</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X44UC4?jcsearch=563%20f%202d%201331&amp;summary=yes#jcite">563 F.2d 1331</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X44UC4?jcsearch=563%20f%202d%201331&amp;summary=yes#jcite">1345</a> n. 11
(9th Cir. 1977) (per curiam) (internal quotation marks omitted).
The first two interests, which are regulatory in nature, may be
asserted as legitimate justifications for restricting the
constitutional rights of pretrial detainees, but the
government's <i>correctional</i> interest in punishment or
rehabilitation may not. <i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X44UC4?jcsearch=563%20F.2d%201331&amp;summary=yes#jcite">Id</a>.; see, e.g., Bell v.</i>
<i>Wolfish</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9P3?jcsearch=441%20us%20520&amp;summary=yes#jcite">441 U.S. 520</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9P3?jcsearch=441%20us%20520&amp;summary=yes#jcite">537</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9P3?jcsearch=99%20supreme%20court%201861&amp;summary=yes#jcite">99 S.Ct. 1861</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5C9P3?jcsearch=60%20l%20ed%202d%20447&amp;summary=yes#jcite">60 L.Ed.2d 447</a>
(1979); <i>Mauro v. Arpaio</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X36BMG?jcsearch=188%20f%203d%201054&amp;summary=yes#jcite">188 F.3d 1054</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X36BMG?jcsearch=188%20f%203d%201054&amp;summary=yes#jcite">1065</a> (9th
Cir. 1999). Instead, "the Due Process Clause requires conditions
of pretrial confinement to be analyzed according to whether
they are appropriate to ensure the detainees' presence at trial
and to maintain the security and order of the detention
facility." <i>Halvorsen v. Baird</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X4VHB2?jcsearch=146%20f%203d%20680&amp;summary=yes#jcite">146 F.3d 680</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X4VHB2?jcsearch=146%20f%203d%20680&amp;summary=yes#jcite">689</a> (9th
Cir. 1998). As <i>Halvorsen</i> observed, these principles are
of ancient vintage. <i>See <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X4VHB2?jcsearch=146%20F.3d%20680&amp;summary=yes#jcite">id</a>.</i> Blackstone, for example,
wrote that pretrial detention "is only for safe custody, and
not for punishment: therefore, in this dubious interval between
the commitment and trial, a prisoner ought to be used with the
utmost humanity; and neither be loaded with needless fetters,
or subjected to other hardships than such as are absolutely
requisite for the purpose of confinement only." IV William
Blackstone, Commentaries on the Laws of England 297 (1769)
(quoted by <i>Halvorsen</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X4VHB2?jcsearch=146%20f%203d%20680&amp;summary=yes#jcite">146 F.3d at 689</a>).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Second, the temporary context of Loughner's pretrial
confinement means that inquiry into the effectiveness and
cost-efficiency of involuntary medication as compared to
alternatives must be limited to the relative short-term. Some
alternatives may be more appropriate than involuntary
psychotropic medication if they are equally effective and
cost-efficient over that short-term, even if they will not
affect the detainee's long-term dangerousness. So, while
<i>Harper</i> rejected physical restraints as an acceptable
substitute for involuntary medication in part because
<span CLASS="page_no" data-cite="672 f 3d 793" data-cite-type="PrimaryFederalReporter" data-cite-pageno="793" data-primary-citation="672 F.3d 731">[*793]</span> 
"[p]hysical restraints are effective only in the short
term," <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 226</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>, that rejection might
not carry over in some pretrial contexts. Involuntary
<span CLASS="page_no" data-cite="2012 bl 51594 p 62" data-cite-type="Bloomberg" data-cite-pageno="62" data-primary-citation="">[**62]</span> medication may therefore be appropriate as a long-term solution
for a dangerous, mentally-ill convicted prisoner and yet
inappropriate as a short-term solution for a dangerous,
mentally-ill pretrial detainee.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In light of these adjustments of perspective appropriate to the
pretrial context, I am skeptical that the prison's asserted
justification for involuntary medication could carry the day on
the present record.<a HREF="#fn1201" name="fnref_fn1201">[fn12]</a> Doctor Tomelleri concluded that
psychotropic medication is justified because it "is the
treatment of choice for conditions such as Mr. Loughner is
experiencing," and rejected various alternatives because they
are "merely protective temporary measures with no direct effect
on the core manifestations of the mental illness." But, in the
pretrial context, "protective temporary measures" may be
precisely what is called for, and there may therefore be no
cognizable governmental interest in addressing "the core
manifestations of the mental illness." Doctor Tomelleri's
justifications thus demonstrate a misapprehension of the
appropriate inquiry in the pre-trial context.<a HREF="#fn1301" name="fnref_fn1301">[fn13]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This criticism is not meant to presage that the outcome of the
medication for dangerousness-to-self inquiry in the pre-trial
context is foreordained. Instead, it is to say that attention
to the <i>particular</i> circumstances of a specific pretrial
detainee is essential in determining whether there are ready
alternatives to medication. In Loughner's case, those
circumstances might include the likely significant length of
the pretrial period, as well as the needs and capabilities of
the mental health facility to which he is committed.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                  ii. Specificity of Proposed Treatment
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>Harper</i> instructed that a decision to medicate
involuntarily must be medically appropriate. <i>See</i>
<i>Harper</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 227</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. <i>Sell</i>,
which incorporated <i>Harper's</i> medical appropriateness
requirement, observed that "[d]ifferent kinds of antipsychotic
drugs may produce different side effects and enjoy different
levels of success." <i>Sell</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 181</a>,
<cite>123 S.Ct. 2174</cite>. Interpreting the medical appropriateness requirement in
<i>United States v. Hernandez-Vasquez</i>, we observed that
"<i>Sell</i>'s discussion of specificity would have little
meaning if a district court were required to consider specific
drugs at a <i>Sell</i> hearing but then could grant the
Bureau of Prisons unfettered discretion in its medication of a
defendant." <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20f%203d%20908&amp;summary=yes#jcite">513 F.3d at 916</a>.
<span CLASS="page_no" data-cite="672 f 3d 794" data-cite-type="PrimaryFederalReporter" data-cite-pageno="794" data-primary-citation="672 F.3d 731">[*794]</span> 
We therefore held that, to satisfy the medical
appropriateness requirement, "the district court's order must
identify: (1) the specific medication or range of medications
that the treating physicians are permitted to use in their
treatment of the defendant, (2) the maximum dosages that may be
administered, and (3) the duration of time that involuntary
treatment of the defendant may continue before the treating
physicians are required to report back to the court on the
defendant's mental condition and progress." <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20F.3d%20at%20916-17&amp;summary=yes#jcite">Id.
at 916-17</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We have never identified the government's <i>purpose</i> in
seeking involuntary medication, whether dangerousness or trial
competency, as a relevant factor in applying the <span CLASS="page_no" data-cite="2012 bl 51594 p 63" data-cite-type="Bloomberg" data-cite-pageno="63" data-primary-citation="">[**63]</span> medical
appropriateness requirement. Instead, we have assumed that the
same requirement for a specific treatment plan applies in both
contexts. In <i>United States v. Williams</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X6COPO?jcsearch=356%20f%203d%201045&amp;summary=yes#jcite">356 F.3d 1045</a>
(9th Cir. 2004), for example, we applied the medical
appropriateness requirement, under the <i>Harper</i>
standard, to a supervised release condition that required the
convict to take antipsychotic medication under threat of
reincarceration. <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X6COPO?jcsearch=356%20F.3d%201045&amp;summary=yes#jcite">Id. at 1056-57</a>. And in
<i>Rivera-Guerrero</i>, we held that <i>Williams's</i>
interpretation of the medical appropriateness requirement
applies to the medical appropriateness inquiry under <i>Sell.</i>
<i>See</i> <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20f%203d%201130&amp;summary=yes#jcite">426 F.3d at 1137</a> (citing <i>Williams</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X6COPO?jcsearch=356%20f%203d%201045&amp;summary=yes#jcite">356 F.3d at 1056</a>). <i>Hernandez-Vasquez</i> should therefore apply
with equal force in all involuntary medication contexts.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, the reasons supporting a specification requirement in
the <i>Sell</i> context apply with equal force where
medication is justified on dangerousness grounds. <i>Sell</i>
proceeded from that premise, stating that "[t]he specific kinds
of drugs at issue may matter here <i>as elsewhere." Sell</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. at 181</a>, <cite>123 S.Ct. 2174</cite> (emphasis added). With no
specific limits &mdash; or at least prescribed ranges or
categories &mdash; covering the types, dosages, and duration of
a patient's involuntary medication, Dr. Tomelleri could not
meaningfully evaluate the medication proposal, as compared to
alternatives (including an alternative medication regime). This
particularized focus, for reasons already noted, is of special
importance with regard to pretrial medication for
dangerousness. In this context, the governmental interest in
long-term correction evaporates: Drugs with serious side
effects, though appropriate where ultimate cure is the goal,
may not be medically indicated (or may be indicated in lower
doses) for elimination of symptoms alone.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The majority maintains that cabining the discretion of
Loughner's treating physicians in this way would prevent them
from adjusting his medication regimen to changing
circumstances. This concern was addressed by
<i>Hernandez-Vasquez.</i> In that case, we held that the
specifications in the involuntary medication order "should be
broad enough to give physicians a reasonable degree of
flexibility in responding to changes in the defendant's
condition," and noted that the government or the defendant "may
move to alter the court's order as the circumstances change and
more becomes known about the defendant's response to the
medication." <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X18DROK003?jcsearch=513%20f%203d%20908&amp;summary=yes#jcite">513 F.3d at 917</a>.<a HREF="#fn1401" name="fnref_fn1401">[fn14]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I would therefore hold that an involuntary medication order
premised on dangerousness to self or others, like an order
<span CLASS="page_no" data-cite="672 f 3d 795" data-cite-type="PrimaryFederalReporter" data-cite-pageno="795" data-primary-citation="672 F.3d 731">[*795]</span> 
premised on restoration to competency, must identify the
types, maximum dosages, and estimated duration of an inmate's
involuntary medication. In the procedural regime I favor for
this case, in which the involuntary medication decision would
be made as part of the proceedings concerning commitment for
restoration of competency, the order could provide substantial
medical flexibility; in the administrative regime the majority
presupposes, the order can be more focused, as adjustments can
be accomplished on site and through the facility's independent
<span CLASS="page_no" data-cite="2012 bl 51594 p 64" data-cite-type="Bloomberg" data-cite-pageno="64" data-primary-citation="">[**64]</span> hearing officers). The policy approved in <i>Harper</i>
operated in just this way, providing regular review by the
administrative hearing committee as to both the type and dosage
of the drugs to be administered. <i>See Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 216</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">232-33</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Because Dr. Tomelleri did not tailor his analysis to the
temporary, nonconviction, pretrial context, and did not provide
specific directions to Loughner's treating physicians regarding
the types of drugs, the maximum dosages to be administered, or
the estimated duration of involuntary medication, I would hold
that FMC-Springfield did not properly determine whether
involuntary medication was medically appropriate, even for the
period of Loughner's prior commitment.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>B. Procedural Due Process</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                           i. Periodic Review
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Both the predecessor to the currently operative regulation and
the state policy at issue in <i>Harper</i> contained
provisions requiring periodic administrative review of an
inmate's involuntary medication. <i>See</i>
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/1?citation=57%20federal%20register%2053820&amp;summary=yes#jcite">57 Fed.Reg. 53820-01</a>, <cite>1992 WL 329581</cite> (Nov. 12, 1992); <i>Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 216</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">232-33</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. The present regulation,
28 C.F.R. &sect; 549.46, does not include such a periodic review
requirement. The majority, concluding that periodic review is
not constitutionally required, holds that its absence does not
render 28 C.F.R. &sect; 549.46 constitutionally infirm. Majority
Op. at 753-54.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I disagree. <i>Harper</i> concluded that a judicial hearing
might "not be as effective, <i>as continuous</i>, or as
probing as administrative review using [the prison's] medical
decisionmakers," in part because the state policy at issue
required the administrative hearing committee to "review[] on a
regular basis the staffs choice of both the type and dosage of
drug to be administered." <i>See id.</i> at 232-33,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a> (emphasis added). Such continuity is especially important
because involuntary medication is, as the majority notes, "a
fluid process" that "must be adjusted depending on how the
patient reacts and why[sic], if any, side effects are
experienced." Majority Op. at 767. Under such circumstances,
periodic review is necessary to ensure the continued
accountability of the inmate's treating physicians.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The majority maintains that the short-term context of a
pretrial detainee's confinement alleviates the need for
periodic review. Majority Op. at 753. Not so, or at least, not
necessarily. Pretrial confinement, although inherently
temporary, is not inherently brief. In
<i>Rivera-Guerrero</i>, for example, we observed that the
defendant had been committed at FMC-Springfield for nearly two
years and had been involuntarily treated with antipsychotic
medication for approximately one year. <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X13CQTI003?jcsearch=426%20f%203d%201130&amp;summary=yes#jcite">426 F.3d at 1143</a>. In
<i>United States v. Weston</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEK857?jcsearch=326%20f%20supp%202d%2064&amp;summary=yes#jcite">326 F.Supp.2d 64</a>
(D.D.C. 2004), the district court authorized an additional
six-month commitment, even though defendant had already been
committed for roughly five years and had been treated with
involuntary medication for two and one half years. <i>See</i>
<i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEK857?jcsearch=326%20F.%20Supp.%202d%2064&amp;summary=yes#jcite">id. at 67</a>. I cannot reconcile the concept of due process
with
<span CLASS="page_no" data-cite="672 f 3d 796" data-cite-type="PrimaryFederalReporter" data-cite-pageno="796" data-primary-citation="672 F.3d 731">[*796]</span> 
the conclusion that a pretrial detainee may be
involuntarily treated with psychotropic medication for several
years on the basis of a single administrative hearing.<a HREF="#fn1501" name="fnref_fn1501">[fn15]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In this case, I am concerned that Loughner's deterioration
after the discontinuation <span CLASS="page_no" data-cite="2012 bl 51594 p 65" data-cite-type="Bloomberg" data-cite-pageno="65" data-primary-citation="">[**65]</span> of medication in July will be used to
justify involuntary medication for years on end. I find this
possibility deeply troubling both because the absence of
periodic review deprives Loughner of the opportunity to
demonstrate that he no longer needs medication, or as much
medication, and because the true causes of Loughner's
psychological deterioration remain murky. The particular
symptoms provoking particular concern for Loughner's own safety
were not observed before his medication was suddenly withdrawn.
On the record made available to us, it is impossible to
ascertain whether the rapid deterioration Loughner experienced
in July was caused by the emergence of his underlying mental
illness, by the jarring manner in which his medication was
discontinued, or, perhaps, by the imposition of the rigors of a
suicide watch. Periodic administrative review could perhaps
(although not necessarily) mitigate some of these causation
concerns by providing for routine reevaluation of the need for
involuntary psychotropic medication, as well as the type and
amount of medication prescribed.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                          ii. Right to Counsel
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On my preferred approach, the involuntary medication
determination in this case would have been made in court, and
Loughner's ordinary right to full representation by counsel
would pertain. But even for mid-commitment dangerousness
determinations made pretrial, I disagree with the majority's
conclusion that Loughner is not entitled to the assistance of
counsel, to a limited extent, in connection with the
administrative involuntary medication hearing. Majority Op.
at 756.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As the majority points out, <i>Harper</i> held (in the
post-conviction context) that lawyers are not necessary
participants is an administrative involuntary medication
determination, because their legal expertise bears no relation
to the relevant medical judgment. <i>See Harper</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=494%20us%20210&amp;summary=yes#jcite">494 U.S. at 236</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X5CBS7?jcsearch=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>. In the pretrial context, however, there
is, as pointed out earlier, heightened potential for
<i>legal</i> confusion among the detention facility's
physicians as to both their statutory responsibilities and the
proper purpose of an administrative involuntary medication
order. Here, for example, Loughner's treating psychologist
initially viewed competency restoration as the primary purpose
of Loughner's involuntary medication, and the involuntary
medication decisions seem focused on long-term cure rather than
short-term safety. <i>See <cite>supra</cite></i> Section II(C)(i).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Staff representatives are insufficient protection against such
confusion. They lack the requisite legal expertise and, as
here, often do not assert themselves in the medication hearing.
<i>See Morgan</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3OCSV?jcsearch=193%20f%203d%20252&amp;summary=yes#jcite">193 F.3d at 266</a>; <i>United States v.</i>
<i>Humphreys</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X287DJ?jcsearch=148%20f%20supp%202d%20949&amp;summary=yes#jcite">148 F.Supp.2d 949</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X287DJ?jcsearch=148%20f%20supp%202d%20949&amp;summary=yes#jcite">953</a> (D.S.D. 2001); <i>United</i>
<i>States v. Weston</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3M9V3?jcsearch=55%20f%20supp%202d%2023&amp;summary=yes#jcite">55 F.Supp.2d 23</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3M9V3?jcsearch=55%20f%20supp%202d%2023&amp;summary=yes#jcite">26-27</a> (D.D.C. 1999).
Moreover, and critically, lawyers for pretrial detainees are in
the process of preparing and implementing an overall defense
strategy. As that strategy will often be influenced by the
events during, and results of, a medication hearing,
<span CLASS="page_no" data-cite="672 f 3d 797" data-cite-type="PrimaryFederalReporter" data-cite-pageno="797" data-primary-citation="672 F.3d 731">[*797]</span> 
excluding lawyers from any involvement in that hearing
constitutes an impediment to the right <span CLASS="page_no" data-cite="2012 bl 51594 p 66" data-cite-type="Bloomberg" data-cite-pageno="66" data-primary-citation="">[**66]</span> to counsel with regard
to the impending prosecution. A misstep at the administrative
medication hearing could well impact the ultimate likelihood of
conviction in a manner that could be foreseen by the
defendant's lawyer but not by the defendant &mdash; a lay
person who is, by definition, incompetent &mdash; or the lay
staff representative. Thus, pretrial detainees have a
significantly greater interest in the right to counsel than
convicted prisoners.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Conversely, the government's interest in excluding counsel from
the administrative hearing is weaker with regard to a pretrial
detainee than with respect to a convicted prisoner. In the
pretrial context, there is no punitive or rehabilitative
interest in isolating the inmate from society generally. That
is why, in the pretrial context, "part of the process due to a
person if his liberty is taken is the opportunity to
communicate with someone outside the institution where he is
held, at a time and in a manner consistent with practical
management of booking and confinement procedures and
institutional security and order." <i>Halvorsen</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X4VHB2?jcsearch=146%20f%203d%20680&amp;summary=yes#jcite">146 F.3d at 689</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Given the different balance of interests in the context of
pretrial confinement for restoration, I would hold that a
pretrial detainee has a limited right to the participation of
counsel in connection with the administrative involuntary
medication hearing. Briefly sketching the contours of this
right, I would hold that the prison must: (1) notify the
pretrial detainee's counsel of its intention to conduct an
involuntary medication hearing, as well as the types, maximum
dosages, and expected duration of the proposed involuntary
medication; (2) provide the detainee's counsel an opportunity
to confer with the staff representative prior to the
involuntary medication hearing; and (3) allow the detainee's
counsel to observe the involuntary medication hearing or, if
there is a good reason to exclude the attorney from the
proceedings, provide an audiovisual recording of the hearing.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Providing the detainee's counsel with notice of the involuntary
medication hearing and an opportunity to confer with the staff
representative would allow counsel to apprise the staff
representative of relevant legal issues, including: the
importance of identifying a valid purpose for an administrative
medication decision and of establishing the requisite
specificity in the medical record; proper consideration of
available alternatives; and the detainee's various procedural
rights in connection with the administrative hearing.
Recognizing these benefits, courts have often ordered detention
facilities to inform counsel of any proposed involuntary
medication hearings and to provide an opportunity for counsel
to engage in pre-hearing conference with the detainee's staff
representative. <i>See Humphreys</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X287DJ?jcsearch=148%20f%20supp%202d%20949&amp;summary=yes#jcite">148 F.Supp.2d at 953</a>;
<i>Weston</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3M9V3?jcsearch=55%20f%20supp%202d%2023&amp;summary=yes#jcite">55 F.Supp.2d at 26</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Furthermore, just as a public trial "remind[s] the prosecutor
and judge of their responsibility to the accused and the
importance of their functions," <i>United States v.</i>
<i>Waters</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1EM1FC003?jcsearch=627%20f%203d%20345&amp;summary=yes#jcite">627 F.3d 345</a>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1EM1FC003?jcsearch=627%20f%203d%20345&amp;summary=yes#jcite">360</a> (9th Cir. 2010), allowing counsel
to witness the administrative <span CLASS="page_no" data-cite="2012 bl 51594 p 67" data-cite-type="Bloomberg" data-cite-pageno="67" data-primary-citation="">[**67]</span> hearing would remind the
hearing's participants of the important <i>legal</i> rights
affected by an involuntary medication determination. And
counsel's observation of the administrative hearing would
expedite judicial review of any resulting involuntary
medication order, because counsel would not need to resort to
discovery to familiarize itself with the administrative
proceedings. These benefits more than justify the limited right
to counsel sketched above.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As to whether the lawyer must be permitted to participate in
the hearing, I
<span CLASS="page_no" data-cite="672 f 3d 798" data-cite-type="PrimaryFederalReporter" data-cite-pageno="798" data-primary-citation="672 F.3d 731">[*798]</span> 
would leave that question to be decided on a case-by-case
basis. With notice, the attorney will have the opportunity to
seek full representation rights from the court on a showing
that, in the particular circumstances, there is a need for
direct representation so as to preserve the defendant's rights
as to ultimate conviction.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
            iii. Adequacy of Loughner's Staff Representative
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Quite aside from the exclusion of counsel, the staff
representation in this case was a charade, and violated even
the majority's lax due process standards.<a HREF="#fn1601" name="fnref_fn1601">[fn16]</a> Throughout the
successive administrative involuntary medication hearings,
Loughner's staff representative consistently failed to seek out
or present any witnesses, cross-examine or challenge the
prison's witnesses, or advocate in any other meaningful way
against forced medication. What he did was sit in the room and,
after the hearing concluded, see that Loughner's appeal form
was filed. No more. Such anemic "representation" falls well
below the standard demanded by due process and
28 C.F.R. &sect; 549.46(a)(3). <i>See Morgan</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3OCSV?jcsearch=193%20f%203d%20252&amp;summary=yes#jcite">193 F.3d at 266</a>;
<i>Humphreys</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X287DJ?jcsearch=148%20f%20supp%202d%20949&amp;summary=yes#jcite">148 F.Supp.2d at 953</a>; <i>Weston</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3M9V3?jcsearch=55%20f%20supp%202d%2023&amp;summary=yes#jcite">55 F.Supp.2d at 26-27</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Judge Bybee (but not Judge Wallace) recognizes the troubling
deficiencies in the representation afforded by Loughner's staff
representative. But he regards them as effectively harmless
because, he insists, the district court's September 28
commitment hearing provided Loughner sufficient opportunity to
challenge the prison's involuntary medication decision.
Majority Op. at 764-65.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Not so, as review of the district court's orders and statements
surrounding the September 28 hearing demonstrates. The district
court reiterated, in its September 30 order, the position it
had taken consistently theretofore &mdash; that its only role
with respect to the institution's medication for dangerousness
decisions was to review for adequacy of procedures, not to
entertain evidence or arguments substantively challenging the
determination. The evidentiary aspect of the September 28
hearing was therefore restricted to the specific question
whether Loughner's prior treatment &mdash; that is, involuntary
medication &mdash; would, if continued, likely result in his
timely restoration to competency, not whether that treatment
was needed to mitigate Loughner's dangerousness to himself or
medically appropriate for that purpose.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Judge Bybee's suggestion to the contrary has no basis in the
sequence of events leading up to the September 28 hearing or in
the record of that hearing. First, in its July 1 order
reviewing the prison's <i>Harper I</i> determination, <span CLASS="page_no" data-cite="2012 bl 51594 p 68" data-cite-type="Bloomberg" data-cite-pageno="68" data-primary-citation="">[**68]</span> the
district court held that Loughner was not entitled to an
evidentiary hearing to contest the administrative determination
of dangerousness. Instead, the court adopted the holding of
<i>Morgan</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3OCSV?jcsearch=193%20f%203d%20252&amp;summary=yes#jcite">193 F.3d at 262-63</a>, and reviewed the prison's
<i>Harper I</i> determination for arbitrariness and
compliance with 28 C.F.R. &sect; 549.46. The district court then
consistently reaffirmed this holding, stating in its August 30
order that "[t]he defense's motion for a post-deprivation
[judicial] hearing is denied."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Consistent with the district court's settled view of its
extremely limited role as to the involuntary medication
decision, its September 1 order scheduling Loughner's
<cite>&sect; 4241(d)(2)(A)</cite> commitment hearing gave no indication that the
court intended to reverse its prior practice and hold an
evidentiary
<span CLASS="page_no" data-cite="672 f 3d 799" data-cite-type="PrimaryFederalReporter" data-cite-pageno="799" data-primary-citation="672 F.3d 731">[*799]</span> 
hearing on the involuntary medication issue. Instead, the
court stated quite clearly that "the scope of the [commitment]
hearing will be limited to the question of whether an
additional period of time should be granted to actually restore
the defendant to competency." Although the court also suggested
that the parties should be prepared to state their positions
regarding the necessity of scheduling a <i>Sell</i>
involuntary medication hearing at some later point, the court
never suggested allowing an evidentiary hearing on the prison's
involuntary medication for dangerousness determination as
part of its commitment hearing.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  During the pre-hearing telephonic conference, the district
court further explicated its concern that a <i>Sell</i>
hearing may be required where a court orders a pretrial
detainee recommitted for restoration through the involuntary
administration of psychotropic medication. "I think it is a
game changer and a significant event that I &mdash; if I do
extend him, the purpose for the extension is for restoration,"
the court stated, "Knowing that he is being involuntarily
medicated, I think it is incumbent upon the court at that point
to conduct a <i>Sell</i> hearing." The court, however,
reiterated its decision to focus on the commitment decision and
leave the involuntary medication issue for another day,
stating: "As I forecast, I think[the necessity of a
<i>Sell</i> hearing is] an issue that is timely now and that
we have to get to. But the immediate issue is whether there is
enough evidence to support an extension on the substantial
probability that [Loughner] can be restored. How they restore
him and what due process rights he has during that period is a
secondary issue. It's one I intend to get to ultimately. But
the immediate issue is just this question of whether an
extension is warranted."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  At the September 28 hearing, the district court repeatedly
declared its intention to restrict the evidentiary hearing to
the commitment issue. Doctor Pietz provided detailed testimony
concerning Loughner's condition and his prospects for
restoration. When defense counsel attempted to cross-examine
Dr. Pietz regarding Dr. Sarrazin's diagnosis and its relation
to the prescribed antibiotics, however, the government objected
on relevance grounds and the court sustained the <span CLASS="page_no" data-cite="2012 bl 51594 p 69" data-cite-type="Bloomberg" data-cite-pageno="69" data-primary-citation="">[**69]</span> objection,
reminding the defense that "the limited focus here is whether
an extension is likely &mdash; substantially probable to
restore [Loughner]." The court further stated: "I'm well
familiar with all of the background reports. I've read them
myself. You'll have the opportunity, obviously, at some point
when that's relevant to go over those. But the questions should
focus on going forward."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Doctor Ballenger provided generalized testimony about the
likelihood and duration of psychiatric restoration through
involuntary medication, gave an opinion as to Loughner's
prospects for restoration based on his medical history and
medication regimen, and passed on the propriety of Loughner's
current medication. But when defense counsel attempted to
cross-examine Dr. Ballenger regarding the <i>medical</i>
<i>appropriateness</i> of Loughner's involuntary medication
regimen, the court chided the digression. "[T]he
appropriateness of the treatment is a matter for a
<i>Sell</i> hearing or some later hearing," the court said,
"It's not the subject of this hearing." Defense counsel
responded that "[t]he restoration depends upon the treatment
that's going to be given." The court, however, persisted in its
refusal to expand the scope of the evidentiary hearing, stating
that "[t]he question here is whether he's likely to be restored
with an extended commitment to Springfield. I'd like both sides
to keep focused on that. . . . I want to focus on the issue of
the day, which is whether he's to be extended and whether the
standard of proof is met by the evidence."
<span CLASS="page_no" data-cite="672 f 3d 800" data-cite-type="PrimaryFederalReporter" data-cite-pageno="800" data-primary-citation="672 F.3d 731">[*800]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Then, in response to defense counsel's request for a ruling on
its motion to stay Loughner's involuntary medication, the court
responded that its "view continues to be . . . that because
[the involuntary medication order is] predicated on the ground
of dangerousness and really has nothing to do with[Loughner's]
competency to stand trial, that that's an issue with the Bureau
of Prisons and the physicians there, and for good reason."
Following the approach adopted in its July 1 order, the court
applied <i>Morgan's</i> arbitrariness standard and concluded
that "there's no arbitrariness in the third <i>Harper</i>
hearing and that the medication going forward, at least of
today, is authorized pursuant to the <i>Harper</i> case." The
Court reaffirmed this holding in its written order, which
appropriately characterized its review of the administrative
<i>Harper III</i> determination as "minimal."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In short, the district court's pre-hearing orders, the
statements it made during the September 28 hearing itself, and
its written post-hearing order, all demonstrate, without doubt,
that the evidentiary aspect of the hearing was restricted to a
specific question &mdash; whether Loughner's current treatment
will likely result in his timely restoration, <i>assuming</i>
the continuation of involuntary medication. No evidentiary
challenge to that treatment was permitted. Instead, following
the approach outlined in its July 1 Order, the court conducted
a "minimal review" of the prison's <i>Harper III</i>
determination and concluded that the decision was not
arbitrary. Nowhere did the court <span CLASS="page_no" data-cite="2012 bl 51594 p 70" data-cite-type="Bloomberg" data-cite-pageno="70" data-primary-citation="">[**70]</span> contemplate or suggest a
reversal of its previous holdings that Loughner is not entitled
to an evidentiary hearing on the issue of his involuntary
medication for dangerousness. Indeed, when defense counsel
argued that the district court had simply deferred to the
Bureau of Prisons on the <i>Harper</i> determination, the
district court responded: "What I've said is that there is
another basis for him being medicated that has nothing to do
with me. It has to do with dangerousness."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In light of the district court's strict limitations on the
scope of its evidentiary hearing and the extraordinary
deference it accorded the prison's involuntary medication
decisions, the majority's conclusion that the September 28
hearing provided Loughner an adequate opportunity to challenge
his involuntary medication rests on air, nothing more.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                             <b>IV. Conclusion</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For the foregoing reasons, I would reverse the district court's
order approving Loughner's commitment for restoration of
competency. And although on my view there would be no reason
independently to consider the propriety of the September 15
involuntary medication for dangerousness decision at this
juncture, were I to do so I would conclude that it was invalid
for failure to provide Loughner with the due process and right
to counsel protections appropriate to the circumstances. I
therefore respectfully dissent.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn101" name="fn101">[fn1]</a></span> Doctor Pietz noted that "medication is the only option
for restoring Mr. Loughner to competency" and recommended that
Loughner "should be returned to [FMC-Springfield], pursuant to
Title 18, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)&amp;summary=yes#jcite">Section 4241d</a> for restoration to competency."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn201" name="fn201">[fn2]</a></span> Before the hearing began, Getchell asked Loughner if he
desired any witnesses present for the hearing. Loughner
responded, "Just my attorney." Getchell interpreted this
statement as a request for legal representation at the hearing,
and so informed the doctors conducting the administrative
hearing. Loughner's attorneys were not contacted.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn301" name="fn301">[fn3]</a></span> If Loughner refused the oral solution, he would instead
be treated twice daily with 5 mg intramuscular injections of
Haloperidol Lactate and 1 mg intramuscular injections of
Benztropine.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn401" name="fn401">[fn4]</a></span> Getchell's appeal form failed to specify any grounds for
reversal. The procedural defect in the <i>Harper II</i>
proceeding may have been brought to the warden's attention
through complaints raised earlier in the district court by
Loughner's attorneys.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn501" name="fn501">[fn5]</a></span> The majority styles the district court's decision to
commit Loughner pursuant to <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)(A)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2)(A) as an
"extension" of his previous commitment under <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(1)&amp;summary=yes#jcite">&sect; 4241(d)(1)</a>.
That is not precisely so. <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(1)&amp;summary=yes#jcite">Section 4241(d)(1)</a> authorizes the
district court to "commit the defendant" for the purpose of
evaluating "whether there is a substantial probability that in
the foreseeable future he will attain the capacity to permit
the proceedings to go forward." <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(1)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(1).
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)(A)&amp;summary=yes#jcite">Section 4241(d)(2)</a>(A) authorizes the court to commit the
defendant "for an additional reasonable period of time until
his mental condition is so improved that trial may proceed, if
the court finds that there is a substantial probability that
within such additional period of time he will attain the
capacity to permit the proceedings to go forward."
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)(A)&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>(d)(2)(A). So, the purposes of the two periods of
commitment are different, and the judicial findings required to
trigger them are concomitantly different.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn601" name="fn601">[fn6]</a></span> <i>Sell</i> concerned the involuntary medication of a
pretrial detainee on trial competency grounds. <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20us%20166&amp;summary=yes#jcite">539 U.S. 166</a>,
<cite>123 S.Ct. 2174</cite>. After finding Sell incompetent to stand trial
for various criminal charges, a magistrate judge ordered him
committed to FMC-Springfield for the purpose of evaluating
whether he would attain the capacity to allow his trial to
proceed. <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20166&amp;summary=yes#jcite">Id. at 171</a>, <cite>123 S.Ct. 2174</cite>. FMC-Springfield's
medical staff administratively authorized Sell's involuntary
medication on both trial competency and dangerousness grounds.
<i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20166&amp;summary=yes#jcite">Id. at 171-72</a>, <cite>123 S.Ct. 2174</cite>. When Sell filed a
motion challenging his involuntary medication, the magistrate
who had committed Sell held an evidentiary hearing and also
issued an order authorizing Sell's involuntary medication on
both trial competency and dangerousness grounds. <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20166&amp;summary=yes#jcite">Id.
at 172-73</a>, <cite>123 S.Ct. 2174</cite>. On review of the magistrate's
decision, the district court held that the magistrate's
dangerousness finding was clearly erroneous, but further held
that involuntary medication was justified on trial competency
grounds. <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20166&amp;summary=yes#jcite">Id. at 173-74</a>, <cite>123 S.Ct. 2174</cite>. The Eighth
Circuit affirmed. <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20166&amp;summary=yes#jcite">Id. at 174</a>, <cite>123 S.Ct. 2174</cite>. The
Supreme Court assumed that Sell was not dangerous, because the
government did not contest the dangerousness issue.
<i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20166&amp;summary=yes#jcite">Id. at 184</a>, <cite>123 S.Ct. 2174</cite>. Focusing on the trial
competence justification, the Court developed a four-pronged
standard for determining whether involuntary medication is
justified on trial competency grounds. <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20166&amp;summary=yes#jcite">Id. at 180-82</a>,
<cite>123 S.Ct. 2174</cite>. It further held, however, that courts should
determine whether involuntary medication can be justified on
"alternative, <i>Harper-type</i> grounds," such as
dangerousness, before attempting to determine whether
involuntary medication is necessary to restore a detainee's
trial competency. <i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XRO4M8II8BG0?jcsearch=539%20U.S.%20166&amp;summary=yes#jcite">Id. at 182-83</a>, <cite>123 S.Ct. 2174</cite>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn701" name="fn701">[fn7]</a></span> The majority notes that our decision in <i>United States</i>
<i>v. Ruiz-Gaxiola</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1E7A46003?jcsearch=623%20f%203d%20684&amp;summary=yes#jcite">623 F.3d 684</a> (9th Cir. 2010), references
the district court's decision "order[ing] the government to
conduct an administrative hearing pursuant to <i>Harper</i>,
in order to evaluate whether involuntarily medicating Ruiz was
justified on the alternative basis that his mental illness
rendered him gravely disabled or dangerous to himself or
others." Majority Op. at 750 (citing <i>Ruiz-Gaxiola</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1E7A46003?jcsearch=623%20f%203d%20684&amp;summary=yes#jcite">623 F.3d at 689</a>). The quoted language, however, comes from the
court's factual recitation, and therefore does not even
constitute dicta.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn801" name="fn801">[fn8]</a></span> An inmate may, for example, prove significantly more
dangerous in prison than he would in a properly equipped mental
ward. In <i>United States v. Weston</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3F9L5?jcsearch=206%20f%203d%209&amp;summary=yes#jcite">206 F.3d 9</a>
(D.C. Cir. 2000) (per curiam), for example, the D.C. Circuit
overruled the district court's finding of dangerousness, on the
basis of expert testimony that the facilities at FMC-Butner
were sufficient to prevent the detainee from harming himself or
others. <i>Id.</i> at 13. Conversely, a detainee might
present a greater danger in the hospitalization context than in
pretrial detention, because the therapeutic needs of a facility
committed to the inmate's restoration may dictate a lower
degree of isolation than he would receive in the penal
context.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn901" name="fn901">[fn9]</a></span> Nor is this a one-time problem. The district court's
opinion in <i>Sell</i>, which expressed concern that the
government's "claim of dangerousness may . . . be a post hoc
justification," noted that Sell's Notice of Medication Hearing
and Advisement of Rights form stated "that the reason for
[Sell's] treatment [with antipsychotic medication] was to
`Restore competency to stand trial.'" <i>United States v.</i>
<i>Sell</i>, No. 4:97-cr-290, <cite>2001 WL 35838455</cite>, at *5
(E.D.Mo. April 4, 2001).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1001" name="fn1001">[fn10]</a></span> The fair trial concerns associated with
government-ordered, pharmacologically-induced sanity may be
mitigated by the availability of other evidence pertaining to
the insanity defense. <i>See Weston</i>, <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X3F983?jcsearch=206%20f%203d%209&amp;summary=yes#jcite">206 F.3d at 22</a>
(Tatel, J., concurring) (suggesting that, on remand, the
district court should determine whether the combination of
psychiatric testimony and video recordings of the defendant in
his delusional state would enable defense counsel to mount an
effective insanity defense).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1101" name="fn1101">[fn11]</a></span> Insisting that <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)(A)&amp;summary=yes#jcite">&sect; 4241(d)(2)(A)</a> obligates the courts
to determine only whether the defendant will become competent
to stand trial, the majority holds that the district court was
not required to determine prospectively whether the
pharmacological means used to effect Loughner's restoration
will infringe his right to a fair trial. Majority Op.
at 768-69. But nothing in <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20U.S.C.%20%204241(d)(2)(A)&amp;summary=yes#jcite">&sect; 4241(d)(2)(A)</a> supports such a
restrictive reading. Congress could have used the word
"competency" if it so desired, but instead it chose a more
inclusive, functionally-focused phrase &mdash; "the capacity to
permit the proceedings to go forward" &mdash; which, in plain
terms, encompasses any psychological condition that might
prevent a trial from ensuing.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1201" name="fn1201">[fn12]</a></span> Of course, on my analysis, the present record would not
be the pertinent one with respect to the commitment
determination. Instead, the district court would hold a hearing
at which both sides would present witnesses addressing the
availability of approaches other than medication to alleviate
dangerousness.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1301" name="fn1301">[fn13]</a></span> I do not mean to suggest that an involuntary medication
order must disregard any consideration of a pretrial detainee's
long-term reaction to psychotropic medication. Indeed, we have
held that involuntary psychotropic medication may only be
considered medically appropriate where the "likelihood and
value of the long-term benefits outweigh the likelihood and
severity of the long-term harms." <i>Ruiz-Gaxiola</i>,
<a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1E7A46003?jcsearch=623%20f%203d%20684&amp;summary=yes#jcite">623 F.3d at 706</a>. The medical appropriateness inquiry, however, is
only triggered <i>after</i> medication is justified for some
legitimate governmental purpose (e.g., restoration to trial
competency, dangerousness to self or others, etc.). <i>See</i>
<i></i><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1E7A46003?jcsearch=623%20F.3d%20at%20706&amp;summary=yes#jcite">id. at 703</a>. Unlike the medical appropriateness inquiry,
the determination of whether or not medication is justified
must be focused on the specific context of confinement &mdash;
and it is at this stage of the analysis that the short-term
nature of a pretrial detainee's confinement becomes salient.
Doctor Tomelleri failed to acknowledge this vital
distinction.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1401" name="fn1401">[fn14]</a></span> The majority, of course, holds that no judicial hearing
was necessary. All the more reason to require that the
involuntary medication order include a fairly specific
treatment plan, as a treating physician could, with minimal
effort, seek modification of an administrative involuntary
medication order issued by a member of the same prison medical
staff.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1501" name="fn1501">[fn15]</a></span> Under my preferred approach, on the other hand, the
district court would be required to review the justification
for involuntary medication at each commitment hearing. Because
pretrial detainees may only be committed for a "reasonable
period of time," to be ascertained in advance by the district
court, <i>see</i> <a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/XEHU22003?jcsearch=18%20usc%204241&amp;summary=yes#jcite">18 U.S.C. &sect; 4241</a>, the provision of
regularly recurring commitment proceedings would satisfy the
need for periodic review.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1601" name="fn1601">[fn16]</a></span> Of course, under my approach, the district court would
have determined the propriety of involuntary medication at the
commitment hearing and Loughner would have been entitled to
representation by counsel.
</p></div>
<!--BBLS DD 1691585413123-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1H7D5I003/history">Direct History (5)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1H7D5I003/analysis">Case Analysis (5)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1H7D5I003/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
4
</span>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/distinguished.png'>
<div class='citation distinguished icon printHide' title='Distinguished'></div>
<a class='citationAnalysisLabel' href='/bcite/X1H7D5I003/analysis?analysis=distinguished'>
Distinguished
</a>
<span class='citationNumberLabel'>
1
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Judgment Affirmed, Appeal Dismissed</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1Q6LNBUATO2">11-10339 (9th Cir.)</a></div><div class='facetItemLabel'><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1Q6M0ODFTO2">11-10432 (9th Cir.)</a></div><div class='facetItemLabel'><a href="/s/opinion/172c55d351f5030f8037b1b2000320c9/document/X1Q6M1G7LN82">11-10504 (9th Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Constitutional Law</div><div class='facetItemLabel'>Criminal Law</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/172c55d351f5030f8037b1b2000320c9/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "172c55d351f5030f8037b1b2000320c9";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY5ba62d&previousPageId=&previousActivityInstanceId=ENTITY07d5c2&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:38:02-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1H7D5I003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY07d5c2&previousPageId=&previousActivityInstanceId=ENTITY5640bc&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:37:55-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1H7D5I003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1H7D5I003";
$('#page_loader').show().spin();
JUDGE_IDS=["2397859","3661169","4212867"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
